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SUMMARY 
To live in the 21^' Century means to live in a toxic world, where we are exposed 
daily to numerous environmental toxins and pollutants. Environmental toxins are on 
the increase and pose a problem in the form of serious health risks, as thousand of 
toxic substances find their way into our air, water and soil in which we grow our 
food. 
We spend our days inhaling pollutants such as car fumes and cigarette smoke. We 
drink water that has been thoroughly treated with chemicals, and eat food that is 
gTOvra m toxic soil and packaged vddwpreservatives. 
While our livers, kidneys, skin and lymphatic systems work round the clock to 
eliminate these dangerous toxins from our body, they very often just cannot keep 
up, and the result is a build up poisons in the system which destroy body tissues, 
damage organs, depress the immune system and leave the door open to a number of 
serious illnesses. Industrial solvents, in general, are extensively used in industry as 
well as in daily life. They are used for degreasing, dry cleaning, extractions of fats 
and oils and can be found in a wide range of products including paints, thinners, 
glues, inks, pesticides and cosmetics (ATSDR, 1997; Khan et al., 2009). In 
addition, organic solvents have been detected in a variety of urban and rural areas of 
U.S and other regions of the world and have been found in food chains, soil and 
drinking water (Veeramachaneni et al., 2001; Lock and Reed, 2006). Thus these 
solvents are major occupational hazards and potential concern to general 
population. Since these solvents are lipophilic in nature, they are readily absorbed 
and widely distributed throughout the body and especially concentrated/ 
accumulated in the kidney. Studies in experimental animals, case reports, case 
studies, and epidemiological studies have documented the acute and chronic effects 
of various industrial solvents on human health (Brautbar, 2004). Industrial solvents 
including aliphatic/ aromatic/ chlorinated hydrocarbons are known to alter the 
structure and functions of various organs such as the intestine, liver, kidney and 
brain. Animals studies have shown that a number of xenobiotics require enzymatic 
transformation to reactive metabolites to elicit their toxic effects (Renner et al., 
1994; Seaton et al., 1995; Medinsky et al., 1995; Snyder and Hedli, 1996; Lash et 
al., 2000a; DuTeaux et al., 2003). The bioactivation may take place in the kidney or 
in extrarenal tissues, or extrarenally formed metabolites may further metabolize to 
toxic products in the kidney (Voss et al., 2003). In general xenobitics including 
solvents are metabolized by two major pathways; (a) by involving mixed function 
monooxygenases of the cytochrome P450 pathway, (b) by conjugation reaction with 
endogeneous substrates; glucouronic acid, sulphates, amino acids or mainly 
glutathione (Koss et al., 1979; Lash et al., 2000a, b; 2006). The enzymes involved 
in biotransformation vary vdth structure of compoimd in question. Although the 
metabolic processes commonly facilitate excretion and reduce toxicity of non-polar, 
lipophilic compounds, in some cases the metabolites are highly reactive and more 
toxic than the parent compound. 
The present thesis mainly focused on two classes of hydrocarbon solvents. 
1. Chlorinated hydrocarbons e.g. trichloroethylene (TCE) and 
hexachlorobenzene (HCB). 
2. Non-chlorinated hydrocarbons e.g. benzene and toluene. 
Exposure to a number of solvents, in general, have been associated with 
nephrotoxicity, hepatotoxicity, neurotoxicity and other disorders of immime, 
endocrine, reproductive and cardiovascular systems. The solvents and metabolites 
are known to be concentrated in the kidney causing solvent induced disruption of 
the structural and fimctional integrity of the membrane of the kidney cells 
(Ravnskov, 2000; Brautbar, 2004). The proximal tubules of the kidney are 
especially affected resulting in renal dysfunctions (Ravnskov, 2000; Brautbar N, 
2004). The brush border membrane (BBM), mitochondria, microsomes and 
lysosomes were shown to be critical target of solvent induced toxicity. A nimiber of 
studies have demonstrated that solvent exposure is associated with increased risk in 
the development of chronic kidney diseases, glomerulonephritis and renal failure 
(Ravnskov U, 2000). The tubular damage is associated with high/ low molecular 
weight protein excretion and changes in glomerular basement membrane (Mutti, 
1996). Earlier studies identified membranous nephropathy as the most common 
histological type, whereas more recent studies point to IgA nephropathy (Coppo, 
1988; Emancipator, 1990). Acute and chronic renal failures are also listed as 
occupational and experimental hazards by solvent intoxication. 
The liver has been reported to be the next major target organ after kidney of 
hydrocarbons/ solvent toxicity (San Martin de Viale et al., 1977; Bull, 2000; 
Adeyemi et al., 2009). Histopathological studies have shown that TCE/ HCB/ 
benzene or toluene or their metabolites cause morphological alterations in the liver 
and kidney leading to their enlargement and necrosis (Lash et al., 2000; Ravnsko, 
2000; Rahman et al., 2000; Khan et al., 2001; DuTeaux et al 2003; Chaufan et al., 
2006; Lock and Reed, 2006). Although chlorinated and non-chlorinated 
hydrocarbon/ solvents induced nephrotoxicity, ototoxicity have been extensively 
studied, detailed histological/ biochemical effects of these solvents on kidney, 
intestine, liver and brain, in general, are not completely elucidated. Neither 
biochemical events/ nor mechanism of their toxic and other adverse alterations in 
various tissues are well understood. 
Although studying human biology/ pathophysiology is ideal, such studies are 
neither feasible nor ethical. Thus, a vast majority of current biomedical research is 
performed on laboratory animals such as rats. In view of the above, the present 
studies were performed using Wistar rats as a model for humans due to their close 
physiological proximity to that of humans. 
To imderstand the mechanism of industrial solvents induced nephrotoxicity and 
other adverse effects in major tissues such as intestine, liver and brain, the 
following parameters/ biomarkers of energy metabolism/ mitochondria/ lysosomes/ 
BBM and oxidative stress were determined. 
a) Serum parameters such as cholesterol, blood urea nitrogen (BUN), 
creatinine, inorganic phosphate, and phospholipids were estimated to 
determine the effect of industrial solvents (TCE, HCB, benzene and 
toluene) induced nephro- and hepatotoxicity. 
b) Various enzymes of carbohydrate metabolism e.g., LDH, MDH, G6Pase, 
FBPase, G6PDH and ME were determined as representatives enzymes of 
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glycolysis, TCA cycle gluconeogenesis and HMP-shunt pathway. 
respectively. 
c) Activities of ALP, GGT, LAP, and/ or sucrase were measured as these 
enzymes are biomarkers of BBM and were used to assess structural/ 
functional integrity renal and mucosal BBMs, which are major TCE/ HCB/ 
benzene and toluene targets. 
d) ACP was determined to assess lysosomal dysfunction, as lysosomes are also 
affected by these hydrocarbon solvents. 
e) LPO, SOD, catalase, were also evaluated as indicators of oxidative stress. 
f) Pi transport was evaluated as a functional marker of BBM, and for its 
involvement in nutrition/ energy metabolism. 
THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS 
Part-I 
(a) Effect of TCE on body weight and various serum parameters: 
The effect of TCE was determined on body weight and various serum parameters 
and on the enzymes of carbohydrate metabolism, brush border membrane (BBM) 
and oxidative stress in different rat tissues. TCE was given orally by gavage with 
the dose of lOOOmg/kg body weight for 25 days. TCE caused a small but significant 
decrease in the body weights. TCE exposure resulted in significant increase in 
serum creatinine and blood urea nitrogen (BUN) whereas serum glucose, inorganic 
phosphate Pi and phospholipids significantly decreased, serum cholesterol and the 
activity of serum alkaline phosphatase increased. 
^ . 
(b) Effect of TCE on enzymes of brush border membrane (BBM) and lysosome in 
different tissues: 
The effect of TCE was determined on BBM and lysosomal biomarker enzymes in 
the liver, intestine, brain and renal cortical and medullary homogenates and in the 
isolated BBM vesicles from renal cortex and intestinal mucosa to assess the 
integrity of these organelles by TCE exposure. TCE differentially altered the 
activities of various enzymes in the homogenates of different rat tissues. The 
activity of ALP markedly decreased in all tissues except in brain where the activity 
was only slightly declined. The activity of GOT significantly lowered in intestine, 
renal cortex, renal medulla and liver whereas not affected significantly in brain. In 
contrast, TCE exposure resulted in marked decrease of LAP in the liver and renal 
cortex, increase in the brain and intestine but did not change significantly in renal 
medulla. 
TCE also altered lysosomal enzyme, acid phosphatase (ACP) differentially in 
different tissues. The activity of ACP markedly increased in the intestine and liver 
whereas significantly decreased in the brain but not affected in the kidney. The 
activity of sucrase, a marker of intestinal BBM, however, significantly increased in 
the mucosal homogenate. 
Similar to homogenates, the activities of ALP and GGT decreased whereas those of 
LAP and sucrase significantly increased in intestinal BBM by TCE exposure. 
Accordingly TCE caused significant reduction of ALP, GGT and LAP activities in 
the BBM, isolated from renal cortex. 
(c) Effect of TCE on enzymes of carbohydrate metabolism: 
The effect of TCE was determined on the enzymes involved in various pathways of 
carbohydrate metabolism in different rat tissues to ascertain any effect on energy 
metabolism. TCE administration caused significant increase in hexokinase activity 
in the liver followed by mtestine whereas the activity declined in the brain, renal 
cortex and medulla. However, LDH activity, a marker of anaerobic glycolysis 
profoundly increased in the liver, intestine and brain whereas significantly lowered 
in renal cortex and medulla. In contrast, TCE significantly decreased the activity of 
MDH, a TCA cycle enzyme in the liver, intestine, brain and renal cortex but the 
activity markedly increased in renal medulla. 
The effect of TCE was also determined on the activities of enzymes involved in 
gluconeogenesis and hexose monophosphate (HMP) - shunt pathway. The activities 
of both G6Pase and FBPase declined in the liver, brain and renal cortex whereas 
increased in renal medulla. The maximum decrease and increase was observed in 
renal cortex and renal medulla, respectively. The activity of G6PDH was 
profoundly increased in the liver, intestme, brain and renal cortex whereas 
decreased in renal medulla. In contrast, TCE caused significant reduction in ME 
activity in the liver, brain, renal cortex but not significantly in intestine. However, 
ME activity markedly increased in renal medulla. 
(d) Effect of TCE on Na-gradient dependent transport of inorganic phosphate 
f^Pi) in brush border membrane isolated from renal cortex: 
The Pi is transported by secondary active transport mechanism that requires 
expenditure of energy in the form of ATP generated by cellular metabolism. The 
rate of concentrative uphill uptake of ^^ Pi in the presence of Na-gradient (NaCl in 
the medium) was markedly increased in TCE compared to control rats. However, 
the uptake of ^^ Pi at the equilibrium phase, at 120min when Na outside = Na inside was 
not significantly different between the two groups. Also Na-independent uptake (in 
the absence of a Na gradient, when NaCl in the medium was replaced by KCl where 
Koutside> Kinside) of Pi at 30s and 120min were also not affected by TCE treatment 
indicating specific alteration only when Na-gradient was present. The net uptake of 
^^ Pi was also significantly enhanced. 
(e) Effect of TCE on oxidant/ antioxidant parameters: 
To ascertain the role of antioxidant system in TCE induced toxicity, the effect of 
TCE was examined on certain parameters of oxidative stress. TCE administration 
caused significant decrease in SOD and catalase activities in almost all tissues. 
However the decrease in SOD and/ or catalase activity was appeared to be tissue 
specific. The decrease in antioxidant enzyme activities was associated with 
significant elevation in lipid peroxidation (LPO) measured in terms of 
malondialdehyde (MDA). 
Part-Il 
(a) Effect ofHCB on body weight and various serum parameters: 
Hexachlorobenzene (HCB), one of the most persistent environmental pollutants 
induces porphyria cutanea turda (PCT) and produces multiple adverse effects in 
human and experimental animals. The present investigation was undertaken to 
determine the effect of HCB on the enzymes of carbohydrate metabolism, brush 
border membrane and oxidative stress in various rat tissues including the kidney, 
liver, intestine and brain for better understanding of its mechanism of action. HCB 
was given orally by gavage with the dose of 15mg/ kg b.w/ d for 25 days. HCB 
treated rats had a small decline in the body weight as compared to control rats. HCB 
exposure resulted in significant increase in serum creatinine, BUN, serum 
cholesterol and phospholipids but inorganic phosphate was significantly decreased. 
(b) Effect of HCB on enzymes of brush border membrane and lysosome in the 
different tissues: 
To assess the integrity of certain membranes/organelles, the effect of HCB was 
determined on BBM and lysosomal marker enzymes in the liver, brain, intestinal, 
renal cortical and medullary homogenates and in the isolated BBM vesicles from 
renal cortex and intestinal mucosa. HCB affected the activities of various enzymes 
albeit differentially in all tissues including brain. The activity of ALP, GOT and 
LAP significantly decreased in cortex, medulla, liver and brain. However, the 
activities of these enzymes markedly enhanced in the mucosal homogenates by 
HCB exposure whereas the activity of sucrase, an intestinal BBM marker was 
significantly lowered. Similar activity pattern of BBM enzymes in BBM 
preparations isolated from renal cortex and intestinal mucosa, observed in the 
homogenates, however, the magnitude of HCB effect was more pronounced 
especially in the mucosal BBM. HCB caused profoimd increase in the activity of 
ALP, GGT and LAP but slightly lowered sucrase activity in intestinal BBM. 
n 
Similar to cortical homogenates, the activities of ALP, GOT and LAP decrease in 
the renal BBM, isolated from renal cortex. 
HCB also altered lysosomal enzymes activity, acid phosphatase (ACP) but 
differentially in different tissues. The activity of ACP decreased in the intestine, 
renal cortex and medulla and brain but increased in liver homogenates. 
(c) Effect of HCB on enzymes of carbohydrate metabolism: 
The activities of hexokinase and LDH (glycolysis), MDH (TCA cycle), G6Pase and 
FBPase (gluconeogenesis) were determined in the homogenates of various rat 
tissues. HCB treatment caused profound increase in LDH activity in the intestine 
and slight increase in brain whereas the activity markedly decreased in the liver, 
renal medulla and to some extent in renal cortex. The activity of hexokinase 
significantly increased in the cortex and liver but decreased in renal medulla, 
intestine and brain. In contrast, HCB caused marked increase in MDH activity in all 
tissues except in brain and intestine where the activity was decreased. 
The effect of hexachlorobenzene was also determined on the activities of enzymes 
involved in gluconeogenesis and hexose monophosphate (HMP) - shunt pathway. 
The enzymes of these pathways were differentially altered by hexachlorobenzene in 
different tissues. The activity of G6Pase and FBPase significantly lowered in all 
tissues albeit differentially. The activities of G6Pase and FBPase were maximally 
decreased in the liver (the major site of gluconeogenesis). However, they were also 
decreased in the renal tissues followed by the intestine and brain. The activity of 
G6PDH increased in all tissues but to much greater extent in the liver whereas ME 
decreased in all tissues except intestine and liver where they were significantly 
increased. 
(d) Effect of HCB on oxidant/antioxidant parameters: 
To ascertain, the role of antioxidant system in HCB induced tissue injury, the effect 
of HCB was examined on certain enzymatic and non-enzymatic parameters of 
oxidative stress. HCB administration caused significant increase in LPO, measured 
as malondialdehyde (MDA) in almost all tissues except medulla. It appears that 
^ . 
HCB exposure caused severe tissue injury as indicated by profound increase in LPO 
in the liver, intestine, brain and renal cortex. HCB cause marked decrease in the 
activities of SOD and catalase although to different extent in different tissues. 
However, the effect of HCB on these parameters was differentially observed in the 
medulla where HCB caused profound increase in SOD and catalase activities which 
was associated with marked decrease in LPO. 
Part-Ill 
(a) Effect of benzene and toluene on body weight and various serum parameters: 
In general, the rats remained active through out the study. There were no significant 
changes in body weights and food intake between any of the treated and control 
rats. 
Benzene and toluene exposure resulted in significant increase in serum creatinine 
and BUN indicating benzene and toluene induced nephrotoxicity. Serum cholesterol 
and phospholipids were significantly increased whereas inorganic phosphate 
significantly decreased by both benzene and toluene. 
(b) Effect of benzene and toluene on enzymes of brush border membrane and 
lysosome in different tissues: 
Benzene and toluene caused differential/ and variable alterations in BBM enzyme 
activities in the homogenates of different rat tissues. The activity of ALP, GGT and 
LAP decreased in homogenates of renal cortex and medulla, and brain. The 
activities of these enzymes lowered in liver but the magnitude of the effect was 
significantly lowered in toluene compared to benzene treated rats. The activities of 
ALP and GGT significantly decreased by benzene whereas increased by toluene 
exposure in intestine. In contrast, LAP activity decreased by both benzene and 
toluene. The activity of sucrase, a marker of intestinal BBM, however, was 
significantly decreased by both benzene and toluene in the mucosal homogenate. 
The activity of ACP markedly increased in the renal cortex and medulla whereas 
significantly decreased in the intestine, liver and brain by benzene administration. 
^ . 
In contrast, toluene administration significantly increased ACP activity in the 
intestine but decreased in the cortex, medulla and brain. Similar to respective 
homogenates, the activities of ALP, GGT and LAP significantly declined by 
benzene treatment in both renal and intestinal BBM preparation. However, the 
activities of these enzymes decreased in renal BBM by toluene whereas the activity 
of ALP and GGT were significantly increased but the activity of LAP and sucrase 
decreased in intestinal BBM by toluene. 
(c) Effect of benzene and toluene on enzymes of carbohydrate metabolism: 
The activity of hexokinase decreased in renal cortex, medulla and in the brain but 
increased in the intestine and liver by both benzene and toluene. However, LDH a 
marker of anaerobic glycolysis significantly enhanced in all tissues by benzene and 
toluene except in liver where the activity decreased by both of them. Benzene 
administration profoundly increased LDH activity in the intestine followed by 
brain, renal cortex and renal medulla. Similar to benzene, toluene administration 
markedly increased LDH activity in the intestine, renal medulla, renal cortex and 
brain. In contrast, benzene zind toluene significantly decreased MDH decreased 
activity in all tissues. Exposure of toluene significantly decreased MDH activity in 
renal medulla, intestine, liver but slightly in renal cortex and brain. 
The activity of G6Pase and FBPase declined in all tissues although differentially. 
The activity of G6PDH and ME were also differentially altered in all tissues by 
benzene and toluene exposure. The activity of G6PDH profoundly increased in the 
intestine, renal cortex, liver, renal medulla and brain by benzene and toluene 
administration. In contrast, both benzene and toluene caused significant reduction in 
the activity of ME in all tissues; renal cortex, renal medulla, intestine, liver and 
brain. The results indicate that solvent exposure resulted in decrease in 
gluconeogenesis and oxidative metabolism whereas the activity of LDH 
significantly enhanced. 
\ o . 
(d) Effect of benzene and toluene on oxidant/ antioxidant parameters: 
Benzene and toluene exposure resulted in profound increase in the production of 
malondialdehyde (MDA), an end product of lipid peroxidation (LPO), in the renal 
cortex and medulla, liver and to some extent in brain. The increase in LPO by 
benzene and toluene was much more pronounced in the liver followed by renal 
cortex and medulla. However, in the intestine benzene caused significant increase in 
LPO whereas toluene caused significant decrease in LPO. Further, benzene 
significantly enhanced LPO but toluene had no significant effect on LPO in the 
brain. The increase in LPO was associated with marked decrease in the activity of 
SOD and catalase by benzene/ toluene in most tissues except in the intestine where 
decrease in LPO by toluene was associated with significant increase in activities of 
SOD and catalase. The results indicate that both benzene and toluene caused 
significant perturbation in antioxidant defense mechanism, although variably in 
different rat tissues. 
In summary, the results embodied in this thesis demonstrate that exposure of TCE, 
HCB, benzene and toluene caused nephrotoxicity and produce multiple adverse 
effects in different rat tissues as reflected by increase in serum creatinine, BUN, 
cholesterol and decrease in serum Pi, decrease in the activities of brush border 
membrane enzymes, increase in LPO with associated decrease in antioxidant 
enzymes. The results also indicate that these industrial solvents caused global 
toxicity to the kidney, liver, intestine and brain. However, certain alterations 
appeared to be solvent/ tissue specific. The activities of ALP, GOT and LAP 
significantly decreased by TCE, HCB, benzene and toluene in a similar manner in 
almost all the tissues except that HCB increased ALP, GGT and LAP and toluene 
increased ALP and GGT activities in the intestine. The activity of sucrase increased 
by TCE but decreased by HCB, benzene and toluene. The decrease in the activities 
of BBM enzymes especially in the cortex, medulla and liver indicate that these 
solvents caused severe damage to the kidney and liver. In the kidney, renal 
proximal tubule and its BBM appeared to be the critical target as has been shown by 
morphological and some biochemical studies. The activity of ACP, a lysosomal 
enzyme was differentially affected by both types of hydrocarbons. 
^ ^ ^ 
A marked increase in LDH activity and decrease in MDH activity by benzene and 
toluene in most tissues except liver indicated a shift in the energy dependence on 
anaerobic glycolysis rather than on aerobic metabolism most likely due to 
mitochondrial damage. This was accompanied by suppressed gluconeogenic 
activity as reflected by decrease in G6Pase and FBPase activities also due to solvent 
induced mitochondrial dysfunction as oxalate produced by MDH may not be 
available for both TCA cycle and gluconeogenesis. TCE and HCB also affected 
carbohydrate metabolism in the same manner in some tissues but differentially in 
other tissues e.g., kidney and liver. The activity of G6PDH was significantly 
increased whereas NADP-ME decreased by TCE, HCB, benzene and toluene in 
almost all tissues. The NADPH produced by either enzyme is known to be needed 
for several anabolic reactions especially lipogenic reactions and also play an 
important role in antioxidant defense mechanism. This is supported by the fact that 
serum cholesterol and to some extent phospholipids increased in significant amount 
following the exposure of solvents. These are membrane components and may be 
required for regeneration processes after solvents exposure. 
Taken together, the data indicated that solvent caused impairment in the energy 
metabolism followed by certain adaptive changes. The nephrotoxic and other 
adverse effects appeared to mediated in part due to solvents induced oxidative 
damage as reflected by an increase in LPO and decrease in the activities of SOD 
and catalase in all the tissues by TCE, HCB, benzene and toluene except in medulla 
by HCB and in the intestine by toluene where an opposite pattern was observed. 
The mechanism by which TCE, HCB, benzene or toluene produce toxic effects are 
not well understood. It has been reported that these solvents/ hydrocarbons must be 
bioactivated to exert their toxic effects. In general, they are metabolized by 
glutathione conjugation and/ or by cytochrome P450 dependent oxidation pathways. 
In the case of TCE, reactive metabolites derived from P450 oxidation are associated 
with liver, lung and reproductive toxicity (Hahnes et al., 1997; Lash et al., 2000a, b; 
Forkert et al., 2003) where as those derived fi-om GSH conjugation is responsible 
for kidney and hematopoietic system (Lash et al., 2001; Lock and Reed, 2006). 
However, some has not been specified for HCB, benzene and toluene. The binding 
of reactive metabolites with cellular macromolecules are considered an initiating 
event in target-tissue organ toxicities (Bruning and Bolt, 2000). Histopathological 
studies has revealed that these metabolites caused morphological/ structural/ 
biochemical alteration in the proximal tubule of the kidney and liver (Nomiyama et 
al., 1986; Goel et al.,1992; Lash et al., 2000b; Kumar et al., 2001; Lock and Reed, 
2006). Little has been reported on the effects of these industrial solvents on 
gastrointestinal tract (or small intestine). Generation of ROS and other free radicals 
have been considered as one of the mechanism for tissue injury (Cojocel et al., 
1989). 
In conclusion, the present results show that solvents including TCE, HCB, benzene 
and toluene induce global toxicity in different rat tissues. They elicited nephrotoxic 
and other deleterious effects by causing major damage to mitochondria, lysosomes, 
plasma membrane especially renal proximal tubular and mucosal BBM as reflected 
by decrease in the activities of their specific biomarkers with some exceptions 
confirming earlier morphological and biochemical observations. Exposure of these 
solvents caused alterations in the energy metabolism and in certain cases energy 
dependence was shifted fi-om oxidative metabolism to anaerobic glycolysis. The 
nephrotoxic, hepatotoxic, neurotoxic or gastrotoxic effects appeared to be 
medicated at least in part due to imbalances in the antioxidant defense mechanism. 
The variation in effect by different solvents in different tissue can be attributed to 
the differences in their metabolism and accumulation and interaction of the reactive 
metabolites produced. 
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Introduction 
INTRODUCTION 
GENERAL 
We are exposed daily to numerous toxins and pollutants that pose problem in the 
form of very serious health risks. A number of environmental contaminants 
including certain chemicals, drugs and various industrial solvents (chlorinated and 
non-chlorinated) alter the structure and functions of various organs including 
intestine, liver, heart, brain and kidney and produce multiple adverse effects 
(Fatima et al., 2004, 2005; Kohn et al., 2005; Ruder, 2006; Farooq et al., 2007; 
Banday et al., 2008a, b). Industrial solvents (hydrocarbons or substituted 
hydrocarbons) are used extensively in industry, as well as in daily life. The 
principal classes of industrial solvents are chlorinated hydrocarbons such as 
trichloroethylene (TCE), hexachlorobenzene (HCB) and non chlorinated 
hydrocarbons such as benzene and toluene. Workers routinely exposed to such 
solvents include painters, parts fabricators, auto parts cleaners, degreasers, research 
technicians or researchers, police officers and fire fighters and also those who work 
in oil refineries, garages and shoe industry (Andrew et al., 1977; Sammett et al., 
1979; Anonymous, 1993; Brautbar, 2004). In addition, organic solvents have been 
detected in a variety of urban and rural areas of U.S and other regions of the world 
and have been found in food chains, soil and drinking water (Veeramachaneni et al., 
2001; Lock and Reed, 2006). During production, storage and use, they evaporate in 
the atmosphere as they are quiet volatile and have been identified as common 
contaminants of air. Their leakage from chemical wastes leads to contamination of 
ground water. Thus these solvents are major occupational concern and potential 
concern to the general population (MauU and Lash, 1998; Ruder, 2006). It has been 
estimated that in the USA about four million workers are exposed to variety of 
chemicals (European Commision, 1993). Among the organic chemicals, solvents 
form a structurally heterogeneous group of chemicals with a wide spread use for a 
variety of products. Solvents are used for degreasing, dry cleaning, extraction of 
fats and oils, and can be found in a wide range of products including paints, 
thinners, glues, inks, pesticides and cosmetics (ATSDR, 1997). 
The largest demand for solvents comes from paints and coating industry which uses 
almost two million tonnes every year in Western Europe (Fig-1), but demand in the 
pharmaceutical sector is steadily growing (Voss et al., 2003). 
Studies in experimental animals, case reports, case studies, and epidemiological 
studies have documented the acute and chronic effects of various industrial solvents 
on human health (Brautbar, 2004). Solvents are generally absorbed or enter the 
body by inhalation through lungs, ingestion or cutaneous contact. The main route of 
absorption is pulmonary and depends on many factors, including the frequency of 
breathing, diffusion of solvents vapors across the alveolar membrane, partial 
pressures of solvent vapors in spread air and blood, solvent in the blood as the result 
of the blood-air partition coefficient, and blood flow through lungs (Morroson and 
Boyd, 1987; Pederen, 1987). Skin absorption, the second most important route of 
solvent entry into the body is at times much more toxic than inhalation. Factors that 
affect cutaneous absorption of solvents include the composition of the skin, health 
of the skin and lipid solubility of the solvent. The gastrointestinal tract is not 
commonly a significant route of absorption (Brautbar, 2004). Solvents absorbed via 
gastrointestinal tract are removed immediately by the liver through the first pass 
metabolism. However, if the quantity of solvents ingested exceeds the capacity of 
the liver to metabolize, a gastrointestinal tract route becomes significant (Ervin et 
al., 1983; Janssen et al., 1988). In the kidney organic solvents are concentrated 
causing solvent-induced disruption of the structural and functional integrity of the 
membrane of kidney cells (Ravnskov, 2000; Brautbar, 2004). The distribution of 
organic solvents in the human body depends upon its partial pressure in the arterial 
blood and its solubility in the tissue, as well as the rate of blood flow through the 
tissue (Smith et al., 1985). Since organic solvents are lipophilic in nature, they 
undergo considerable distribution into lipids in body tissues and variably 
accumulated in certain tissues and causes toxicity. 
In general, organic solvents are shown to be absorbed and biotransformed into the 
reactive metabolites. Biotransformation plays an important role in the toxicity of 
many chemicals due to the metabolic formation of toxic metabolites (Lash et al., 
1995,2000a; DuTeaux et al., 2003). These may be classified as stable but toxic 
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Figure 1; Solvents marketed in Western Europe (1995). Data from 
European Solvent Industry Groups (ESIG), 1999. 
resulting in cellular damage, cell death and toxicity (Clayton et al., 1981; WHO. 
1985; Dekant and Vamvakas, 1996). Thus, bioactivation appears to be responsible 
for cytotoxic and carcinogenic effects (Fig-2). Exposure to organic solvents has 
been associated with number of short term or long term adverse health effects 
depending upon the maimer by which they enter into the body, amount of exposure 
and nature of reactive metabolites. Short term effects include dizziness, fatigue, 
headaches, and/ or skin rashes. Long term side effects include chronic skin 
problems damage to a wide range of organs and organ system including liver, 
kidney, skin, nervous, immune, endocrine and reproductive is known to be affected 
by these envirormiental contaminants. The proximal tubules of the kidney are 
especially affected resulting in renal dysfunctions (Brautbar, 2004). The brush 
border membrane (BBM), mitochondria, microsomes and lysosomes were shown to 
be critical targets of solvent induced toxicity (Wolfgang et al., 1990; Beach et al., 
1992). A nimiber of studies have demonstrated that solvent exposure is associated 
with increased risk in the development of chronic kidney diseases such as 
glomerulonephritis (Yaqoob et al., 1993; Ravnskov, 2000). The tubular damage is 
associated with high molecular weight protein excretion and changes in glomerular 
basement membrane (Mutti, 1996). Earlier studies identified membranous 
nephropathy as the most common histological type, whereas more recent studies 
point to IgA nephropathy (Coppo, 1988; Emancipator, 1990). Acute and chronic 
renal failure are also listed as occupational and experimental hazards by solvent 
intoxication (Mutti, 1996; Ravnskov, 2000; Brautbar, 2004). 
The liver has been reported to be the next major target organ after kidney of 
hydrocarbons/ solvent toxicity (San Martin de Viale et al., 1977; Bull, 2000). 
Histopathological studies have shown that TCE/ HCB/ benzene or toluene or their 
metabolites causing morphological alterations in the liver and kidney leading to 
their enlargement and necrosis (Bouthillier et al., 1991; Lash et al., 2000a, b; 
Ravnskov, 2000; Rahman et al , 2000; Khan et al., 2001; DuTeaux et al 2003; 
Chaufan et al., 2006). These industrial solvents are also considered to be wide 
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Figure 2: Mechanism of toxicity of organic solvents 
spread environmental contaminants as they are used as anesthetics (TCE. 
chloroform), in agriculture applications as fungicide and pesticides (HCB), in 
consumer products such as cosmetic, paints, glues and spot removers, dyes 
(benzene and toluene). 
Although the toxicity of mdustrial solvents has been extensively investigated but 
their mechanisms of action has not been completely elucidated. Neither biochemical 
event/ nor mechanism of their toxic and other adverse alterations in various tissues 
are well understood. Generation of reactive oxygen species (ROS) and perturbation 
in antioxidant defense system have been linked with cell/ tissue injury (Cojocel et 
al., 1989; Halifeoglu et al., 2000; Dundaroz et al., 2003; Li et al., 2006). 
The present work was undertaken to elucidate detailed biochemical events/ cellular 
response/ mechanisms of TCE, HCB (chlorinated hydrocarbons), benzene and 
toluene (non-chlorinated hydrocarbons) induced nephrotoxicity and other adverse 
effects in rat kidney, liver, intestine and brain. 
The work embodied in thesis demonstrate that TCE/ HCB/ benzene and toluene 
administration caused specific alterations in various serum parameters and in the 
activities of various enzymes in different tissues confirming nephrotoxic and other 
adverse toxic effects. The results further indicate that exposure of TCE/ HCB/ 
benzene and toluene produced significant biochemical and metabolic alterations in 
different rat tissues albeit differentially, most likely by inducing oxidative stress. 
THE STRUCTURE AND FUNCTION OF KIDNEY: 
The kidney is a vital organ that plays an essential role in health and diseases. The 
main function of the kidney is to maintain total body fluid volimie, its composition 
and pH within physiologic range. This is achieved collectively by the presence of 
several millions of architectural and functional units of the kidney, known as 
"nephron". A nephron is consisting of glomerulus with an extended tubular 
structure. A rat kidney contains 30,000-35,000 nephrons whereas a human kidney is 
made up of about 1, 30,000 nephrons. All these nephrons contribute to maintain 
renal functions by selective reabsorption of various ions and solutes. 
The structure of the mammaHan kidney apparently looks very homogenous, 
however, can be viewed as a composite of several tissue organs, geometrically, 
functionally and metabolically (Schmidt and Guder, 1976). Thus each nephron 
consists of group of organs arranged in series coursing through four concentric 
tissue planes, the cortex, outer and inner zones of the outer medulla and the inner 
medulla (papilla) (Schmidt and Guder, 1976). Each tissue plane also has individual 
"organ" characteristics with respect to their ionic contents and metabolic rates 
(Schmidt and Guder, 1976; Guder, 1973). The luminal brush border membrane 
(BBM) of renal proximal tubule is the major site for reabsorption of various solutes 
including amino acids, sugars and other nutrients, certain ions and minerals such as 
Na+ and inorganic phosphate (Pi). Reabsorption of most ions and solutes from the 
tubular lumen is coupled by an active transport with sodium (Na"^ ) via a carrier 
located on apical side and is driven by an electrochemical gradient of Na+ 
generated by NaVK^-ATPase located on basolateral side (McCrory et al., 1952; 
Bonjour and Caverzasio, 1984; Massary and Fleisch, 1980). Thus the transport of 
Na+ is considered to be a major work fiinction of the kidney upon which all other 
transport are dependent (Ullrich et al., 1977). The energy for the sodium transport is 
mainly provided by the hydrolysis of ATP at antiluminal membrane site involving 
Na+/K+ ATPase (Evan et al., 1983; Balagura-Baruch et al., 1973). Since the 
production of ATP is usually coupled to oxidative metabolism occurring in 
mitochondria, Na+ transport appears to be linked with the oxidative metabolism or 
oxygen tension (PO2) of the renal tubular cells. A direct linear relationship between 
O2 uptake/ utilization and Na+ reabsorption has been found (Thurau, 1961; Torelli 
et al., 1986). There appears to be a reverse cortico-medullary gradient for tissue 
oxygen tension (PO2) i.e. p02 in inner medulla is far lower than in cortical tissue 
(Aperia and Leibow, 1964; Aukland, 1960, 1961,1962). 
The proximal tubule in cortex has been demonstrated to be the major site for ions 
and solute reabsorption including water reabsorption which occurs at luminal or 
brush border membrane (BBM) site of the proximal tubules (Evan et al., 1983). 
Thus ions and solutes such as sodium, phosphate, sugars and amino acids etc. are 
reabsorbed at the BBM of the proximal tubule as secondary active transport which 
is energized by the transcellular transport of sodium ions (primary active transport) 
from luminal membrane (inwardly) out of the epithelial cell by basolateral 
membrane (Kempson and Dousa, 1986; Hammerman and Schwab, 1984). 
According to several studies, fatty acids, glutamine, lactate, citrate and in particular 
glucose are the major substrates which support the transport work of the kidney 
(Mandel and Balaban, 1981; Park et al., 1974; Leal-Pinto et al., 1973; Pitts and 
MacLeod 1975; Pitts, 1975). It is well established that various nephron subsegments 
located in different tissue zones of the kidney have different functions in solute and 
fluid transport, as well as in substrate metabolism. For example, the renal cortex is 
characterized mostly by aerobic oxidative metabolism (Lee et al., 1962) while the 
renal medulla is the site of anaerobic metabolism and glycolysis. Moreover, the 
renal cortex is also capable of producing glucose (Guder, 1973; Burch et al., 1978; 
Maleque et al., 1980). The oxidation of glucose in kidney may occur by several 
different metabolic pathways depending on the location and type of a particular 
nephron segment in the kidney: (1) the tricarboxylic acid (TCA) cycle, in which 
glucose undergoes glycolysis to pyruvate, which in turn may oxidize to CO2; (2) the 
hexose-monophosphate (HMP) shunt pathway; and (3) the glycolysis in which 
glucose is partially oxidized to lactate. On the other hand glucose is known to be 
produced in the kidney by gluconeogenesis perhaps in the proximal tubule of the 
cortex (Schmidt and Guder, 1976; Burch et al., 1978; Maleque et al., 1980). The 
enzymes belonging to the above pathways are found to be present and distributed 
differentially in the kidney. The renal medulla is the major region for the production 
of lactate from glucose by glycolytic enzymes (Guder, 1973; Hems and Gaja, 1972) 
whiles the oxidative conversion of glucose to CO2 was shown in renal cortex (Lee et 
al., 1962; Cohen, 1979). 
Nephron, which is consisting of various subsegments, showed distinct structural 
and functional differences (Francois and Danielle, 1985; Lise et al., 1987). Thus 
nephron heterogeneity also contributes to the variation in the kidney functions. Both 
inter and intra-nephronal heterogeneity exists in the mammalian kidney that 
depends on the origin and location of the nephrons in the cortical region of the 
kidney (Francois and Danielle, 1985; Lise et al., 1987). The nephron which 
originates in the glomerulus located in superficial cortex is known as "superficial 
nephron" while the nephron which originates from deep cortical region is called as 
"deep" or "juxtamedullary nephron". These populations of nephrons have been 
found to be distinct in structures as well as in functions (Francois and Danielle, 
1985). In inter-nephronal heterogeneity, proximal convoluted tubules of superficial 
nephrons always touch the surface of the kidney. In intra nephron or axial 
heterogeneity, the proximal tubules have been divided into three distinct 
morphological subsegments SI, S2, S3. The early PCT both in superficial and 
juxtamedullary nephrons is defined as 81-segment and can be identified by its 
attachment with glomeruli on one side. S2 is defined as the late superficial proximal 
convoluted tubule, early superficial proximal straight tubule and late juxtamedullary 
proximal convoluted tubule. S3 is located principally in the outer stripe of outer 
medulla and is terminal superficial proximal straight tubule and entire 
juxtamedullary proximal straight tubule. S3 is identified by its medullary location 
and by its connection with thin limbs on distal part. All S3-subsegments (pars 
recta), as they descend from cortex into the outer stripe of the outer medullar 
change from S2 to S3 cell type. Thus the outer stripe of the outer medulla contains 
proximal tubular cells but only the S3 type (Woodhall et al., 1978). These segments 
can be characterized by then* biomarker enzymes (Yusufi et al., 1994). 
Acute Renal Failure: 
A number of environmental variables and heavy metals like chromium, mercury, 
cadmium, lead, uranium (Bank et al., 1967; Sanchez et al., 2001) including drugs 
like aminoglycosides, cephalosporin, cisplatin etc. (Humes, 1988; Mahmood and 
Waters, 1994; Mingeot-Leclercq and Tulkens, 1999) affects the structure and 
function of the kidney leading to acute renal failure (ARF). The term "Acute Renal 
Failure" denotes a dramatic clinical situation in which both the kidneys stop their 
function v^ithin a short period of time or immediately depending on the severity of 
ARF. Acute Renal Failure is a process rather than a state. Often it denotes a 
reversible insufficiency of the glomerular and tubular excretion functions which 
may be triggered by renal or extrarenal mechanisms. ARF is best characterized by 
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10 
increase of nitrogenous waste products, such as serum creatinine and blood urea 
nitrogen and appearance of proteimic and enzymic components in the urine. 
ARP can be grossly divided into three phases; pathogenic phase, manifestation 
phase and recovery phase. In the first phase, a progressive disintegration and 
necrosis especially of tubular epithelial cells has been observed, leading to the 
functional loss of the kidney which is manifested by the reduction of inulin 
clearance. In the second phase, long lasting effects are observed that severely affect 
the clearance of both creatinine and inulin and which can continue for several days 
after recovery begins, depending on the degree of renal damage. In the recovery 
phase there is an increase in concentrating ability of the kidney with eventual 
normalization of kidney function. 
Generally ARF caused by drugs and chemicals is much more severe and 
irreversible and the recovery sometimes is not possible (Loghman-Adham et al., 
1987). The pathophysiologic mechanism of ARF has been investigated extensively 
in the last few decades (Maleque et al., 1980). Four major possible causes of ARF 
have been generalized which include renal vasoconstriction, glomerular 
permeability, tubular obstruction and tubular leakage (Maleque et al., 1980). 
THE STRUCTURE AND FUNCTION OF INTESTINE: 
The digestion and absorption of food components are major functions of the 
intestinal mucosa. It is the most metabolically active tissue in the body. Many 
complex compounds while passing through the small intestine are degraded into 
simple compounds which cross the intestinal epithelium before reaching the various 
body organs. Thus this epithelium not only regulates diverse absorptive and 
secretory processes but also process the substances that traverse it. The small 
intestine extends from the pyloric orifice where it is continuous with the stomach to 
the ileocecal junction where it continues to the large intestine. It is divided into 
three distinct structural and functional parts:-
(i) Duodenum 
(ii) Jejunum 
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(iii) Ileum 
To perform all these functions, the absorptive surface is greatly amplified b> 
transverse folds. The small intestine is consisting of four layers 
(i) serosa (outermost) 
(ii) muscularis mucosa 
(iii) submucosa 
(iv) mucosa (innermost) 
The absorptive cells of the small intestine are highly polarized tall columnar cells 
with a general architecture and structure that is similar to a number of other 
epithelial cell types whose major fimction is absorption (Grosser et al., 1992). They 
are distinguished by the presence of an apical striated border which forms the 
absorbing surface in contact with luminal contents. The plasma membrane of these 
enterocytes consists mainly of two different regions; brush border and the 
basolateral membrane which are morphologically, structurally and functionally 
different. 
Brush Border Membrane: 
The small intestinal mucosa is one of the largest areas of contact of the human 
organism with the environment (Schumarm et al., 1999). The mucosa of the small 
intestine has transverse folds known as villi, which are finger like projections 0.5-
1.5 mm in length. The villus is lined with a single layer of epithelial cells, 
containing a network of capillaries and lymphatic vessels (Lacteals). The plasma 
membrane covering the microvilli is covered with a polysaccharide coat referred to 
as glycocalyx and consists of glycolipids and glycoproteinic enzymes that 
hydrolyze carbohydrates and peptides. The cytoplasm beneath the microvilli 
contains fine filaments known as terminal web. The products of digestion may go 
through the microvillar membrane traversing the terminal web into cytoplasm. 
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Brush Border membrane (BBM) lining the enterocytes (intestinal cells) constitutes 
one of the most important cellular membranes owing to its role in terminal digestion 
and absorption functions which are carried out by certain hydrolytic enzymes e.g. 
disaccharidase, dipeptidases, oligopeptidases, y-glutamyl transpeptidase, maltase, 
lactase, sucrase and alkaline phosphatase (Kenny and Booth, 1978). These enzymes 
are differentially distributed in the thickness of BBM e.g. sucrase being 
superficially located (Brasitus et al., 1979) whereas alkaline phosphatase and 
ATPase are more deeply embedded within the membrane (Sigrist-Nelson et al., 
J 977). 
The absorption of digestive food and various ions occurs by passive as well as 
active transport (Hopfer et al., 1973; Shultz, 1977). The transport of water, sugars 
and amino acids is a Na dependent secondary active transport energized by an 
electrochemical gradient due to differences in Na* concentrations across the BBM 
(Hopfer et al., 1973; Shultz, 1977; Hopfer, 1978; Ramaswamy et al., 1991). The 
role of proton motive force as a source of energy (in terms of ATP) has also been 
demonstrated (Rajendran et al., 1987; Vorum et al., 1988; Ganapathy et al., 1991). 
This is carried out by sodium pumps (Na"^ K"^ ATPase); which is a highly conserved 
integral membrane protein. 
The activities of certain enzymes belonging to glycolysis, TCA cycle, HMP shunt 
pathway, have been reported under various experimental conditions (Farooq et al., 
2004). The presence of hexokinase, glucokinase, 6-phosphofructokinase, G-6-
Phosphatase, FBPase, oxoglutarate dehydrogenase, citrate synthase, PEP 
carboxykinase, NADP-malic enzyme and glutamines indicate that gluconeogenesis 
is also operational in the small intestine (Farooq et al., 2004). The fiinction of small 
intestme appears to be metabolic as opposed to be absorptive. Thus the studies 
involving metabolic activities may in some way reflect the absorption properties of 
the intestinal mucosa. 
The process of digestion as well as absorption is a regulatory process which is 
regulated by various drugs, hormones, and is also affected by nutritional and dietary 
status (Farooq et al., 2004; 2006). The small intestine is also the primary site for 
great exposure to hazardous and life threatening environmental toxicants such as 
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heavy metals (uranium) and drugs (aminoglycoside antibiotics and antineoplastic 
agents). Recent studies have clearly demonstrated that the enzymes present in the 
small intestine are not only altered by dietary stress such as starvation and fasting 
(Farooq et al., 2004; 2006) but also by antibiotics such as gentamicin (Farooq et al., 
2007). 
Most prominent pathophysiological mechanism of gastrointestinal toxicity include 
direct effects on cell membrane, inhibition or stimulation of mucosal proliferation, 
nerve damage, activation of emetic pathways, disruption of intracellular signal 
transduction, generation of reactive oxygen substances, activation or inhibition of 
metabolic enzymes, intracellular toxicity etc. Reactive oxygen metabolites/species 
are the major causative factors for the mucosal lesions through oxidative stress. The 
major toxic effects of ROS include direct cytotoxicity towards epithelial cells, net 
fluid secretion into the lumen and alteration in functions of intestinal 
microvasculature that lead to increased permeability and membrane damage 
(Grishametal., 1990). 
THE STRUCTURE AND FUNCTION OF LIVER; 
The liver weighing roughly 1.2-1.6 kg performs many of the functions necessary for 
staying healthy. The liver is the first organ that comes into contact with enterally 
absorbed nutrients and xenobiotics via portal blood (Kahl, 1999). Two large vessels 
carry blood to the liver: the hepatic artery comes from the heart and carries blood 
rich in oxygen, whereas the portal vein brings to the liver, blood rich in nutrients 
from the small intestine. These vessels are divided into smaller and smaller vessels, 
ending in capillaries, which further divide into thousands of lobules. Each lobule is 
composed of hepatocytes, and as blood passes through, they are able to monitor, 
add or remove substances from it (Sherwood, 1997). 
Among the most important liver functions are: 
1. Removing and excreting body wastes and hormones as well as drugs and 
other foreign substances. Enzymes in the liver alter some toxins so they can 
be more easily excreted in the urine. 
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2. Removing and excreting body wastes and hormones as well as drugs and 
other foreign substances. Enzymes in the liver alter some toxins so they can 
be more easily excreted in the urine. 
3. Synthesizing plasma proteins, including those necessary for blood clotting. 
Most of the 12 clotting factors are plasma proteins produced by the liver. 
4. Producing immune factors and removing bacteria, helping the body fight 
infection. 
5. Producing bile to aid in digestion. Bile salts aid in fat digestion and 
absorption. 
6. Excretion of bilirubin. Bilirubin is one of the waste products excreted in 
bile. Macrophages in the liver remove worn out red blood cells from the 
blood. Bilirubin results from the breakdown of hemoglobin and its excreted 
by hepatocytes. 
7. Storing certain vitamins, minerals and sugars. The liver stores enough 
glucose in the form of glycogen to provide a days energy. 
One of liver's most interesting ability is self repair and the regeneration of the 
damaged tissues. In clearing the body of toxins, the liver is damaged by exposure to 
harmful substances, demonstrating why this capability is important (Tzanakakis et 
al., 2000). 
Toxic damage to the liver parenchymal cells presents histologically as degenerative 
alterations of the cell or as abnormal storage, usually of fat (steatosis) (Arias et al., 
1994). Cell death in liver injury may be of two types; it can be programmed cell 
death, or necrosis, a toxic lysis of the cell (Zimmerman, 1993). 
THE STRUCTURE AND FUNCTION OF BRAIN; 
Every living organism has a property called irritability to show a response to its 
environmental changes. An environmental change is known as stimulus. In 
mammals and other vertebrates, the nervous system consists of mainly three parts. 
Central nervous system (CNS) comprising brain and spinal cord. 
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• Peripheral nervous system (PNS) comprising of nerves that arise from brain 
(cranial nerves) and spinal cord (spinal nerves). 
• Autonomic nervous system (ANS) comprising of motor nerve fibres that 
emerge from the brain and spinal cord and pass through the autonomic 
ganglia and also emerge from them to supply smooth muscles and glands. 
ANS work independently to regulate the involuntary activities of the body 
like peristaltic movements of alimentary canal, heart beat etc. 
The nervous system is an extraordinarily complex network of cellular connections. 
It forms the structural basis of recognition, perception, memory, speech, 
locomotion, and feeling, as well as unconscious hormonal and autonomic functions. 
The brain and spinal cord are the principal components of the central nervous 
system. All the parts of central and peripheral nervous systems are potential targets 
to toxic effects. Neurons are the primary functional cell type of the nervous system. 
The system that receives the stimulus, transmit it to other parts of the body, and the 
corresponding effects shown is knovm as nervous system. It is concerned with the 
following main functions: 
1. Control and regulation: It control and regulates various activities of the 
organs and finally the organism whole. 
2. Coordination: It coordinates the working of various glands and tissues of the 
body thus regulating the internal environmental of the body. 
3. Reaction of organism: It helps the organism to react to external 
environmental fluctuations. 
The biological pathway of energy metabolism in the brain are in the most respect 
like those of other tissues, but special condition peculiar to the central nervous 
system in vivo limits full expression of biochemical potentialities. Although the 
brain is said to be unique among tissues in its high rate of oxidative metabolism, the 
overall central metabolic rate of oxygen is of the same order as the unstressed heart 
and renal cortex (Chung et al., 1995). All the major pathways for carbohydrate 
metabolism are present in the brain tissue having different regulatory mechanism 
and perform under oxygen rich environment. 
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TRICHLOROETHYLENE: PATHOPHYSIOLOGY 
1,1, 2-Trichloroethylene (TCE) is an important organic solvent that is widespread 
in the environment. TCE is a nonflammable colorless liquid with a sweet odor 
similar to ether or chloroform. It is uncharged, nonpolar and highly lipophilic 
compound that readily cross membrane by diffusion. The chemical formula for 
TCE is C2HCI3 and molecular weight is 131.40g/ mol. It is not a persistent chemical 
in the atmosphere; its half-life is about 7 days (ASTDR, 1997). It has been 
extensively used in consumer products, industrial applications and as general 
purpose solvent. The main use of TCE is in vapor degreasing of metal parts and 
cleaning operations, as an extraction solvent for greases, oils, fats, waxes, tars and 
as a refrigerant. It is used in consumer products such as typewriter, correction fluid, 
paint remover strippers, adhesives, spot removers and rug cleaning fluids (ATSDR, 
1997). Trichloroethylene was also used in the past as a general anesthetic. In 
addition to being found in the work place, TCE has been detected in a variety of 
urban and rural areas of the U.S and other regions of the world and has been found 
in food chain and drinking water (Veeramachaneni et al., 2001; Lock and Reed, 
2006). Thus, TCE invariably carries an exposure risk for industrial workers as well 
as general populations and poses significant health concerns. 
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Figure 7: Structure of trichloroethylene 
TCE can be absorbed through the lungs, mucous membranes, gastrointestinal tract 
and the skin and rapidly distributed to various tissues. Since TCE is lipophilic, it 
undergoes considerable distribution into lipid in body tissues and alters their 
functions. Occupational TCE exposure have been associated with a number of 
adverse health effects, including central nervous system, cardiovascular system, 
immune system, reproductive system, liver and kidney toxicity (Allemand et al., 
1978; Chakrabarti and Tuchweber, 1988; Ruijten et al., 1991; Bruning and Bolt, 
2000; Lash et al., 2001; Wartenberg and Scott, 2002; DuTeaux et al., 2003; 
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Nonnan, 2005; Ruder, 2006). Acute and chronic TCE exposure causes toxicity in 
variety of organs in human and experimental animals (Lash et al., 2006; Lock and 
Reed, 2006; Ruder, 2006). In humans, acute inhalation exposure of TCE causes 
central nervous system symptoms such as headache, dizziness, confusion, nausea 
and unconsciousness (U.S.EPA, 1985). Among the reported effects from 
occupational exposure is fatigue, light-headedness, sleepiness, vision distortion, 
abnormal reflexes, tremors, neurobehavioral or psychological changes, 
cardiovascular and precordial pain (Grandjean et al., 1955; Milby, 1968; Landrigan 
et al., 1987). The use of TCE as an anesthetic has been associated with cardiac 
arrhythmias (U.S.EPA, 1985; Dhuner et al., 1957). Cases of severe liver and kidney 
damage including necrosis have been reported in humans following acute exposure 
of TCE (Defalque, 1961). In animals, TCE has produced liver enlargement with 
hepatic biochemical and/ or histological changes (Nomiyama et al., 1986; 
Kjellstrand et al., 1981, 1983; Stott et al., 1982; Tucker et al., 1982) and kidney 
enlargement, renal tubular alterations and/ or toxic nephropathy (NTP, 1982, 1986, 
1988). Also observed in animals were hematological effects (Tucker et al., 1982; 
Mazza and Brancaccio, 1967) and immunosuppression (Sanders et al., 1982). Like 
other organic solvents TCE produces contact dermatitis, rashes and bums. TCE was 
shown as severe skin and eye irritant. Based on animal and human evidences 
prolonged contact with the liquid has caused reddening of the skin, irritation and 
blister formation. The concentrated vapor, especially at elevated temperatures, can 
also cause severe redness and irritation. Severe eye irritation, with temporary 
clouding of the cornea, has been reported in people exposed to high vapor 
concentrations. When swallowed TCE causes gastrointestinal (GI) irritation with 
possible inflammation of Gl-tract, manifested as nausea, vomiting, diarrhea and 
abdominal pain (ATSDR, 2007). 
A recent analysis of available epidemiological studies reported TCE exposure to be 
associated with several types of cancers especially kidney, liver and lymphatic 
system. Animal studies have reported increases in lung, liver, kidney and testicular 
tumors and lymphoma from inhalation and oral exposure in rats and mice 
(U.S.EPA, 1985; ASTDR, 1997; U.S.EPA, 2001). 
21 
The major organs affected by TCE are the Hver, kidney and lung, with severity of 
toxicities being dependent on species, strain, gender, physiological state, route of 
exposure and differential TCE metabolism (Lash et al., 2000a; b). The toxicities 
evoked by TCE are attributable to its metabolites. It is believed that TCE must be 
bioactivated to elicit its toxic effects (Bruning and Boh, 2000; Lash et al., 2005). It 
is extensively metabolized by glutathione (GSH) conjugation and cytochrome 
P450-dependent oxidation pathways (Fig-8). 
The metabolic flux through the oxidative and GSH dependent pathways differs in 
various tissues. Hence mode of action for each target organ, which is largely 
dependent on the chemical species generated, will differ. The reactive metabolites 
derived from GSH-conjugation pathway have been associated with renal toxicity 
and nephro-carcinogenicity whereas the metabolites of P450 dependent pathway 
have been associated wdth specific target organ such as liver, lungs, reproductive 
toxicity. As shown in Fig-8, glutathione conjugation of TCE results in the formation 
of diclorovinyl glutathione (DCVG), which is processed by gamma-
glutamyltransferase (GGT) and dipeptidases (DP) to dichlorovinyl cysteine 
(DCVC). The DCVC can be bioactivated by cysteine-conjugate p-lyase resulting in 
the formation of reactive thiol or chlorothiolketene (Van de Water et al., 1996; 
Volkel et al., 1998). The reactive metabolites formed by kidney P-lyase can bind 
cellular proteins including protein in kidney mitochondria resulting in cytotoxicity 
and mitochondrial dysfunction (Hassall et al., 1983; Jones et al., 1988; Van de 
Water et al., 1996; Cummings et al., 2000). This may be the initiating event in TCE 
induced nephrotoxicity (Lash et al., 1995; Bruning and Bolt, 2000; Lash et al., 
2005). Additionally, TCE is metabolized by cytochrome P450 (P450) dependent 
oxidation, primarily by the P450 (CYP2E1) isoform (Miller and Guengerich, 1982). 
The metabolite formed is chloral which exists in equilibrium with chloral hydrate 
(Dekant et al., 1986). Chloral and chloral hydrate are rapidly oxidized to 
trichloroethanol (TCOH), trichloroacetate (TCA) and dichloroacetate (DCA). 
Reactive metabolites derived from P450 pathway bind to hepatic proteins and 
enzymes (Lash et al., 1995; Bolt et al., 1977; Halmes et al., 1996; 1997) and has 
been directly associated with liver toxicity (Lash et al., 2000a, b). The formation of 
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reactive metabolites and their binding to cellular macromolecules and/ or certain 
organelles has been proposed as an important event in target organ toxicity (Cohen 
etal., 1997). 
Health effects of trichloroethylene: 
More than 3 million individuals are estimated to be exposed to TCE through 
occupational and environmental exposures armually (ATSDR, 1997). Animal 
studies show that trichloroethylene acts as a complete carcinogen. A recent 
epidemiological study showed associations between chlorinated solvent exposures 
and decreased semen concentrations, decreased sperm motility, and increased 
percentages of abnormal sperm (Tielemans et al., 1999). Evidence from animal and 
epidemiologic studies suggests that several reproductive and developmental toxicity 
end points may be associated with trichloroethylene exposure, including infertility 
in males and females, impaired fetal growth, and cardiac teratogenesis. Multiple 
rodent studies indicate that trichloroethylene affects spermatogenesis and the 
fertilizing capability of sperm in males and decreased fertilizability of oocytes in 
females. The effects appear to depend on metabolic activation of trichloroethylene 
by CYP2E1, but which oxidative metabolite is the proximate toxicant remains 
unknown. Impaired fetal growth was also a consistent finding in different 
commxinity studies of mothers exposed to drinking water contaminated with 
trichloroethylene. Evidence that trichloroacetic acid and dichloroacetic acid are as 
potent as trichloroethylene suggests that CYP2E1 metabolic activation as well as 
fractional formation of trichloroacetic acid from chloral, is important in 
trichloroethylene cardiac teratogenesis (U.S EPA, 1985; ASTDR, 1997; U.S EPA, 
2001). Some of TCE-induced toxicities especially in the kidney and liver are 
discussed in detail and are described in the following pages. 
(a) Nephrotoxicity: 
The kidneys are highly susceptible to damage caused by TCE toxic insult (Lash et 
al., 2000b; Lash et al., 2005; Lock and Reed, 2006). This occurs due to their high 
blood flow and the presence of myriad transport mechanism that allow renal 
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epithelial cells, particularly those of proximal tubule to concentrate blood borne and 
filtered chemicals to high intracellular levels. Moreover, renal epithelial cells 
contain a large array of bioactivating enzymes that metabolize chemicals to reactive 
and toxic species (Dekant et al., 1986; Lash et al., 1994a; b). It is believed that TCE 
metabolites derived from the GSH conjugation pathway are responsible for the 
majority of nephrotoxic and nephrocarcinogenic effects (Lash et al., 1995; Bruning 
and Bolt, 2000; Lash et al., 2001; Lash et al., 2005; Lock and Reed, 2006). 
Investigations of nephrotoxicity in humans show that highly exposed workers 
exhibit evidence of damage to the proximal tubules in the kidney. Toxic metabolites 
derived from TCE induce chronic renal tubular lesions and may have genotoxic 
effects. TCE protein adducts have been shown to alter cellular structure and 
function in the kidney (DuTeaux et al., 2003, Lash et al., 2000a, b; Van de Water et 
al., 1996; Bolt et al., 1977).TCE induced cytomegaly was first observed in inner 
cortex and outer stripe of outer medulla of rats (Green et al., 1997). The epithelial 
cells of pars recta of proximal tubule (S3 segments) were often enlarged and 
contained nuclei several times to their normal size (Karyomegaly). Other lesions 
observed in severely affected kidneys were described as toxic nephropathy. TCE 
induced tubular injury was manifested by an increase in the excretion of proteins 
and enzymes in the urine. TCE produced elevation in urinary NAG, GGT, glucose 
excretion and BUN all of which are characteristic sign of proximal tubular damage 
(Chakrabarti and Tuchweber, 1988). Increased excretion of high molecular weight 
proteins such as albumin, P-2nglobulin in the urine was also detected, suggesting 
some of glomerular injury. Histological alterations were observed in glomeruli in 
renal proximal tubules (Mensing et al., 2002). TCE exposure also results in large 
amoimt of formic acid excretion that contributes to renal damage. Cojocel et al. 
(1989) assessed the role of oxidative stress in TCE induced nephrotoxicity, ROS are 
considered to be an important mechanism of toxicity by various drugs and 
chemicals. TCE was found to deplete GSH content and produced elevation of 
malondialdehyde (MDA) in renal cortex along with ethane expiration, which are the 
indicators of lipid peroxidation and oxidative damage. A dose dependent increase in 
BUN levels was also observed, confirming the decrement in renal fiinction induced 
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by TCE. TCE has been shown to cause early MT toxicity as evident by the increase 
in state-3-respiration and inhibition of SDH activity (Lash et al., 1995). 
The plasma membrane, lysosomes in addition to MT v^ere shown to be early and 
sensitive targets or its metabolites such as DCVC. Reactive metabolites derived 
from GSH conjugation e.g., DCVC and DCVG were found to be nephrotoxic in 
species in laboratory animals (Elfarra et al., 1986). Rat kidney compared to mouse 
kidney was affected to greater extent by DCVC (Eyre et al., 1995; Green et al.. 
1997; Vaidya et al., 2003). Both DCVG and DCVC were acutely toxic to human 
ret^l proximal tubules in. primary culture (Lash et al,, 2QQI; McGoldrick et at , 
2003; Lock et al., 2005). Many studies have been conducted in vitro in isolated rat/ 
rabbit renal tubule cells or cell lines. In rabbit cortical slices DCVC induced toxicity 
was evident by release of BBM enzymes; GGT, ALP, and necrosis of S3 sub 
segment were primarily observed (Wolf- gang et al. 1990). Like TCE (Cojocel et 
al., 1989), DCVC (Groves et al., 1993) also showed oxidative stress as manifested 
by increased LPO and decreased GSH. 
(b) Hepatotoxicity: 
Besides kidney, the liver is the other major target organ of TCE induced toxicity 
(Bull, 2000). TCE is rapidly and extensively absorbed into the circulation and 
subsequently distributed to different target organs including liver. 
TCE produces hepatotoxicity in experimental animals and humans that depends on 
generation of reactive metabolites by the cyt-P450-dependent oxidation pathway. 
Like kidney, the intensity of the effect is species, strain and gender dependent. 
Hepatic histological examination has revealed that TCE induces hepatotoxicity by 
marked centrilobular necrosis with fatty infiltration and by modulating the 
lysosomal enzymes. The lysosomal rupture resulted in increased activity of acid and 
alkaline phosphatase along with reduced glutathione levels in liver tissue (Kumar et 
al., 2001). The activity of catalase was also increased by TCE exposure (Goel et al., 
1992). Goel et al. (1992) also reported significant increase in liver weight, 
degeneration/ necrosis of hepatocytes and characteristic proliferation of endothelial 
cells of hepatic sinusoids upon oral exposure of TCE to male mice. 
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The marked elevation of serum SGPT, SGOT, AST, ALT have been observed by 
TCE exposure (Gehring, 1968; ASTDR, 2007) and can be considered as biomarkers 
of hepatotoxicity. These metabolites include chloral hydrate, trichloroethanol 
(TCOH), dichloroacetate (DCA), trichloroacetate (TCA). Reactive metabolites 
derived from P450-dependent oxidation of TCE (chloral, dichloroacetyl chloride, 
etc) binds to hepatic proteins and enzymes and have been directly associated with 
liver toxicity and carcinogenicity (Lash et al., 2000a, b). It has been indicated that 
TCA mediates the hepatotoxic effect of TCE (Bull, 2000) whereas DCA and TCA 
are responsible for hepatocarcinogenecity (Larson and Bull, 1992; Motohashi et al., 
1999; Pastino et al., 2000). Studies with laboratory animals indicate that TCE and 
its metabolites also produce liver effects independent of hepatotoxicity, including 
elevation in plasma bile acid concentration, accumulation of liver glycogen and 
disturbances in cholesterol metabolism (Nagaya et al., 1993). Furthermore, TCE-
end stage metabolites, TCA and DCA were shown to increase lipid peroxidation 
concomitant with increased cell and peroxisomal proliferation (Channel et al., 
1998). TCE and its metabolites also showed mitochondrial toxicity both in the liver 
and kidney to similar extent followed by decrease in respiration (Lash et al., 1995, 
2001). In Fisher rats, a single dose of TCE resulted in increase in TBARS in the 
liver (Torasson et al., 1999). TCE induced oxidative stress in the liver is almost 
certainly related to hepatic peroxisomal proliferation following metabolism of TCE 
to TCA (Laughter et al., 2004). 
(c) Neurotoxicity: 
Past evidence showed that inhalation of trichloroethylene causes neurotoxic effects 
in laboratory animals and humans that are similar in nature (e.g., masseter reflex 
latency, motor incoordination, changes in heart rate) and occur at comparable 
concentrations of exposure. Some studies suggest a contribution of 
trichloroethylene to Parkinson's disease (McDonnell et al., 2003). 
CNS symptoms are the primary effects and depending on the duration and intensity 
of exposure, symptoms can include drowsiness, dizziness, visual disturbances, light 
headedness, fatigue, headache, lethargy, confusion, ataxia, impaired judgment and 
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respiratory depression (ATSDR, 2007). Chronic TCE exposure results in failure of 
confounding variables and lack of controls. Although some CNS symptoms can 
disappear within several weeks after TCE exposure, other CNS adverse health 
effects such as memory loss may persists in persons who have been exposed to TCE 
for long duration. Some of the observed neurological effects from long term 
exposure of TCE is impaired trigeminal nerve function (e.g., blink reflex). 
(d) Enterotoxicitv: 
When, swallowed TCE causes gastroiatestinal (Gl) irritation, with possible 
inflanmiation of the GI tract, manifested as nausea, vomiting, diarrhea and 
abdominal pain. However, the biochemical events and mechanism involved in the 
cellular response to intestinal injury is not completely elucidated (Khan et a!., 
2009). 
HEXACHLOROBENZENE; PATHOPHYSIOLOGY 
Hexachlorobenzene (HCB) is a chlorinated hydrocarbon with molecular formula C-
eCU and mol wt 284.16. HCB is a white crystalline solid which is highly insoluble 
in water and highly soluble in organic solvents; diethyl ether, benzene and 
chloroform. It is very persistent and quite volatile and thus can be partitioned in the 
atmosphere. It has been also detected in arctic air, water and organisms (Barrie et 
al., 1992). HCB has significant ability to bioaccumulate in fish and wild life. It is 
used in the aluminum industry (Selden et al., 1997; 1999) and electrochemical 
factories (Sala et al., 1999; Ballester et al., 2000). Based upon the several studies of 
effectiveness and agricultural efficiency, HCB was recommended in 1945 for use as 
a fungicide for the treatment of Tilletia tritici- a wheat based fungus. Currently, the 
main sources of HCB are the impurities present in other chlorinated pesticides and 
byproduct of several industrial emissions, noted in the chlorinated solvent industry 
through inappropriate manufacturing or waste disposal (Tobin, 1986) and as 
intermediate in the production of pentachlorophenol, maleic anhydride, pesticides 
and Mg (Vladimir Zitko, 2005). Humans are exposed to HCB primarily by 
inhalation (Grimhalt et al., 1994), through absorption across respiratory tract, GI 
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tract or by ingestion of contaminated food including fish, dairy products, certain 
vegetables and meat and through maternal transfer including breast milk 
(Nakashima et al., 1999; 2000). HCB has very low acute toxicity. HCB 
administration induces a specific condition of imbalance in heme metabolism in the 
liver between the formation and inactivation of reactive intermediates which are 
associated with hepatic porphyria. Porphyria is the major potential toxic 
manifestation both in experimental animal and humans (To-Figueras et al., 1997). 
The most notable episode involving the effect of HCB on humans involved the 
ingestion of HCB treated seed grain in Turkey between 1954-1959. Approximately 
3000-4000 developed porphyria turcica, a disorder of heme biosysthesis (Peters et 
al., 1986). HCB has been reported to induce porphyria cutanea turda (PCT) 
resulting from a HCB mediated decrease in the activity of uroporphyrin 
decarboxylase in the liver (Elder, 1998). 
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Figure 9: Structure of HCB 
Since HCB is lipophilic in nature, it is rapidly distributed and frequently 
accumulated in various tissues after inhalation/ ingestion. Preferential distribution 
of HCB was found to be highest in fat and other high lipid tissues than in the liver, 
brain and kidney and least in the blood (Lecavalier et al., 1994). HCB is slowly 
metabolized in mammals and majority of HCB is excreted unchanged (in feces). 
Reductive dechlorination of HCB catalysed by enzymes located in microsomal 
fraction of liver, lung, kidney and intestine appears to be an important pathway for 
the metabolism of HCB (Ingebrigtsen, 1986). It has been reported that epoxide 
formation also occurs in during HCB metabolism (Lui et al., 1976). 
Little is known about the metabolism of HCB in humans despite several complete 
rodent studies. Various phenolic derivatives, notably pentachlorophenol (PCP), 
tetrachloro-l, 4-hydroquinone, and diverse tetra and trichlorophenols have been 
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identified in the excreta of rats dosed with HCB (Koss et al., 1976). The presence of 
PCP in human urine has been reported in several studies (Gomez-Catalan et al.. 
1987). Because HCB is ubiquitous in human tissues, it has been hypothesized that 
most of the PCP found in urine may arise from metabolism of the accumulated 
HCB (Koss et al , 1986). 
Another major metabolic pathway observed in rodents is the conjugation of HCB 
with glutathione (Koss et al., 1979). Conjugation of HCB with GSH, leading to the 
formation of hydrosoluble sulfhur metabolites, is quantitatively more important 
than hydroxylation and formation of phenolic metabolites. The glutathione 
conjugate is further metabolized by cleavage of the glycine and glutamate residues 
to become pentachlorophenyl-N-acetyl-L-cysteine. Part of mercapturate is 
eliminated unchanged via urine (Smith et al., 1983; To-Figueras et al., 1995). It 
may be further metabolized by cleavage of the C-S bond to produce 
pentachlorobenzenethiol (PCBT), pentachlorothioanisol, tetrachloro-1,4-
benzenedithiol, tetrachlorobenzenethiol, pentachlorobenzene and other minor 
metabolites (Renner et al., 1994). A summary of the main HCB biotransformation 
pathways in rodents is shown in Fig-10. 
Health effects of hexachlorobenzene: 
Repeated exposure to HCB has been shown to be hepatotoxic, nephrotoxic and 
neurotoxic (EHC, 1997). The effect of HCB on tissues and blood parameters were 
studies in different species and were found to be immunotoxic (Bemhoft A et al., 
2000), carcinogenic , hepatotoxic-hepatocarcinogenic (Erturk et al., 1986; Sala et 
al., 1999; Kishima et al., 2000), toxic in the reproductive tract (Alvarez et al., 
2000), porphyrogenic (Selden et al., 1999; Cochon et al., 1999; de Catabi et al., 
1999; Fernandez-Tome et al., 2000) and nephrotoxic (Smith et al., 1983; Andrews 
et al., 1986; Kessabi et al., 1990; Bouthillier et al., 1991), and it also had toxic 
effects on skin, lung and brovm adipose tissue (Chu et al., 1983; Alvarez et al., 
1999; Michielsen et al., 1999). HCB has been linked with disturbances in porphyrin 
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metabolism, enlarged liver, enlargement of thyroid, osteoporosis or arthiritis, and 
increased glycogen content primarily in children (Schimid, 1960; Gochmen et al., 
1989). HCB has been reported to induce thyroid neoplasm (Cabral et al., 1977; 
1979), porphyria (Schimid, 1960; Cam and Nigogosyan, 1963), hormonal 
disruption including progesterone and testosterone (Foster et al., 1992; Jarrell et al., 
1993), depletion of triidothyronine (T3) and thyroxine (T4) (van Raaij et al., 1993), 
goiter (Smith et al., 1987) md hypothyroidism (van Raaij et al., 1993) and decrease 
in body weight (EHC, 1997). HCB has been associated with specific skin changes 
sucii as Wistering m svm exposed aieas, hyper pigmentaluion and hypertikivasis. 
HCB may induce premature ovarian failure or premature menopause in women 
(Alvarez et al., 2000), decreased estradiol and prolactin concentration in serum. 
HCB also affects the immune system. Several studies have demonstrated that oral 
exposure to HCB increases the incidence of tumor formation in the liver and 
kidney. The evidence of carcinogenicity was found to be strongest in the liver. 
HCB has been shown to induce hyperplasia (in rats, mice, dogs and monkey) and 
metaplasia (in rats) and malignant tumors (hepatocarcinoma in rats, mice, hamsters; 
bile duct carcinoma in rats). HCB pollution has been linked with elevated blood 
levels of HCB and hepatic effects (increased porphyrin and hepatic enzymes) and 
increase in serum cholesterol and decrease in ALP activity (Andrews et al., 1989; Li 
et al., 2006). Additionally, phototoxicity occurs as porphyrins accumulated in the 
skin are activated by sunlight to generate ROS causing tissue damage. As a result 
skin lesions occur most commonly on areas exposed to sunlight such as face and 
hands. Animal studies have shown that repeated exposure to HCB affects wide 
range of organ system including kidney, liver, brain and nervous system (EHC, 
1997). Some of the specific health effects are described below. 
(a) Nephrotoxicity: 
HCB is a well known hazardous, environmental chemical contaminant. There are 
numerous toxic and carcinogenic effects on several tissues and organs (Kessabi et 
al., 1990; Bouthillier et al., 1991; Fernandez-Tome et al., 2000). The effect of HCB 
on kidney has been studied by Fernandez Tome et al. (2000). Several detectable 
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histological changes were found in the kidney of HCB treated rats. Histology of 
male rat kidney revealed degenerative and regenerative cellular foci accompanied 
by accumulation of protein droplets in epithelial cells of the proximal tubules along 
with alterations in renal function by HCB treatment (Bouthillier et al., 1991). 
Koptagel and Bulut. (2002) have shown various distinctive renal cortical 
ultrastructural changes. HCB treated rat demonstrated glomeruli with a thickened 
basement membrane, hyperaemic and dilated capillaries. The proximal tubular cells 
had myelin figures in their cytoplasm and increased intracytoplasmic foldings 
whereas distal tubular cells had large, electron-dense mitochondria along with a 
significant microvillous loss. Cortical alterations were more distinctive when 
animals were treated with higher doses of HCB. Proximal tubular cells were 
distinctively degenerative whereas distal tubulzir cells had apical cells cytoplasmic 
protrusion with microvillous loss and numerous vacuoles like structures in the 
cytoplasm. Increased vascularization was also observed in the interstitial region 
indicating precancerous condition in renal cortex following high dose (Koptagel 
and Bulut, 2002). The histological observation in male rats corresponds to protein 
droplets nephropathy and accumulation of a-2^globulin in kidney cells. Hence, 
HCB induced nephropathy was more apparent in males rats as compared to females 
rats (Bouthillier et al., 1991). 
(b) Hepatotoxicitv: 
Liver is the main target organ of HCB (San Martin de Viale et al., 1977). 
Histological studies have revealed changes in several tissues such as liver, thyroid 
and spleen (Rios de Molina et al., 1996). The changes were associated with 
enlarged hepatocytes, increased liver weight, high content of iron deposits, small 
lipid droplets, polymorphic nuclei and microsteatosis in the liver. Mollenhauer et al. 
(1975, 1976) found proliferated SER structures and accumulation of glycogen like 
material along with elongated and swollen autophagic vacuole in rat hepatocytes. 
The histological study fiirther revealed epithelium disorganization in 
hepatopancreas tubules in crabs confirming the existence of structural damage 
caused by HCB (Chaufan et al., 2006). HCB caused decrease in several 
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phospholipids suggesting pronounced akerations in membrane fluidity (Adriana et 
al., 1999). HCB resulted in increased G6PDH and ME activity in rat hepatocyte 
whereas decreased in adipose tissue (Carvalho et al., 1993; Alvarez et al., 1999). 
HCB administration decreased mitochondrial respiration as evidenced by 
irreversible decrease in state 3 respiration and uncoupling effect in state 4 
respiration and induce lipid peroxidation (Feldman and Bacon, 1989). HCB 
decreased the pyruvate kinase (PC), PEPCK and G6Pase in liver and thus produces 
impairment in gluconeogenic pathway (Mazetti et al., 2002; Taira et al., 2004). The 
plasma glucose was reduced while the hepatic glucose was stimulated by HCB 
treatment. It has been suggested that changes in membrane fluidity by LPO and 
mitochondrial respiration is the contributing factor in HCB induced hepatotoxicity 
(Masini et al., 1988; Feldman and Bacon, 1989). HCB exposure resulted in 
increased malonaldehyde; an end product of LPO production, in rat hepatocytes and 
the activity of GSH-Px and SOD were found to be decreased by HCB exposure 
(Rizzardini et al., 1988; Li et al., 2006). 
(c) Neurotoxicity: 
HCB has been reported to cause neurological effects. Repeated dose of HCB even 
at small dose are found to be toxic (Ecobichon, 1991). HCB has been reported to 
cause tremors, paralysis, muscular incoordination, weakness and convulsions 
(Edwards et al., 1991). HCB enhanced LPO and the oxidative stress plays an 
important role in the mechanism of neurotoxicity (Li et al., 2006). 
NON-CHLORINATED HYDROCARBONS; PATHOPHYSIOLOGY 
Aromatic hydrocarbons are those hydrocarbons that possess the special properties 
associated with the benzene nucleus or ring, in which six carbon-hydrogen groups 
are arranged at the comers of a hexagon. Aromatic hydrocarbons are widespread in 
the biosphere because of their physical and chemical properties and their uses. They 
are widely used as ingredient in household product such as paints; varnishes and 
wax all contain organic solvent (IPCS, 1986; WHO, 2000). Aromatic hydrocarbons 
are capable of causing acute and chronic central nervous system depression, 
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respiratory failure and death (Ozdikicioglu and Dere, 2004). Acutely, they can 
cause headaches, nausea, dizziness, disorientation and confusion (IPCS, 1986; 
ATSDR, 2000; NPIS, 2005). High acute doses can even result in loss of 
consciousness and respiratory depression. Respiratory irritation (cough and sore 
throat) is a well-known acute effect. Cardiovascular symptoms can include 
palpitations and light-headedness. Neurological symptoms of chronic exposure can 
include behavioral changes, depression, mood alterations, and changes in 
personality and intellectual function (Midzenski et al., 1992; ATSDR, 1997). 
Chronic exposure has also been known to cause or contribute to distal neuropathy in 
some patients. Chronic effects can also include dry, irritated, cracked skin, and 
dermatitis (ATSDR, 2007; Von Burg, 1993; Shibata et al., 1994). The best 
characterized components of volatile glues and thirmers are aromatic hydrocarbons 
such as benzene and toluene which are also recognized as carcinogens (i.e. 
benzene), reproductive hazards and neurotoxins (i.e. toluene). 
Benzene 
Benzene is the simplest aromatic hydrocarbon, parent substance of large class of 
chemical compounds. It was discovered by Michael Faraday in 1985 (Luoping et 
al„ 2002). It is colorless toxic liquid with sweet aromatic odor, flammable 
hydrocarbon of chemical formula Ceiie, a hexagon of six carbon atoms joined by 
alternating single and double bonds and each bearing one hydrogen atom. 
Figure 11: Structure of benzene 
Benzene has been used extensively in the manufacture of styrene, phenols, maleic 
anhydride and a number of detergents, explosives, pharmaceuticals and dye-stuffs. 
It has been used as a fuel, chemical reagent and extracting agent for seeds and 
nuts (Wallace, 1990). The mono-, di-and tri-alkyl derivatives of benzene are used 
primarily as solvents and thinners in the manufacture of perfumes and dye-stuff 
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intermediates. These substances are present in certain petroleum and in distillates 
of coal tar. The current uses of the aromatic compounds as pure products include 
the chemical synthesis of plastics, synthetic rubber, paints, dyes, explosives. 
pesticides, detergents, perfumes and drugs (ASTDR, 1997; Ozdikiciogki and 
Dere, 2004). These compounds are used mainly as mixtures in solvents and 
constitute a variable fraction of gasoline which increases its effects (Pascal et al., 
2002). 
Most people are exposed to a small amount of benzene on a daily basis. Exposure 
of the general population to benzene is through inhalation, dermal/ eye contact 
and by ingestion. Inhalation is the major route of exposure. Benzene is rapidly 
absorbed by the lungs following inhalation exposure. The major sources of 
benzene exposures are tobacco smoke, exhaust from motor vehicles, and 
industrial emission (ATSDR 1997; Pascal et al., 2002). Repeated or prolonged 
skin contact of liquid benzene degreases the skin, causing it to crack and peel. 
Acute toxic effects can result from ingestion of benzene such as burning sensation 
of mucous membranes, nausea, and abdominal pain (ATSDR, 2007). Water and 
soil contamination are also the important pathways of concerns for transmissions 
of benzene contact. Drinking water supplies are contaminated with benzene, most 
frequently from leaking underground petroleum storage tanks (ATSDR, 1997). 
Benzene, being lipophilic in nature is transported in the blood and absorbed by red 
cell membrane, it tends to accumulates in tissues and is metabolized in liver 
primarily by cytochrome P450E1 (P-450) systems (Hannumantharoa et al., 2001). 
The metabolism of benzene is quantitatively the same for animals and humans. 
Metabolism in both systems involves P450 mixed function oxidase enzymes. P450 
found throughout the body and concentrated in the liver. As a result, benzene is 
predominantly metabolized in the liver. Metabolism of benzene is a key in benzene 
induced toxicity (Iron, 1985; Estmond et al., 1987; Barale et al., 1990) however, 
this process is complex, consisting of multiple pathways (Fig-12). There are two 
alternative routes by which first step of benzene metabolism, namely, phenol 
formation, can occur. 
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1) Cytochrome P450 El, or other cyt P450, generate H2O2 when acting as oxidase 
of nicotinamide adenine dinucleotide phosphate (NADPH). The hydrox>l 
radical formed from H2O2 can hydroxylate benzene to yield phenol (Fig-12A). 
2) An alternative mechanism for phenol formation is desingned to reflect on the 
fate of the benzene oxide-oxepin system. Benzene oxide is the first product 
which rearranges itself nonenzymatically to form phenol. Alternatively, benzene 
oxide can be hydrated via epoxide hydroxylase to yield 1, 2-benzene 
dihydrodiol, which can in turn oxidize via dihydrodiol dehydrogenase to form 
catechol (Fig-12B). 
Phenol is further oxidized to polyhydroxylated metabolite hydroquinone and 
catechol then partition to the blood and tissues. Phenol, hydroquinone, and catechol 
are the main metabolites of benzene (Henderson et al. 1989; Smith et al., 1990; 
Ciranni et al., 1991; Ong et al., 1996). Any of the phenolic metabolite conjugates 
with either sulfate or glucouronide. Phenyl and hydroquinone sulfates and 
glucuronides are major metabolites excreted in urine (Sabourin et al., 1989). 
Benzene dihydrodiol is also as sulfates and glucouronide of conjugates. Once in 
blood, these polyhydroxylated metabolites undergo further oxidation to form 
benzequinone (BQ). Benzequinone (BQ) is myelotoxic and clatogenic responsible 
for benzene toxic effects. BQ are probably the electrophillic species which 
covalently bind to cellular macromolecules including DNA and protein and thereby 
may be the ultimate carcinogenic form of benzene. 
Health effects of benzene: 
Benzene exposure has been associated with several serious health effects. The short 
term breathing of high levels of benzene can result in death. Drinking or eating 
foods containing high levels of benzene cause vomiting, irritation to stomach, 
dizziness, sleepiness, and convulsions. The major effects of benzene are chronic 
(long-term). Benzene damages the bone marrow and cause a decrease in red blood 
cells, leading to anemia. It can also cause excessive bleeding and depress the 
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immune system, increasing the chance of infection. Some women who breathed 
high level of benzene for many months had decrease in the size of their ovaries; 
reduce the number of live fetuses as well as the incidence of pregnancy (ATSDR. 
1993; Strucker et al., 1994). In animal, exposure to benzene through inhalation 
produced several harmful effects such as low birth weight, delayed bone formation 
and bone marrow damage (ToxProbe- Benzene). Benzene was first reported to 
induce cancer in humans in the 1920s and cause DNA strand breaks and 
chromosomal damage. Benzene causes leukemia and is associated with other blood 
cancers. Benzene targets kidney, liver and brain and causes global health problem 
(Dundaroz et al., 2003). Some of the specific health effects are described below. 
(a) Nephrotoxicity: 
Studies on experimental animals, case reports, case studies and epidemiologic 
studies have documented the acute and chronic effects of solvents, including 
benzene on the kidney. Organic solvents enter into the human body (inhalation, skin 
contact or ingestion) and undergo circulation. The blood passes through the kidney 
carrying solvent has effects on kidney that are of clinical significance. Although 
within the kidney metabolic processes are less efficient than in liver, 
biotransformation eventually leading to reactive metabolites is known to occur in 
tubular cell (Lock, 1989). This supports the view that certain organic solvents may 
give rise to target specific biotransformation into intermediates metabolites acting 
as genotoxic carcinogens with in the kidney. 
Damage to the kidney has been shown in the experimental animals in the form of 
acute damage to various parts of nephron, especially tubules. This has usually been 
described as tubular degeneration with regenerative epithelium, deposits of mineral 
crystals and of intralobular proteins and interstitial inflammation (Browning, 1965; 
Carpenter et al., 1977; Clayton and Clayton, 1981; Mehlman et al., 1984; Gibson 
and Bus, 1988; Haider et al., 1986). Glomerular damage in experimental animals 
(Coppo, 1988; Emancipator, 1990) suggested that long term solvent exposure alters 
the immune system. Goyers. (1990) suggested an autoimmune mechanism 
39 
responsible for glomerular lesions and induce an initial cell injury sufficient to 
damage cell membranes and to provide the antigen triggering immune response, 
accelerating cascade reactions ending with glomerulonephritis. Chronic glomerular 
damage/ or failure appears to be immunogenically mediated. Degree of exposure 
was significantly higher in patients who had more severe glomerulonephritis. The 
risk of renal cell carcinoma increased with the duration of exposure to benzene (Hu 
et al., 2002). 
Renal function and glomerulonephritis is strongly predicted by degree of 
tubulointerstitial damage, but not by the degree of glomerular damage (Ravnskov, 
1989; 1998) and the urinary excretion of low molecular mass proteins (Johansson 
BG and Ravnskov, 1972) and N-acetyl P-glucosaminidase (Hultberg and Ravnskov, 
1981), markers of tubular cell damage, is increased in most patients with 
glomerulonephritis (Ravnsko, 2000). The impairment in the tissue respiration and 
oxygen phosphorylation and active transport was reported due to benzene 
intoxication (Jonek et al., 1975). Mitochondrial respiration was inhibited 50% by 
benzene. Inhibition of mitochondrial respiration might be likely mechanism for the 
observed additive toxicity (Beach et al., 1992). Earlier studies have shown that 
benzene produce oxidative stress by affecting the activities of antioxidant enzymes 
activities (Rao et al., 1995; Ulakoglu et al., 1998; Halifeoglu et al., 2000). Chronic 
inhalation of volatile substances can alter the levels of antioxidant enzymes 
including SOD, GSH-Px and increase LPO in adolescent abusers (Dundaroz et al., 
2003). Based on the above studies, it is proposed that chronic exposure to low level 
of solvent may mduce an initial cell injury sufficient to damage cell membranes and 
provide the antigen triggering the immune response, accelerating the cascade of 
reactions ending with glomerulonephritis. 
(b) Hepatotoxicitv: 
A number of chemically inert aromatic hydrocarbons, including benzene, are 
converted by hepatic microsomal enzymes to alkylating agents that produce 
centrolobular necrosis by reacting with tissue macromolecules resulting in liver 
damage (Perez et al., 2006). It has been demonstrated that benzene metabolites 
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attach to hepatic enzymes, proteins, monosaccharide and disaccharides resulting in 
energy metabolism dysfunction. Benzene affects enzymes activities in the liver and 
other tissues, decreasing the activity of Glucose-6-phospahtase and causing 
hyperglycemia in blood and decreasing the level of glycogen in the liver 
(Chierpotta et al., 1984; Sukhodub, 1997; Ozdikicioglu and Dere, 2004). 
Benzene exposure increased the activities of LDH and ALP in the serum indicating 
hepatic structural and biochemical damage (Rahman et al., 2000; Khan et al., 2001; 
Dere and Ari, 2008) due to tissue necrosis and plasma membrane dysfunction. 
Benzene has been shovm to decrease the activities of hepatic enzymes; ALP, ACP 
and y-glutamyl transpeptidase suggesting possible hepatic failure among people in 
developing countries (Adeyemi et al., 2009). Benzene exposure also resulted 
alteration in the functions of hepatic microsomes (Sukhodub and Padalko, 1999). 
Several studies have indicated the role of apoptosis and oxidative stress in benzene 
induced liver toxicity (Ugumal et al., 1995; Constan et al., 1996). Malondialdehyde 
and diene conjugate levels were found to be increased in liver homogenates. Pawar 
and Mungikar. (1975) demonstrated increase in liver weight and decrease in protein 
concentration in the postmitochondrial fractions; changes in hepatic drug 
metabolism and lipid peroxidation in the exposed animals. 
(c) Enterotoxicitv: 
Ingestion of benzene is known to cause GI effects. These effects include congestive 
gastritis, intense toxic gastritis, and burning sensation of oral mucous membranes, 
esophagus and stomach. Nausea, vomiting, diarrhea and abdominal pain may also 
result firom oral ingestion of benzene (ATSDR, 2007). However detailed 
histological and biochemical effects in GI system are generally lacking. 
(d) Neurotoxicity: 
Benzene is a known neurotoxicant (Hsieh et al., 1990). Acute inhalation and oral 
exposure of benzene lead to CNS depression or cardiac collapse and respiratory 
arrest. These effects are believed to be caused by itself rather than its metabolites, 
because the onset of CNS effects at extremely high doses is too rapid for 
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metabolism to have occurred. Benzene exposure may cause effects on peripheral 
(Juntunen et al., 1980) and central (Goldstein, 1989) nervous systems. The signs 
and symptoms reported increased incidences of headache, fatigue, paralysis, 
convulsions, memory loss and unconsciousness among workers with significant 
exposures (Fielder et al., 1982; Davies and Levine, 1986). Benzene is also a CNS 
anesthetic- like agent at high concentration due to its solubility in lipids. 
Toluene 
In the research, toluene is now often used as a substitute for benzene. The solvent 
properties of the two are similar but toluene is less toxic and has a wider liquid 
range. Toluene, also known as methyl benzene or phenyl methane, was originally 
named by Jons Jakob Berzeluis. It is a clear, water insoluble, non-corrosive, volatile 
liquid with an aromatic odor/ or typical smell of paint thinner. The molecular 
formula of toluene is CyHg (CeH 5CH3) and molecular mass is 92.14g/ mol. Toluene 
reacts as a normal aromatic hydrocarbon. The methyl makes it around 25 times 
more reactive than benzene. 
C113 
Figure 13: Structure of toluene 
This compound has number of industrial uses: as a solvent carrier, or thinner, in 
paints, rubber, cosmetics and is used to manufacture of other chemicals such as 
benzoic acid, benzaldehyde, benzene, phenol and toluene diisocyanates 
(polyxirethane resins). It is used in the manufacture of detergent and significantly 
contributes to the causation of smog. Toluene can be used to break open red blood 
cells in order to extract hemoglobin in biochemistry experiments. Toluene is also 
present in some of the household products such as adhesives (airplane glue), stains, 
varnishes or lacquers and their associated cleaning solvents; nail polish; art 
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supplies; automotive products; spot removers, pesticides (IPCS, 1986; Low et 
al.,1988; WHO, 2000). 
Absorption of toluene takes place by inhalation, ingestion and in some quantity 
through intact skin (ASTDR, 2000). The main route of exposure to toluene is via 
inhalation i.e. vaporing in ambient air, cigarette smoke, solvent abuse and use of 
household agents (WHO, 2000). Ingestion (contaminated food or water) and dermal 
exposure (use of fuels, solvents and cosmetics) are less common routes of exposure 
to toluene. Exposure to toluene can occur in the workplace. Shoemakers, printers 
and individuals who are involved in the production of toluene or toluene containing 
products are at risk of exposure to considerably higher levels of toluene than the 
general population. Toluene is also released into the environment during its 
transport, production, use and disposal. Toluene has been detected in drinking 
water, well water and in raw water (IPCS, 1986). However, exposure to toluene via 
drinking water is minimal, except in situations where unusually heavy 
contamination occurs (WHO, 2000). Toluene may enter the human system not only 
through vapor inhalation from the liquid evaporation, but also following soil 
contamination events, where human contact with soil, and by ingestion of 
contaminated groundwater. 
Following absorption, toluene is rapidly distributed throughout the body. Human 
and animal inhalation studies have shown high toluene concentrations in adipose 
tissue, bone marrow, adrenals, kidney, liver, brain and blood (DEFRA, 2004). The 
toxicity of toluene can be explained mostly by its metabolism. As toluene has very 
low water solubility, it cannot exit the body via the normal routes (urine, feces, or 
sweat). It must be metabolized in order to be excreted. The methyl group of toluene 
is more easily oxidized by cytochrome P450 than the benzene ring. Following 
inhalation or oral exposure to toluene, approximately 60 - 75% of absorbed toluene, 
is metabolized to benzoic acid (WHO, 2000). The initial step involves side chain 
oxidation to benzyl alcohol by cytochrome P450 enzymes. The toxic metabolites 
are created by the remaining 5% (Chapman et al., 1990; Hanioka et al., 1995) (Fig-
14A). Benzyl alcohol is then further oxidized to benzoic acid by alcohol 
dehydrogenase and aldehyde dehydrogenase to form benzoic acid. Benzoic acid is 
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subsequently conjugated with glycine to form hippuric acid, a major urinary 
metabolite (IPCS, 1986). Benzoic acid may also be conjugated with glucuronic acid 
to form benzoyl glucuronide in the urine. Thus, following inhalation, toluene is 
predominantly excreted in the urine as the metabolite, hippuric acid (Fig-14B). 
Health effects of toluene: 
Toluene is an aromatic hydrocarbon with widespread industrial use as an organic 
solvent. Habitual or sniffing of toluene containing thinner solutions or glues result 
in toxicity. Complications following toluene poisoning include electrolyte and acid-
base disturbances, gastrointestinal complaints (abdominal pain and haematemesis) 
and neurophysiachitric disorder such as altered mental state, cerebellar 
abnormalities and peripheral neuropathy (Streicher et al., 1981). Higher 
concentrations of toluene may result in a narcotic coma, euphoria, headaches, 
nausea and loss of apetite. Toluene has been reported to be fetotoxic. Increased 
risks of spontaneous abortions were observed in occupationally exposed 
women(Lindbohm et al., 1992; Ng et al., 1992; Taskinen et al., 1989). Occupational 
exposure has been associated with decreased plasma level of luetinizing hormone, 
follicle stimulating hormone and testosterone level in males (Svensson et al., 1992a, 
b). However, animal studies showed no evidence for impaired reproductive 
performance (Ono et al., 1995; 1996; Smith, 1983; Thiel and Chahoud, 1997). 
However during pregnancy toluene exposure has been associated with delayed fetal 
growth, retarded skeletal development and can alter the behavioral development of 
offspring (ASTDR 2000; IPCS, 1986). Long term inhalation studies with toluene 
showed several adverse effects such as kidney damage, enlargement of liver, and 
brain damage and decrease in mean body weight (EHC, 1986). Some of the specific 
effects on kidney, liver, intestine and brain described in the following pages. 
(a) Nephrotoxicity: 
Distal renal tubular acidosis is a common finding in toluene abusers (Kamajima et 
al., 1994; Kao et al., 2000) and first reported by Taher et al. (1974). Acute toluene 
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Figure 14: Steps (A) and (B) showing metabolic transformation of toluene. 
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abuse in a woman was observed to have resulted in muscle weakness of the lower 
extremities and complications of renal tubular injury with metabolic acidosis. 
Similar cases of toluene induced renal tubular acidosis have been reported 
(Kamijima et al., 1994; Kao et al., 2000). Toluene is a tubular toxin and contributes 
to the development of renal tubular acidosis and irreversible renal failure (IPCS. 
1986; Kamijima et al., 1994). Askergren. (1984) reported increased protein 
excretion and increased excretion of erythrocytes and leukocytes/ tubular epithelial 
cells in construction workers exposed to toluene. Increased kidney weight, necrosis 
in kidney tubules and pulmonary lesions were found in rats exposed to toluene (Von 
Burg, 1993; ASTDR, 2000). Exposure of toluene results in patients causing severe 
hypokalemia and hypophosphatemia (Tang et al., 2005). The development of 
hypophosphatemia has been rarely reported in literature (Streicher et al., 1981; 
Voigts and Kaufman, 1983). The exact mechanism of renal tubular acidosis and 
hypophosphatemia and other renal effects remains to be elucidated (Tang et al., 
2005). 
(b) Hepatotoxictv: 
Toluene has been shown to have no direct causative association with liver damage 
(Boewer et al., 1988) although there are some reports suggesting slight hepatotoxic 
effect of toluene (Hobara, 1989; Shiomi et al., 1993). Ungvary et al. (1980, 1982) 
reported subchronic exposure to toluene produced increased in liver weight, 
increased SDHactivity and decrease in liver glycogen content. Histopathological 
lesion were also reported in liver of treated animals such as hepatocellular 
hypertrophy, dilation of RER, variation in shape and decrease in number of 
mitochondria but not significant hepatic histopathological changes have been 
reported (Bruckner and Peterson, 1981; ASTDR, 2000). 
Toluene exposure resulted in increased serum ALP, serum bile acids (SBA) and 
LDH (Franco et al., 1986; EHC, 1986). An increased in SBA reflects an impairment 
of anion transport across liver, an early sign of liver dysfunction. Szadkowski et al. 
(1976) found significant reduction in bilirubin and ALP in the liver of toluene 
exposed group. Exposure of toluene decreased serum GPT and y-GTP levels. 
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Miyake. (1979) has reported that decreased hepatocytes GPT level was associated 
with advanced hepatic injury. Toluene produced no carcinogenic response (lARC. 
1999; ASTDR, 2000). Hepatic reticuloendothelial failure was observed in a male 
with a history of toluene exposure (Shiomi et al., 1993). 
(c) Enter otoxicity: 
Ingestion of toluene can cause severe acute toxicity. Local effects following toluene 
ingestion include oropharyngeal and gastric irritation with vomiting and 
haematemesis (NPIS, 2005; Von Burg, 1993). One case study reported abdominal 
pain, haemorrhagic gastritis following ingestion of a paint thinner containing 
toluene (Caravati and Bjerk, 1997), although other studies did not reveal 
gastrointestinal effects even after oral exposure to a lethal dose of toluene. 
(d) Neurotoxicity: 
The nervous system is the critical target of toluene toxicity (ASTDR, 2000). 
Occupational exposure have shown that toluene exposure results in reduced 
thinking, memory, dizziness, drowsiness, blurred vision , tremors and permanent 
damage to brain and death (IPSO, 1986; ATSDR, 2000; NPIS, 2005). Chronic 
exposure results in decrease brain weight, phospholipids concentration and in 
number of neurons in toluene treated rats (Korbo et al., 1996). Other neurological 
effects include paranoid, impairment in speech, hearing and vision were associated 
with toluene abusers (IPCS, 1986; ATSDR, 2000). 
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SCOPE OF THE THESIS 
We are exposed daily to numerous environmental toxins and pollutants. 
Environmental toxins are on the increase and pose problem in the form of very 
serious health risks. These include certain drugs, chemical agents and industrial 
solvents. Industrial solvents constitute an indispensable ingredient of modem 
living. Thousands of toxins find their way into our air, water and soil in which we 
grow our food. They are used extensively in industry as well as in daily life. They 
are used for degreasing, dry cleaning, extractions of fats and oils and can be found 
in a wide range of products including paints, thinners, glues, inks, pesticides and 
cosmetics (ATSDR, 1997). In addition, organic solvents have been detected in a 
variety of urban and rural areas of U.S and other regions of the world and have been 
found in food chains, soil and drinking water (Veeramachaneni et al., 2001; Lock 
and Reed, 2006). Thus these solvents are major occupational hazards and potential 
concern to general population. Since these solvents are lipophilic in nature, they are 
readily absorbed and widely distributed throughout the body and especially 
concentrated/ accumulated in the kidney. Studies in experimental animals, case 
reports, case studies, and epidemiological studies have documented the acute and 
chronic effects of various industrial solvents on human health (Brautbar, 2004). 
Industrial solvents including aliphatic/ aromatic/ chlorinated hydrocarbons are 
known to alter the structure and functions of various organs such as the intestine, 
liver, kidney and brain. Animals studies have shown that a number of xenobiotics 
require enzymatic transformation to reactive metabolites to elicit their toxic effects 
(Lash et al., 1995, 2000a; Bruning and Bolt, 2000; DuTeaux et al., 2003). The 
bioactivation may take place in the kidney or in extrarenal tissues, or extrarenally 
formed metabolites may further metabolize to toxic products in the kidney (Lash et 
al., 2000a, b; Bruning et al., 2000; Voss et al., 2003; Lash et al., 2005). In general, 
xenobiotics including solvents are metabolized by two major pathways; (a) by 
involving mixed fimction monooxygenases of the cytochrome P450 group, (b) by 
conjugation reaction with endogenases substrates; glucouronic acid, sulphates, 
amino acids or mainly glutathione (Lash et al., 1989; Lash et al., 2000a, b; 2006). 
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These pathways produce reactive metabolites that bind cellular macromolecules and 
results in target organ specificity (Cohen et al., 1997). The enzymes involved in 
biotransformation vary with structure of compound in question. Although the 
metabolic processes commonly facilitate excretion and reduce toxicity of non-polar, 
lipophilic compounds, in some cases the metabolites are highly reactive and more 
toxic than the parent compound. 
The present thesis mainly focused on two classes of hydrocarbon solvents. 
1. Chlorinated hydrocarbons e.g. trichloroethylene (TCE) and 
hexachlorobenzene (HCB). 
2. Non-chlorinated hydrocarbons e.g. benzene (BZ) and toluene (TL). 
Exposure to a number of solvents, in general, have been associated with 
nephrotoxicity, hepatotoxicity, neurotoxicity and other disorders of immune, 
endocrine, reproductive and cardiovascular systems. The solvents and metabolites 
are known to be concentrated in the kidney causing solvent induced disruption of 
the structural and functional integrity of the membrane of the kidney cells 
(Ravnkov, 2000; Brautbar, 2004). The proximal tubules of the kidney are especially 
affected resulting in renal dysfunctions (Ravnkov, 2000; Brautbar, 2004). The brush 
border membrane (BBM), mitochondria, microsomes and lysosomes were shown to 
be critical target of solvent induced toxicity. A number of studies have 
demonstrated that solvent exposure is associated with increased risk in the 
development of chronic kidney diseases, glomerulonephritis and renal failure 
(Ravnskov, 2000). The tubular damage is associated with high molecular weight 
protein excretion and changes in glomerular basement membrane (Mutti, 1996). 
Earlier studies identified membranous nephropathy as the most common 
histological type, whereas more recent studies point to IgA nephropathy (Coppo, 
1988; Emancipator, 1990). Acute and chronic renal failures are also listed as 
occupational and experimental hazards by solvent intoxication. 
The liver has been reported to be the next major target organ after kidney of 
hydrocarbons/ solvent toxicity (San Martin de Viale et al., 1977; Bull, 2000; 
Adeyemi et al., 2009). Histopathological studies have shown that TCE/ HCB/ 
benzene or toluene or their metabolites cause morphological alterations in the liver 
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and kidney leading to their enlargement and necrosis (Rahman et al., 2000; Lock 
and Reed, 2006). Most, if not all, pathological lesions encountered in the toxicology 
of chemicals results from biochemical lesions i.e. derangements of the biochemical 
processes involved in the function and regulation of the cells, tissue, organs or 
organisms. Furthermore, differences in the biochemical processes involved in 
metabolic activation and detoxification also have a major influence on the nature of 
the toxic response with respect to differences in sensitivity to toxic chemicals. 
Generation of reactive oxygen species (ROS) and perturbation in antioxidant 
defense system have been linked with cell/ tissue injury (Cojocel et al., 1989; 
Halifeoglu et al., 2000; Dundaroz et al., 2003; Li et al., 2006). Although chlorinated 
and non-chlorinated hydrocarbon/ solvents induced nephrotoxicity, ototoxicity have 
been extensively studied, detailed histological/ biochemical effects of these solvents 
on major tissues such as kidney, intestine, liver and brain, in general, are not 
completely elucidated. Neither biochemical events/ nor mechanism of their toxic 
and other adverse alterations in various tissues are well understood. 
The present work was undertaken to understand the detailed biochemical events/ 
cellular response/ mechanisms of TCE, HCB (chlorinated hydrocarbons), benzene 
and toluene (non-chlorinated hydrocarbons) induced nephrotoxicity and other 
adverse effects in different rat tissues. The specific objectives of the planned 
research included: 
Part-I 
Experiments were conducted to study the effect of TCE on various biochemical 
parameters in serum and on the enzymes of carbohydrate metabolism, brush border 
membrane, lysosomes and oxidative stress in renal cortex, medulla, intestine, liver 
and brain of normal rats. The effect of TCE was also determined on transport of ^ ^Pi 
in BBMV isolated from renal cortex. 
Part II 
Experiments were carried out to determine the effect of HCB on various 
biochemical parameters in serum and on the enzymes of carbohydrate metabolism, 
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brush border membrane, lysosomes and oxidative stress in kidney tissues (renal 
cortex and medulla), intestine, liver and brain of normal rats. 
Part-III 
Experiments were conducted to study the effect of benzene and toluene on various 
biochemical parameters in serum and on the enaymes of carbohydrate metabolism, 
brush border membrane, lysosomes and oxidative stress in kidney tissues (renal 
cortex and medulla), intestine, liver and brain of normal rats. 
Although studying human biology/ pathophysiology is ideal, such studies are 
neither feasible nor ethical. Thus, a vast majority of current biomedical research is 
performed on laboratory animals such as rats. In view of the above, the present 
studies were performed using Wistar rats as a model for humans due to their close 
physiological proximity to that of humans. 
To understand the mechanism of industrial solvent induced nephrotoxicity and 
adverse effects in other tissues such as intestine, liver and brain. The following 
parameters/ biomarkers of energy metabolism/ mitochondria/ lysosomes/ BBM and 
oxidative stress were determined. 
(a) Serum parameters such as cholesterol, blood urea nitrogen (BUN), creatinine, 
inorganic phosphate, and phospholipids were estimated to determine the effect 
of industrial solvents (TCE, HCB, benzene and toluene) induced nephro- and 
hepatotoxicity. 
(b) Various enzymes of carbohydrate metabolism e.g., LDH, MDH, G6Pase. 
FBPase, G6PDH and ME were determined as representatives enzymes of 
glycolysis, TCA cycle gluconeogenesis and HMP-shunt pathway, respectively. 
(c) Activities of ALP, GGT, LAP, and/ or sucrase were measured as these enzymes 
are biomarkers of BBM and were used to assess structural/ functional integrity 
51 
of renal and mucosal BBMs, which are major TCE/ HCB/ benzene and toluene 
targets. 
(d) ACP was determined to assess lysosomal dysfunction, as lysosomes are major 
targets. 
(e) LPO, SOD, catalase, were evaluated as the indicators of oxidative stress. 
(f) Pi transport was evaluated as a functional marker of BBM, and for its 
involvement in nutrition/ energy metabolism. 
The present results demonstrated that TCE/ HCB/ benzene and toluene 
administration caused specific alterations in various serum parameters and in the 
enzyme activities of various systems in different tissues confirming nephrotoxic and 
other adverse toxic effects. The results further indicate that exposure of TCE/ HCB/ 
benzene and toluene produced significant biochemical and metabolic alterations in 
different rat tissues albeit differentially most likely by inducing oxidative stress. 
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Material 
and 
Metfiods 
MATERIALS AND METHODS 
MATERIALS; 
Animab: 
Adult male Albino rats (Wistar strain) were purchased from Central Animal House 
Facility, Jamia Hamdard University, New Delhi, India. 
Substrates for carbohydrate metabolism and lysosomal enzymes: 
Sodium pyruvate for lactate dehydrogenase, oxaloacetate for malate 
dehydrogenase, L-malic acid for malic enzyme, D-glucose-6-phosphate for 
glucose-6-phosphate dehydrogenase and glucose-6-phosphatase, fructose-1, 6-
diphosphate for fructose-1, 6-bis phosphatase and p-nitrophenyl phosphate for acid 
phosphatase were purchased from Sisco Research Laboratory (SRL, Mumbai, 
India). 
Substrates for BBM marker enzymes of kidney and intestine: 
p-nitrophenyl phosphate for alkaline phosphatase, y-glutamyl-p-nitroanilide for y-
glutamyl transferase and L-leucine-p-nitroaniline for leucine amino peptidase were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA). Sucrose for sucrase 
was purchased from SRL (Mumbai, India). 
Substrates for enzymes involved in free radical scavenging: 
Pyrogallol for superoxide dismutase and hydrogen peroxide for catalase were 
purchased from SRL (Mumbai, India). 
Radio Chemicals: 
Radioactive phosphate (''^ Pi) was purchased from Bhabha Atomic Research Center, 
India. 
Diet: 
The standard rat pellet diet was obtained from Aashirwaad Industries, Chandigarh, 
India. 
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Toxicant, Pollutant and Oil: 
Trichloroethylene, Hexachlorobenzene, benzene and toluene: Sigma 
Chemical Co. (St. Louis, MO, USA). 
Com Oil: Marico, Mumbai, India. 
Miscellaneous: 
All chemicals used were of the finest quality commercially available and their 
sources are indicated against them. Glass double distilled water was used in all 
experiments. 
SRL, India; Acetic acid. Ammonium molybdate, Bovine serum albumin, Calcium 
chloride (CaCh), Cholesterol, Cocktail-T (Scintillation liquid). Copper sulphate 
(CUSO4), Creatinine, 5, 5'-Dithio-bis 2-nitrobenzoic acid. Ferric chloride (FeCb), 
Ferrous sulphate (FeS04), Folin's phenol reagent, Glucose, Glutathione reduced 
(GSH), Glycine, Glycylglycine, Hydrochloric acid (HCl), Maleic acid, Mannitol, 
Nicotinamide adenine dinucleotide phosphate. Nicotinamide adenine dinucleotide 
phosphate reduced. Nicotinamide adenine dinucleotide reduced, Sodium acetate, 
Sodium azide. Sodium carbonate (Na2C03), Sodium chloride (NaCl), Sodium 
hydroxide (NaOH), Sodium potassium tartarate. 
Sigma Chemical Co., USA; Adenosine triphosphate (ATP), Cysteine 
hydrochloride, N-2-Hydroxyethyl-piperazine-N-2-ethane Sulphonic acid (HEPES), 
p-nitroaniline. Sodium dodecyl sulphate, Thiobarbituric acid (TBA). 
Qualigens, India; Barium hydroxide {Ba(0H)2}, Calcium carbonate. Chloroform, 
Di-potassium hydrogen orthophosphate (K2HPO4), Di-sodium hydrogen 
orthophosphate (Na2HP04), Ethylene diamine tetra-acetic acid (EDTA), Ethanol, 
Hydrogen peroxide. Magnesium chloride (MgCb), Perchloric acid. Picric acid, 
Potassium dihydrogen orthophosphate (KH2PO4), Sodium arsenate. Sodium 
dihydrogen orthophosphate (NaH2P04), Sodium fluoride (NaF), Succinic acid, 
Sulphuric acid (H2SO4), Trichloroacetic acid (TCA), Tris-(Hydroxymeth>i) 
aminomethane (Tris-base), Zinc sulphate (ZnS04). 
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METHODS: 
ANIMAL PROTOCOL; 
(1). Animal Protocol: 
Male Wistar rats weighing 150-200 g were used in all studies. Animals were 
acclimatized for a week prior to the experiment on standard rat pellet diet with free 
access to water. The animal experiments were conducted according to the 
guidelines of Committee for Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA), Ministry of Environment and Forests, Government of India. 
Body weights of rats were recorded at the start and completion of the procedure. 
TCE (1000 mg/ kg b.w/ d), HCB (15mg/ kg b.w/ d), benzene (2500mg/ kg b.w/ d) 
and toluene (15mg/ kg b.w/ d) were given in com oil for 25 days by gavaging. 
Control rats received same amount of com oil daily. 
Body weights of rats were recorded before and after inducing specific experimental 
conditions. The rats were anesthetized with anesthetic ether and sacrificed. Blood 
samples were collected. Kidney and small intestine were harvested and processed 
for the preparation of homogenates and BBMV, utilized for further analyses as 
described in "Methods". 
Blood collection: Before sacrifice of the rats blood was withdrawn from the left 
jugular vein with the help of a disposable syringe. Semm was obtained by 
centriftigation at 2000 x g for 10 min. 
(2). Analysis of Serum Parameters; 
The serum samples were deproteinated with 3% TCA in a ratio of 1:3. After 
incubation for 10 min at room temperature, the samples were centrifiiged at 4000 
rpm (Remi Centrifuge, India) for 10 min. The protein free supematant was used to 
quantitate serum creatinine (Scr) and inorganic phosphate (Pi) and the precipitate 
was saved to quantitate total phospholipids. Cholesterol wa^t^ar^^dhdif^c^y in 
the serum samples. f^K ^ cr''2-,0"> ^ \ 
./5i 
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(i) Quantitative determination of creatinine: 
Creatinine was determined by the method of Levinson and MacFate [1969]. To 0.5 
ml of the deproteinated serum supernatant, 50 ^1 of 10% NaOH and 200 i^ l of 
satiirated picric acid were added and incubated for exactly 20 min at room 
temperature. A calibration curve was simultaneously prepared using known 
concentrations of creatinine solution ranging between 2.0-5.0 jig. The sample and 
the standards were read at 520 nm in Cintra 5 or 10 spectrophotometer against a 
reagent blank. 
(ii) Determination of inorganic phosphate: 
The inorganic phosphate (Pi) was measured in protein free (TCA precipitated) 
serum supernatant by the method of Tausky and Shorr [1953]. The serum 
supernatant (0.5 ml) was diluted to 3 ml with 1.3 ml of glass distilled water and 1.2 
ml of FeS04 reagent (5 gm FeS04 was dissolved in 10 ml, of 10% w/v ammonium 
molybdate in 10 N H2SO4 and diluted to 100 ml with glass distilled water) was 
added. A calibration curve was prepared simultaneously with test samples using 
known concentrations of KH2PO4 (0.018^moles-0.28|^moles). The blue colour 
obtained was read at 820 run after 20 min incubation at room temperature in Cintra 
5 or 10 spectrophotometer against a reagent blank. 
(Hi) Quantitative determination of phospholipids: 
Phospholipids are determined in the serum TCA-precipitates by the method of 
Bartlett [1959] as modified by Marinetti [1962]. The precipitates were digested with 
1 ml of 70% perchloric acid on an electric digestion unit. On cooling to room 
temperature 3 ml of glass distilled water was added. The phosphate (inorganic) 
released was estimated by adding 2 ml of FeS04 reagent by the method of Tausky 
and Shorr [1953] as described above in Pi estimation. The phospholipid values were 
obtained after multiplying the phospholipid phosphorus by a factor of 25. 
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(iv) Quantitative determination of cholesterol: 
Cholesterol was determined by the method of Zlatkis et al. [1953]. To 3 ml acetic 
acid, 30 |LI1 serum sample was added. To this, 2 ml of FeCla reagent (prepared by 
diluting 1 ml of 10% FeCls w/v in glacial acetic acid to 100 ml with concentrated 
H2SO4) was added carefully from the side to allow the formation of a brown ring. 
The samples were shaken thoroughly, cooled and colour density was read in Cintra 
5 or 10 spectrophotometer at 560 nm against a reagent blank. A calibration curve 
was simultaneously prepared using known concentration (0.02- 0.2 mg) of 
cholesterol. 
(v) Determination of blood urea nitroeen andelucose: 
Levels of urea and glucose were assayed by standard colorimetric procedures, urea 
by reaction with diacetyl monoxime and glucose by reaction with o-toluidene using 
kits from Span Diagnostics (Surat, India). 
(3). Preparation of tissues homogenate(s); 
(i) Kidney homogenate (cortex and medulla) for determination of metabolic enzymes: 
After the completion of treatment (TCE, HCB, benzene and toluene) the kidneys 
were carefully separated from the treated and control animals, and homogenized in 
0.1 M Tris-HCl buffer pH 7.5 by a glass-teflon homogenizer (Thomas PA, USA) by 
passing 5 pulses; at 4°C to make a 15% w/v homogenate. The homogenate was then 
subjected to high speed Ultra-Turrex Kunkel homogenizer (Type T-25, Janke & 
Kunkel GMBH «& Co. KG. Staufen) for 3 pulses of 30 s each with an interval of 30 
s between each stroke. Homogenate was centrifuged at 2000 rpm at 4°C for 10 min 
in Beckman J2-M1 (Beckman instruments. Inc Palo Alto, C.A. USA) high-speed 
refrigerated centrifiage to remove the cell debris. The supernatant was saved in 
aliquots and stored at -20°C for analyses of metabolic enzymes (Fig-15). 
57 
(ii) Intestinal mucosal homogenate for the determination of metabolic enzymes: 
After the completion of treatment schedule (TCE, HCB, benzene and toluene) the 
small intestines from the treated and control animals were removed, washed with 1 
mM Tris-HCl, 0.9% NaCl, pH 7.5 and slit open in the middle. The mucosa was 
gently scraped with a glass slide and was used in the preparation of homogenate. 
Mucosal scrapings were homogenized in 0.1 M Tris-HCl buffer, pH 7.5, in a glass-
teflon homogenizer at 4°C to make a 10% w/v homogenate. The homogenate was 
then subjected to high speed Ultra-Turrex Kunkel homogenizer for 3 pulses of 30 s 
each with an interval of 30 s between each stroke. Homogenate was centrifuged at 
2000 rpm at 4°C for 10 min in Beckman J2-M1 high-speed refrigerated centrifuge 
to remove the cell debris. The supernatant was saved in aliquots and stored at -20°C 
for analyses of metabolic enzymes (Fig 15) 
(iii) Homo2enates for enzymatic and non-enzvmatic antioxidant parameters: 
A 10% homogenate of cortex, medulla and intestinal mucosa was prepared in 0.1 M 
Tris-HCl buffer, pH 7.5, in a glass-teflon homogenizer with 5 complete strokes. The 
homogenate was then subjected to high speed Ultra-Turrex Kunkel homogenizer for 
3 pulses of 30 s each with an interval of 30 s between each stroke. One part of the 
homogenate was saved at -20°C for estimation of total -SH and lipid peroxidation 
and other was centrifuged at 5000 rpm for 15 min at 4°C and supernatant was stored 
at -20°C for analyses of free-radical scavenging enzymes. 
(4). Preparation of Brush Border Membrane(s) (BBM); 
(i) Renal BBM preparations: 
After the completion of treatment schedule, the kidneys from treated and control 
animals were removed, decapsulated and kept in ice-cold buffered saline (154 mM 
NaCl, 5 mM Tris-HEPES, pH 7.4). Each kidney was cut horizontally into two 
halves and the whole cortex (WC) was carefully separated from medullary and 
papillary portions. The BBM vesicles (BBMV) were prepared by the method of 
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Schimtz et al. [1973] using MgCb for precipitation of membranes other than BBM 
as described by Yusufi and Dousa. [1987] and as outlined in schematic diagram 
(Fig-15). In each experiment, tissues from three to six animals (control and 
experimental) were pooled to obtain a sufficient amount of starting material. All the 
steps involved were strictly carried out at 0-4°C unless otherwise specified. 
a) The cortical tissue for the preparation of BBMV was homogenized in a 
buffered solution containing 50 mM maimitol, 5 mM Tris base/HEPES, pH 
7.5 (5ml/g tissue) with four complete passes by glass-teflon homogenizer. 
b) The homogenate (10% w/v) was diluted with the above solution (20ml/gm 
tissue) followed by high speed homogenization (Ultra-Turrex Kunkel 
homogenizer) with three pulses of 30 s each with 30 s interval between each 
pulse. Aliquots of cortical homogenates were saved and quickly frozen for 
further analyses. 
c) 1 M MgCl2 was added to the homogenate (to a final concentration of 10 
mM) and kept on ice for 20 min with intermittent shaking. 
d) The homogenate was then centrifuged at 5000 rpm (2000 x g) for 10 min in 
a Beckman J2-M1 refrigerated centrifuge using JA-17 rotor. 
e) The pellet was discarded and the supernatant was recentrifuged at 17,000 
rpm (35,000 x g) for 30 min. 
f) The pellet thus obtained was resuspended in a solution containing 300 mM 
mannitol, 5 mM Tris base/ HEPES, pH 7.5 with four passes by a loose 
fitting Dounce homogenizer (Wheaton IL, Thomas PA, USA) and 
centrifuged at 17,000 rpm (35,000 x g) for 30 min in 15 ml corex glass tube 
using JA-20 rotor. 
g) The supernatant was discarded and the white outer portion of the fluffy 
pellet was resuspended carefully in a small volume of buffered 300 mM 
mannitol, leaving the dark brown centre of the pellet undisturbed 
(mitochondrial contamination). 
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The suspension thus obtained was homogenized by hand held Douncer. This BBM 
suspension was quickly frozen in small aliquots and used for enzyme analysis while 
aliquots of freshly prepared membranes were used for transport studies. 
(ii) Intestinal BBM Preparation: 
After the completion of treatment schedule (TCE, HCB, benzene and toluene), the 
small intestines from treated and control animals were removed, washed with 1 mM 
Tris-HCl, 0.9% NaCl, pH 7.5 and slit open in the middle. The mucosa was gently 
scraped with a glass slide and was used in the preparation of intestinal BBM. The 
intestinal BBM was prepared as described by Kessler et al. [1978] using CaCb for 
precipitation of membranes other than BBM with a few modifications, as outlined in 
schematic diagram (Fig-15). All procedures were carried out at 0-4°C unless 
otherwise specified. 
(a) The mucosal scrapings for the preparation of BBMV were 
homogenized in a buffered solution containing 50 mM mannitol, 2 mM 
Tris-HCl, pH 7.5 with four complete passes by a glass-teflon 
homogenizer. 
(b) The mucosal homogenate was diluted with the above Tris-mannitol 
buffer (15 ml/g tissue) and further homogenized using Ultra Turrex 
Kunkel homogenizer at high speed with three pulses for 30 s each with 
30 s interval between each pulse. Aliquots of mucosal homogenates 
were saved and quickly frozen for further analyses. 
(c) Homogenate was then passed through four layers of cheesecloth and 
CaCl2 was added to the filtrate (to a final concentration of 10 mM), with 
constant stirring and the solution was left on ice for 15-20 min. 
(d) The homogenate was then centrifuged at 5000 rpm (2000 x g) for 10 min 
in a Beckman J2-M1 refrigerated centrifuge using a JA-17 rotor. 
(e) The pellet was discarded and supernatant was centrifuged at 17000 rpm 
(35000 X g) in JA-17 rotor for 30 min. 
60 
(f) The mucosal scrapings for the preparation of BBMV were homogenized 
in a buffered solution containing 50 mM mannitol, 2 mM Tris-HCl, pH 
7.5 with four complete passes by a glass-teflon homogenizer. 
(g) The mucosal homogenate was diluted with the above Tris-mannitol 
buffer (15 ml/g tissue) and further homogenized using Ultra Turrex 
Kunkel homogenizer at high speed with three pulses for 30 s each with 
30 s interval between each pulse. Aliquots of mucosal homogenates 
were saved and quickly frozen for further analyses. 
The suspension thus obtained was homog,enized by hand held Douncer. This BBM 
suspension was quickly frozen in small aliquots and used for enzyme analysis. 
(5). Enzyme Assay; 
• All enzymes were assayed at zero order kinetics unless otherwise specified. 
• The activities of each enzyme from various comparing groups were 
determined simultaneously under similar conditions by using same solutions 
to avoid day to day experimental variations. One unit of enzyme activity is 
defined as the amount of enzyme required to catalyze the formation of 1 
[imole of product per min or hour under the specified experimental conditions. 
• Specific activity is defined as the enzyme unit per mg protein. 
The enzymes of carbohydrate metabolism, enzymatic and non-enzymatic 
antioxidant parameters were assayed in cortical, medullary and intestinal 
homogenates and marker enzymes of brush border membrane were measured in 
respective homogenates and BBMV. 
(A) Assay of carbohydrate metabolism enzvmes: 
The assays were carried out in kidney {cortical homogenate (CH) and medullary 
homogenate (MH)} and intestine {mucosal homogenate (IH)} by measuring the 
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RAT RENAL CORTEX RAT INTESTINE 
Everted and washed with 
Tris buffered saHne pH 7.5 
CORTICAL HOMOGENATE MUCOSAL SCRAPING 
50 mM Mannitol, 5 mM Tris-HEPES, pH 7.5 
High speed Homogenization (Ultra-Turrex) 
CBBMV IN HOMOGENATE 
,2+ Mg precipitation 
TBBMV IN HOMOGENATE 
• Centrifugation at 2000 x g for 10 min • Ca precipitation 
CBBMV IN SUPERNATANT TBBMV IN SUPERNATANT 
PELLET 
DISCARDED 
CBBMV/IBBMV purification by 
centrifugation at 35000 x g for 
30 min 
CBBMV FN PELLET 
SUPERNATANT 
DISCARDED 
'Centrifugation at 35000 x g 
for 30 min 
TBBMV IN PELLET 
CBBMV IN PELLET 
Suspended in 300 mM Mannitol 
5mM Tris-HEPES pH 7.4 SUPERNATANT DISCARDED 
TBBMV IN PELLET 
Suspended in 
50 mM Sodium Maleate pH 6. 
Figure 15: Schematic representation of BBMV preparation from rat renal cortex 
and intestinal mucosa (CBBMV=cortical BBMV, IBBMV= intestinal 
BBMV). 
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extinction changes in a Calbiometer (Calbiochem, USA) fixed at 340 nm or Cintra 
5 (GBC, Scientific Equipment Pty. Australia) in a final volume of 3 ml at room 
temperature (28-30°C). The net reaction rate was measured by difference of the 
extinction values obtained from addition of the substrate only and for actual 
enzymatic reaction following the addition of substrate. The molar extinction 
coefficient of NADH and NADPH used in calculation of reaction rate was 6.22 
mM''cm'' at 340 nm. G6Pase and FBPase were assayed at 37°C. 
(i) Lactate dehydrogenase (L-Lactate: NAD oxidoreductase; LDH; E.C. 1.1.1.27): 
The activity of LDH was measured by the method of Komberg. [1955]. The 
reaction mixture, in a total volume of 3 ml, contained 150 fimoles Tris-HCl buffer 
pH 7.4; 10 )j,moles MgCla; 5 ^imoles sodium pyruvate; 0.24 ^xmoles NADH and 4.0-
6.0 |ig protein. The activity was measured as decrease in absorbance, by pyruvate 
dependent NADH oxidation to NAD"*^  for 5 min at 340 run. 
(ii) Malate dehydrogenase (L-Malate: NAD oxidoreductase; MDH; E.C. 
1.1.1.37): 
The activity of MDH was measured by the method of Meyer et al. [1948]. The 
reaction mixture, in a total volume of 3 ml, contained 100 ^moles Tris-HCl buffer, 
pH 7.4; 2.5 ^moles oxaloacetate (OAA, pH neutralized to 7.4); 0.24 ^moles NADH 
and 2.0-3.0 ^g protein. The activity was measured as decrease in absorbance, by 
OAA dependent NADH oxidation to NAD"^  for 5 min at 340 nm. 
(ill) Malic enzyme (L-Malate: NADP oxidoreductase; ME; E.C. 1.1.1.40): 
ME was assayed according to the method of Ochoa et al. [1948]. The reaction 
mixture, in a total volume of 3 ml, contained Tris-HCl buffer, pH 7.4, 100 ^imoles; 
10 ^moles MnCb; 5 ^moles L-malic acid (pH adjusted to 7.4); 0.24 ^imoles 
NADP^ and 0.6-1.2 mg protein. The activity was measured as increase in 
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absorbance, by monitoring the malic acid dependent reduction of NADP^ to 
NADPH for 5 min at 340 nm. 
(iv) Glucose-6-phosphate dehydrogenase (D-Glucose-6-phosphate: NADP 
oxidoreductase; G6PDH; E.C. 1.1.1.49): 
G6PDH was assayed by the method of Shonk and Boxer [1964]. The reaction 
mixture, in a total volume of 3 ml, contained Tris-HCl buffer, pH 7.4, 150 f^ moles; 
10 ^moles MgCb; 5 i^ moles glucose-6-phosphate; 0.24 |xmoles NADP*; and 0.6-
1.2 mg protein. The activity was measured by monitoring increase in absorbance, 
by glucose-6-phosphate dependent reduction of NADP* to NADPH for 5 min at 
340 nm. 
(v) Hexokinase (A TP:glucose phospho transferase; HK; E. C. 2.7.1.1.): 
It was assayed according to the method of Crane and Sols [1953]. The reaction 
mixture in a total volume of 1ml contained Tris-HCl buffer, pH 7.4, 50 |imoles; 2 
l^ moles ICH2PO4; 10 ixmoles MgCl2; 5 lamoles ATP; 2 ^moles glucose and 1-1.5 mg 
protein. The reaction was carried out at 37''C and stopped with 0.5 ml of 10% 
ZnS04 and Ba(0H)2 each, after 60 min. The samples were centriftiged at 4000 rpm 
(Remi centrifiige, Mumbai, India) and the remaining glucose was estimated in the 
protein and phosphorylated derivatives free supernatant by the method of Nelson 
[1944]. A calibration curve was simultaneously prepared using a known 
concentration of glucose solution ranging between 5-45 ^ ig. 
(vi) Glucose-6-phosphatase (D-glucose-6-phosphate phosphohydrolase; G6Pase; 
E.C. 3.1.3.9): 
It was assayed according to the method of Shull et al. [1956]. The reaction mixture 
in a total volume of 1.5 ml contained Tris-HCl buffer pH 7.4, 50 ^moles; 10 
lamoles MgCb; 10 [imoles glucose-6-phosphate and 2-3 mg protein. The reaction 
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was carried out at 37°C and stopped with 1ml of 10% TCA after 60 min. The 
samples were centrifuged at 4000 rpm (Remi Centrifuge, Mumbai, India) and 
phosphorus was estimated in the protein free supernatant by the method of Tausky 
and Shorr. [1953]. 
(vii) Fructose-1, 6-Bisphosphatase (D-fructose-1, 6-bisphosphate-l-
phosphohydrolase; FBPase; E.C. 3.1.3.11): 
It was assayed according to the method of Freedland and Harper [1959]. The 
reaction mixture in a total volume of 1.5 ml contained Tris-HCl buffer pH 8.4, 50 
l^moles; 10 ^moles MgCb; 12 |imoles cysteine-HCl; 10 ^imoles fructose-1, 6-
diphosphate; 0.6-0.8 mg protein. The reaction was carried out at 37°C and stopped 
with 1 ml of 10% TCA after 60 min. The samples were centriftiged at 4000 rpm 
(Remi Centrifuge, Mumbai, India) and phosphate released was estimated in protein 
free supernatant by the method of Tausky and Shorr [1953]. 
(B) Assay of lysosomal marker enzymes: 
(i) Acid phosphatase (ACP, E.C. 3.1.3.2): 
The activity of acid phosphatase (ACPase) in cortical, medullary and intestinal 
homogenates was determined by the method of Verjee [1969]. The reaction mixture 
contained 2.4 ml acetate buffer (0.05 M sodium acetate, pH 4.5) and 100 |al enzyme 
(35-40 \xg). The reaction was started by the addition of 0.5 ml p-nitrophenyl 
phosphate (final concentration 0.8 mM in 3ml) and incubated for 15 min at 30''C. 
The reaction was stopped by adding 2ml, 2 N NaOH. A calibration curve of known 
concentrations of p-nitrophenol (0.05-0.4 jamoles) was prepared simultaneously. 
The yellow colour developed was read at 405 nm against a reagent blank. 
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(C) Assay of marker enzymes of brush border membrane: 
The enzymes were assayed simultaneously in kidney {cortical homogenate (CH) 
and cortical BBMV (CBBMV)} and intestine {mucosal homogenate (IH) and 
intestinal BBMV (IBBMV)} under similar conditions by using same solutions to 
avoid day-to-day experimental variations. Aliquots of CH and CBBMV were 
diluted with 10 mM Tris-HCl buffer, pH 7.5 and those of IH and IBBMV with 5 
mM Tris-HCl buffer, pH 7.5 to obtain suitable enzyme protein concentration. 
(i) Alkaline phosphatase (ALP, E.C. 3.1.3.1): 
The activity of ALP in CH, IH and respective BBMV was determined according to 
the method of Shah et al. [1979]. The reaction mixture contained 1.4 ml assay 
buffer (55 mM glycine; 36 mM NaCl and 45 mM NaOH, pH 10.5) and 100 1^ 
enzyme protein (10-25 ^g protein for CH, IH and 4-8 |j,g for BBMV). The reaction 
was started by adding 15 ^ 1 p-nitrophenyl phosphate (final concentration 5.8 mM in 
1.5 ml) and incubated at 37°C for the required time (5-20 min). The reaction was 
stopped by adding 50 ^1 of 5 N NaOH. A calibration curve was prepared 
simultaneously by using known concentration of p-nitrophenol (0.01-0.2 (imoles). 
The colour was read at 405 nm against a reagent blank. 
(ii) y-Glutamyl transferase (GGT, E.G. 2.3.2.2): 
The activity of GGT in CH, IH and respective BBMV was determined according to 
the method of Glossman and Neville [1972]. The reaction was started by adding 
100 ^1 enzyme protein (15-20 ^g for CH; 100 \ig for IH; 2-5^g for cortical BBMV 
and 50 ^g for intestinal BBMV) to 1.9 ml substrate buffer (20 mM MgCb, 2 mM y-
glutamyl-p-nitroanilide, 4 mM glycylglycine, 100 mM Tris-base, pH 8.2) and 
incubated in a shaking water bath maintained at 37°C for the required time (15-30 
min). The reaction was stopped by adding 100 j^ l of 15 M acetic acid. A calibration 
curve of known concentration of standard p-nitroaniline (0.025-0.2 i^ moles) was 
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prepared simultaneously. The yellow colour developed was read at 405 nm against 
a reagent blank. 
(iii) L-Leucine aminopeptidase (LAP, E.C. 3.4.11.2): 
This enzyme was assayed by the method of Goldmann et al. [1976]. The reaction 
was started by the addition of 100 i^l cortical, medullary or intestinal homogenates 
or BBMV (40-60 ^g protein for homogenate and 10-15 |ag for BBMV) to 1.9 ml 
substrate buffer (50 mM sodium phosphate buffer, 0.33 mM L-leucine p-
nitroanilide, pH 7.2) and incubated at 25°C for the required time (15-30 min). The 
reaction was stopped with 100 jxl of 15 M acetic acid. A calibration curve of 
standard p-nitroaniline (0.025-0.20 (xmoles) was also prepared simultaneously. The 
yellow color obtained was read at 405 nm against a reagent blank. 
(iv) Sucrose (KC. 3.2.1.48): 
Sucrase was assayed by the method of Goldstein and Lampen (1975). The reaction 
mixture (0.3 ml) contained 50 pi of 0.1 M sodium maleate buffer, pH 6.0, 200 \i\ of 
diluted BBM or intestinal homogenate and 50 j^ l of 0.1 M sucrose solution. The 
assay mixture was incubated at 37°C for 10 min and the reaction was terminated by 
addition of 200 ^1 of 0.2 M phosphate buffer, pH 7.0, immediately followed by 
heating in a boiling water bath. The tubes were cooled and 0.5 ml of distilled water 
was added. Glucose thus liberated was determined by adding 1 ml of 3, 5-
dinitrosalicyhc acid reagent and kept in a boiling water bath for 5 min, and 3 ml of 
distilled water was again added. A calibration curve was simultaneously prepared 
using known amounts of glucose (0.5-2.5 i^moles) and the colour was read at 540 
nm against a reagent blank. 
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(D) Assay of enzymatic antioxidant parameters: 
The activities of the three key enzymes of the antioxidant defense system i.e. 
superoxide dismutase, catalase and glutathione peroxidase were measured 
simultaneously in the homogenates of cortex, medulla and intestine under similar 
conditions by using same solutions to avoid day-to-day experimental variations. 
(i) Superoxide dismutase (SOD, E.C. 1.15.1.1): 
It was assayed by the method of Marklund and Marklund. (1974). To 0.08 ml of 
supernatant 2.82 ml of 0.05 mM Tris-succinate buffer, pH 8.2 was added, mixed 
well and incubated at 25°C for 20 min. The reaction was started by adding 0.1 ml of 
8 mM pyrogallol solution. Change in absorbance per minute was immediately 
recorded for the initial 3 min at 420 nm. A reference set, containing 0.08 ml 
distilled water instead of supematant solution, was also run simultaneously. 
(ii) Catalase (E.C. 1.11.1.6): 
This enzyme was assayed according to the method of Claiborne [1985] as described 
by Giri et al. [1996]. The assay mixture consisted of 1.95 ml of 0.05 M potassium 
phosphate buffer pH 7.0, 1 ml of 0.019 M hydrogen peroxide and 0.05 ml 
homogenate (50-100 \xg protein) in a final volume of 3 ml. The decrease in 
absorbance at 240 nm was immediately noted after every 30 seconds for 3 min. 
Enzyme activity was calculated using the molar extinction coefficient of H2O2 (436 
M"' cm'' at 240 nm). 
(E) Assay of non-enzymatic antioxidant parameters: 
(a) Lipid Peroxidation: 
Lipid peroxidation (LPO) in various tissue homogenates was determined 
spectrophotometrically by the method of Ohkawa et al. [1979]. To 0.1 ml of tissue 
homogenate 1.5 ml of 20% trichloroacetic acid, 0.2 ml of 8% SDS, 0.7 ml of 
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distilled water and 1.5 ml of 0.8% thiobarbituric acid were added and after mixing 
incubated at 95*'C for 20 min. After cooling to room temperature and centrifiigation 
at 10,000 rpm for 10 min the absorbance of the supernatant was read at 532 nm a 
against reagent blank. Amount of malondialdehyde (MDA, end product of LPO) 
was calculated using the molar extinction coefficient of thiobarbituric acid (8 = 1.56 
xlO^M''cm-'). 
(6). Transport of ^¥i; 
Measurment of inorganic phosphate (^ ^Pi) uptake in BBMVs was carried out at 
25°C by the rapid filtration technique as described by Yusufi et al. (1994) either in 
the presence or absence of a Na-gradient. Uptake was initiated by addition of 30 |al 
incubation medium (100 mM NaCl/KCl, 5 mM Tris-HEPES, pH 7.5, 5 mM 
K2HPO4) and radioactive substrate (^ ^Pi) to 15 ^I BBM suspension (50-100 i^ g 
protein) and incubated for the desired time intervals (see "Results"). At the end of 
the incubation period the uptake was stopped by rapid addition of 3 ml ice cold stop 
solution (delivered by a Cornwall Syringe type pipette) containing 135 mM NaCl, 
10 mM sodium arsenate, 5 mM Tris-HEPES, pH 7.5, and filtered immediately 
through 0.45 \xm DAWP millipore filters and washed 3 times with the same ice cold 
stop solution. Correction for non-specific binding to filters was made by subtracting 
from all data the value of the corresponding blank obtained by filtration of the 
incubation medium without vesicles. The radioactivity of the dried filters was 
measured by liquid scintillation counting (Pharmacia, Sweden) with 10 ml 
scintillation fluid ("Cocktail-T", SRL, Mumbai, India). 
(7). Protein Estimation; 
Protein was measured by the method of Lowry et al. [1951] with minor 
modifications as described by Yusufi et al. [1983]. The samples were made to 0.8 
ml with 0.5% SDS. Then 2 ml alkaline copper reagent was added and after 10 min 
incubation at room temperature 0.2 ml Folin's reagent (1 N) was added with brisk 
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shaking and incubated for 30 min at room temperature. A calibration curve of 
standard BSA (5-80 i^g) was prepared simultaneously. The blue colour obtained 
was read at 660 nm. 
(8). Statistical Analyses; 
Unless specified, all experiments were repeated at least four or five times to 
document reproducibility. AH data are expressed as Mean ± SEM. Significance of 
difference in mean values were evaluated using either one-way analysis of variance 
(ANOVA) followed by a studenfs group t-test for comparison between two mean 
values using SPSS 7.5 software. A probability level of p < 0.05 was selected as 
indicating statistical significance. Most of the changes between various groups were 
compared with control values for better understanding and clarity. 
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and 
discussion 

Hvpothesis-I; 
Trichloroethylene (TCE) is a major environmental contaminant that is both an 
occupational concern and a potential concern for the general population because of 
its widespread use. The effect of TCE was examined on the enzymes of 
carbohydrate metabolism, brush border membrane (BBM) and antioxidant defense 
mechanism in different rat tissues. 
Experimental design I; 
The animal experiments were conducted according to the guidelines of the 
committee for Purpose of Control and Supervision of Experiments on Animals, 
Ministry of Environment and Forests, Government of India. Adult male Wistar rats, 
weighing between 150 andl75 g, were acclimatized to the animal facility for a 
week on standard rat diet (Aashirwad Industries, Chandigarh, India) and allowed 
water ad libitum. Two groups of rats (eight to ten rats/ group) were studied. 
TCE treated rats were given TCE (lOOOmg/ kg body weight/ d) in com oil by 
gavage whereas the control rats received same amount of com oil daily for 25 days. 
The effect of TCE was observed on rats because TCE and its metabolites were 
found toxic to greater extent in male rats compared to female rats and both forms of 
mice (Green et al., 1997; Vaidya et al., 2003). The selection of dose was based on 
preliminary experiments (500-2500mg/ kg/ day) at which TCE produced 
nephrotoxicity with minimal animal's death. After 25 days of TCE administration, 
the rats were sacrificed under light ether anesthesia blood samples were collected 
from non-fasted rats and the liver, kidney, brain and intestine (starting from the 
ligament of Trietz to the end of the ileum) were extracted and kept in buffered 
saline. The intestines were washed by flushing them with ice-cold buffered saline (1 
mM Tris-HCl, 9 g/L of NaCl, pH 7.4). All the preparations and analyses were 
carried out simultaneously under similar experimental conditions to avoid any day-
to-day variations (Fig-16). 
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Figure 16: Experimental Design I 
(TvfD: normal diet: TCE: Trichloroethvlene) 
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Results I: 
Effect ofTCE on body weieht and serum parameters: 
The effect of TCE was determined on body weight and various serum parameters 
and on the enzymes of carbohydrate metabolism, brush border membrane (BBM) 
and oxidative stress in different rat tissues. TCE was given orally by gavage with 
the dose of lOOOmg/kg body weight for 25 days. This dose was chosen on the basis 
of preliminary experiments that have minimal death occurring in experimental 
animals. Apparently, there was no significant difference in food and water intake 
between control and TCE treated rats. However, TCE caused a small but significant 
decrease in the body weights (Table 1). 
TCE exposure resulted in significant increase in serum creatinine (+18%) and blood 
urea nitrogen (BUN, +52%) indicating TCE induced nephrotoxicity. Serum glucose 
(-37%), inorganic phosphate Pi (-37%) and phospholipids (-20%) significantly 
declined whereas serum cholesterol (+25%) and the activity of serum alkaline 
phosphatase (ALP, +20%) increased by TCE administration (Table 2). 
Effect of TCE on enzymes of brush border membrane (BBM) and lysosome in 
different tissues: 
The effect of TCE was determined on BBM and lysosomal biomarker enzymes in 
the liver, intestine, brain and renal cortical and medullary homogenates and in the 
isolated BBM vesicles fi-om renal cortex and intestinal mucosa to assess the 
integrity of these organelles by TCE exposure. The results summarize in (Table 3 & 
4) demonstrate that TCE differentially altered the activities of various enzymes in 
the homogenates of different rat tissues. The activity of ALP markedly decreased in 
all tissues (-27 to -44%) except in brain where the activity was only slightl}' 
declined (-12%). The activity of GOT significantly lowered in intestine (-36%), 
renal cortex (-24%)) and medulla (-18%) whereas not affected significantly. 
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Table 1: Effect of trichloroethylene (TCE) consumption on body weight (grams) of rats. 
Groups Before treatment After treatment % Change 
Control 150±10.2 157.75±5.25 +5 
TCE 156±6.25 137±8.29 -12 
Results are mean ± SEM of eight different preparations. 
Values in parenthesis represent percentage change from control. 
Significantly different at P< 0.05 from controls. 
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Table 2: Effect of trichloroethylene (TCE) on various serum parameters. 
Groups BUN Creatinine Cliolesterol Phospliolipid Inorganic PO4 ALP Glucose 
(mg/dL) (mg/dL) (mg/dL) (ngs/mL) (nmol/mL) (KAunits) (mg/dl.) 
Control 16.1610.38 0.6610.09 170110.90 162113.46 1.3010.78 45.0211.64 78.8317.35 
TCE 24.5910.49' 0.7810.92* 213110.80* 130116.94* 0.8210.08* 54.07+0.18*49.56+2.39* 
(+52%) (+18%) (+25%) (-20%) (-37%) (+20%) (-37%) 
Results are mean ± SEM of eight different preparations. 
Values in parentheses represent percentage change from control. 
Significantly different at P< 0.05 from controls. 
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Table 3: Effect of trichloroethylene (TCE) on brush border membrane enzymes in 
cortical and medullary homogenates. 
Tissue 
Cortex 
Control 
TCE 
Medulla 
Control 
TCE 
ALP 
12.73+2.17 
8.13+1.36* 
(-36%) 
12.78±1.14 
7.8110.35* 
(-39%) 
GGT 
44.94± 2.05 
33.94±4.79* 
(-24%) 
34.33+2.18 
28.11+2.60* 
(-18%) 
LAP 
8.82+0.55 
6.40± 0.29* 
(-27%) 
11.11±0.59 
10.17+0.49 
(-8%) 
ACP 
3.13+0.25 
2.69+0.29 
(-14%) 
1.55±0.15 
1.36±0.20 
(-12%) 
Results are mean ± SEM of eight different preparations. 
Specific activities are expressed in ^mol/ mg protein/ h. 
Values in parentheses represent percentage change from control. 
Significantly different at P< 0.05 from controls 
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Table 4: Effect of trichloroethylene (TCE) on brush border membrane enzymes in 
intestinal, liver and brain homogenates. 
Tissue ALP GGT LAP ACP Sucrase 
Intestine 
Conrtol 5.9212.03 
TCE 4.3410.49* 
(-27%) 
Liver 
Control 1.4310.19 
TCE 0.80+ 0.04* 
Brain 
Control 
TCE 
(-44%) 
0.9710.00 
0.8510.02 
(-12%) 
29.8213.91 
19.1110.11* 
(-36%) 
6.5910.14 
8.1010.66* 
(+23%) 
17.5511.05 0.8810.10 
14.5310.08* 0.4110.03* 
(-17%) (-53%) 
11.75+0.77 0.27+0.09 
10.2311.90 0.4210.02* 
(-13%) (+56%) 
0.76+0.09 16.7811.82 
1.6010.10* 28.8313.15* 
(+111%) (+72%) 
0.28+0.03 
(+mf^... „. )^  
1 . 5 5 + 0 . 2 2 ' N ! V V w ^ ^ , ^ 
0.8710.10* 
(-44%) 
Results are mean 1 SEM of eight different preparations. 
Specific activities are expressed in |amol/ mg protein/ h. 
Values in parentheses represent percentage change from control. 
* Significantly different at P< 0,05 from controls. 
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in the liver (-17%) and brain (-13%). In contrast, TCE exposure resulted in marked 
decrease of LAP in the liver (-53%) and renal cortex (-27%) whereas increased in 
the brain (+56%) and intestine (+23%) but not changed significantly in renal 
medulla. 
TCE also altered lysosomal enzyme, acid phosphatase (ACP) differentially in 
different tissues. The activity of ACP markedly increased in the liver (+96%) and 
intestine (+111%) whereas significantly decreased in the brain (-44%) but not 
affected significantly in the kidney. The activity of sucrase, a marker of intestinal 
BBM, however, significantly increased (+72%) in the mucosal homogenate. 
Similar to homogenates, the activities of ALP and GGT decreased whereas those of 
LAP and sucrase significantly increased in intestinal BBM by TCE exposure (Table 
5b, Fig-18). In accordance with the alterations in cortical homogenate, TCE caused 
significant decline of ALP, GGT and LAP activities in the BBM, isolated from 
renal cortex (Table 5a, Fig-17). 
Effect of TCE on Na-eradient dependent transport of ^^inoreanic phosphate 
^^Pi) in brush border membrane isolated from renal cortex: 
The bulk of filtered Pi in the kidney is reabsorbed by its proximal tubule. The Na-
gradient dependent (Na outside >Na inside) transport of Pi in renal proximal tubule 
across its luminal brush border membrane (BBM) is an initial and regulatory step. 
The Pi is transported by secondary active transport mechanism requires expenditure 
of energy in the form of ATP generated by cellular metabolism. The effect of TCE 
on the uptake of 32Pi was determined in the presence and absence of a Na-gradient 
in the initial uphill phase (10s, 30s) and at equilibrium after 120min in BBM 
preparations. The rate of concentrative uphill uptake of 32Pi in the presence of Na-
gradient (NaCl in the medium) was markedly increased in TCE compared to control 
rats (Table 6, Fig-19). However, the uptake of 32Pi at the equilibrium phase, at 
120min when Na outside = Na inside was not significantly different between the two 
groups. Also Na-independent uptake (in the absence of a Na gradient, when NaCl in 
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Table 5a: Effect of trichloroethylene (TCE) on BBM Vesicles isolated from renal cortex. 
Groups ALP GGT LAP 
Control 74.9+10.77 353.65+1.61 85.87±0.55 
TCE 41.58+5.98 232.86112.97 64.00+0.29 
(-440/0) (.340/0) ( .25%) 
Table 5b: Effect of trichloroethylene (TCE) on BBM Vesicles isolated from small 
intestine. 
Groups ALP GGT LAP Sucrase 
Control 28.1013.71 98.1913.55 24.4714.86 45.3212.73 
TCE 16.3213.48* 54.8412.45* 42.1214.15* 78.4916.97* 
(-42%) (-44%) (+72%) (+73%) 
Results are mean 1SEM of eight different preparations. 
Specific activities are expressed in [imoll mg protein/ h. 
Values in parenthesis represent percentage change from control. 
* Significantly different at P< 0.05 from controls. 
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Table 6: Effect of TCE administration on uptake of Pi by BBMV. 
(a) Na+ gradient dependent uptake 
Groups 10s 30s 
Control 509±96.12 993±95.23 
TCE 1049±98.80* 1877±77.42* 
(+106%) (+89%) 
120min 
1534±160 
1688±92.30 
(+10%) 
(b) Na+ gradient independent uptal^ e 
Groups 
Control 
TCE 
30s 
118±2.17 
197±14.14 
(+67%) 
120min 
20I2±207 
2151+680 
(+7%) 
(c) Net Na+ gradient dependent uptake at 30s 
Groups Na+ gradient dependent Na gradient independent Net uptake (Na-
K) 
Control 
TCE 
(lOOmMNaCl) 
993+95.23 
1877+77.42* 
(+89%) 
(lOOmMNaCl) 
118+2.17 
197+14.14* 
(+67%) 
875+92 
1680+63.28* 
(+92%) 
BBMV were prepared from whole cortex of rats 25 days after administration TCE or com 
oil (control). Values in parenthesis is percent change from control. 
Uptake of 32Pi is expressed as pmole/ mg protein. 
• Significantly different at P<0.05 from respective controls 
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of Pi in BBMV from renal cortex. 
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the medium was replaced by KCl where Koutside> Ki„side) of ^^ Pi at 30s and 120min 
were also not affected by TCE treatment indicating specific alteration only when 
Na-gradient was present. The net uptake of ^ P^i was also significantly enhanced. 
Effect of TCE on enzymes of carbohydrate metabolism: 
The effect of TCE was determined on the enzymes involved in various pathways of 
carbohydrate metabolism in different rat tissues (Table 7 & 8) to ascertain any 
effect on energy metabolism TCE administration caused significant increase in 
hexokinase (glycolysis) activity in the liver (+90%) followed by intestine (+9%) 
whereas the activity declined in the brain (-12%), renal cortex (-18%) and medulla 
(-17%). However, LDH activity, a marker of anaerobic glycolysis profoundly 
increased in the liver (+265%), intestine (+105%) and brain (+21%) whereas 
significantly lowered in renal cortex (-50%) and medulla (-11%). In contrast, TCE 
significantly decreased the activity of MDH, a TCA cycle enzyme in the liver (-
22%), intestine (-39%), brain (-46%) and renal cortex (-23%) but the activity 
markedly increased in renal medulla (+73%). 
The effect of TCE was also determined on the activities of enzymes involved in 
gluconeogenesis and hexose monophosphate (HMP) - shunt pathway (Table 9 & 
10). The enzymes of these pathways were differentially altered by TCE in different 
tissues. The activities of both G6Pase and FBPase significantly declined in the liver, 
brain and renal cortex whereas increased in renal medulla. The maximum decrease 
and increase was observed in renal cortex and renal medulla, respectively. The 
activity of G6PDH was profoundly increased in the liver (+590%), intestine 
(+205%), brain (+71%) and renal cortex (+177%) whereas decreased in renal 
medulla (-59%). In contrast, TCE caused significant reduction in ME activity in the 
liver (-41%), brain (-43%), renal cortex (-35%) but not significantly in intestine (-
8%). However, ME activity markedly increased in renal medulla (+56%). 
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Table 7: Effect of trichloroethylene (TCE) on metabolic enzymes in cortical and 
medullary homogenates. 
Tissue 
Cortex 
Control 
TCE 
Medulla 
Control 
TCE 
Hexokinase 
25.26± 1.57 
20.68±1.49 
(-18%) 
60.56+ 1.30 
50.38+ 1.48* 
(-17%) 
LDH 
10.00+1.35 
5.00±1.00* 
(-50%) 
13.04+0.41 
11.5710.50 
(-11%) 
MDH 
11.41±1.06 
8.75±0.39' 
(-23%) 
21.59±0.20 
37.3612.22* 
(+73%) 
Results are mean 1 SEM of eight different preparations. 
Specific activities are expressed in )amol/ mg protein/ h. 
Values in parenthesis represent percentage change from control. 
* Significantly different at P< 0.05 from controls. 
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Table 8: Effect of trichloroethylene (TCE) on metabolic enzymes in intestinal, liver and 
brain homogenates. 
Tissue 
Intestine 
Control 
TCE 
Liver 
Control 
TCE 
Brain 
Control 
TCE 
Hexokinase 
64.84± 5.94 
70.92± 1.73 
(+9%) 
8.71+0.15 
16.6011.87* 
(+90%) 
41.03±4.06 
36.09±1.13 
(-12%) 
LDH 
3.23+1.03 
6.64+1.07* 
(+105%) 
17.2115.54 
62.8013.92* 
(+265%) 
6.5610.120 
7.9311.00* 
(+21%) 
MDH 
10.5711.03 
6.4211.02* 
(-39 %) 
3.6210.60 
2.8310.33 
(-22%) 
14.8112.22 
8.0710.56* 
(-46%) 
Results are mean 1 SEM of eight different preparations. 
Specific activities are expressed in jimol/ mg protein/ h. 
Values in parenthesis represent percentage change from control. 
Significantly different at P< 0.05 from controls. 
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Table 9: Effect of trichloroethylene (TCE) on metabolic enzymes in cortical and 
medullary homogenates. 
Tissue 
Cortex 
Control 
TCE 
Medulla 
Control 
TCE 
G6Pase 
0.78+0.05 
0.43±0.or 
(-45%) 
0.67±0.01 
1.01+0.06* 
(+51%) 
FBPase 
0.78±0.01 
0.50±0.05* 
(-36%) 
0.35+0.01 
0.41±0.0l' 
(+17%) 
G6PDH 
3.03±0.48 
8.40±0.40* 
(+177%) 
8.20±0.41 
3.37+0.27* 
(-59%) 
ME 
2.43±0.04 
1.57±0.10* 
(-35%) 
1.83±0.01 
2.8610.09* 
(+56%) 
Results are mean ± SEM of eight different preparations. 
Specific activities are expressed in [imoU mg protein/ h. 
Values in parenthesis represent percentage change from control. 
*Significantly different at P< 0.05 from controls. 
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Table 10: Effect of trichloroethylene (TCE) on metabolic en2ymes in intestinal, liver and 
brain homogenates. 
Tissue 
Intestine 
Control 
TCE 
Liver 
Control 
TCE 
Brain 
Control 
TCE 
G6Pase 
2.14±0.33 
1.93+0.28 
(-10%) 
0.18+0.01 
0.14±0.00* 
(-22%) 
0.27±0.01 
0.23+0.02 
(-15%) 
FBPase 
1.42±0.01 
1.24+0.08 
(-13%) 
0.3710.01 
0.35±0.01 
(-5%) 
0.32±0.02 
0.26±0.004* 
(-19%) 
G6PDH 
12.00±0.57 
36.60±1.45* 
(+205%) 
5.5410.54 
38.2310.75* 
(+590%) 
7.5010.50 
12.80+2.77' 
(+71%) 
ME 
3.1410.005 
2.9010.14 
(-8%) 
2.4510.08 
1.4510.11* 
(-41%) 
3.05+0.11 
1.7410.13* 
(-43%) 
Results are mean 1SEM of eight different preparations. 
Specific activities are expressed in i^ mol/ mg protein/ h. 
Values in parenthesis represent percentage change from control. 
Significantly different at P< 0.05 from controls. 
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Effect ofTCEon the antioxidant parameters: 
It is evident that reactive oxygen species (ROS) generated by various toxins are 
important mediators of cell injury and pathogenesis of various diseases especially in 
the kidney and other tissues (Walker et al., 1999). A major cellular defense against 
ROS is provided by superoxide dismutase (SOD), catalase and some other enzymes. 
To ascertain the role of antioxidant system in TCE induced toxicity, the effect of 
TCE was examined on certain parameters of oxidative stress. TCE administration 
caused significant decrease in SOD and catalase activities in almost all tissues 
(Table 11 & 12). However the decrease in SOD and/ or catalase activity was 
appeared to be tissue specific. The decrease in antioxidant enzyme activities was 
associated with significant elevated lipid peroxidation (LPO) measured in terms of 
malondialdehyde (MDA). 
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Table 11: Effect of trichloroethylene (TCE) on enzymatic and non enzymatic antioxidant 
parameters in cortical and medullary homogenates. 
Tissue 
Cortex 
Control 
TCE 
Medulla 
Control 
TCE 
LPO 
98.83±5.53 
132.29+5.32* 
(+34%) 
54.22+3.07 
101.04+3.46* 
(+86%) 
SOD 
37.86±5.16 
19.24+3.42* 
(-49%) 
54.5512.25 
9.14+1.00* 
(-83%) 
Catalase 
224.68±12.47 
108.88+13.78' 
(-52%) 
133.7011.45 
93.5512.37* 
(-30%) 
Results are mean 1SEM of eight different preparations. 
LPO is in nmoles/ g tissue. 
Specific activities of SOD is in units/ mg protein and catalase is in ^mol/ mg protein/ min. 
Values in parenthesis represent percentage change from control. 
'significantly different at P< 0.05 from controls. 
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Table 12: Effect of trichloroethylene (TCE) on enzymatic and non enzymatic antioxidant 
parameters in intestinal, liver and brain homogenates. 
Tissue 
Intestine 
Control 
TCE 
Liver 
Control 
TCE 
Brain 
Control 
TCE 
LPO 
39.51±1.06 
49.02± 3.80* 
(+24%) 
180.9±7.11 
289.26+0.27* 
(+60%) 
207.53110.57 
283.48±4.40* 
(+37%) 
SOD 
31.48±3.63 
8.06+0.168* 
(-74%) 
90.40120.3 
78.08+0.36 
(-14%) 
51.8613.05 
25.1111.70* 
(-52%) 
Catalase 
11.1510.48 
6.76+ 0.06* 
(-39%) 
31.36+0.09 
9.8910.52* 
(-68%) 
95.10+2.49 
56.0711.70* 
(-41%) 
Results are mean + SEM of eight different preparations. 
LPO is in nmoles/ g tissue. 
Specific activities of SOD is in units/ mg protein and catalase is in ittmoi/ mg protein/ min. 
Values in parenthesis represent percentage change from control. 
'Significantly different at P< 0.05 from controls. 
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<Discussion-I 
DISCUSSION 
Trichloroethylene (TCE) is a major environmental contaminant that is both an 
occupational concern and a potential concern for the general population because of 
its widespread use (Maull and Lash, 1998; Ruder, 2006). TCE produces acute 
toxicity or tumors in several tissues, with target organ specificity and sensitivity 
exhibiting species, strain and sex dependent differences (Bruning and Bolt, 2000; 
Lash et al., 2000a, b, 2001, 2006; Lock and Reed, 2006). Most TCE toxicity is 
dependent on bioactivation, which occurs by two pathways, cytochrome P450 
dependent oxidation and glutathione (GSH) conjugation (Lash et al., 2000b, 2001). 
The present investigation was undertaken to understand the mechanism of TCE-
induced toxic effects in different rat tissues. TCE administration significantly 
increased serum creatinine, BUN and serum cholesterol indicating TCE-induced 
nephrotoxicity and hepatotoxicity in confirmation of earlier morphological and 
biochemical studies (Nomiyama et al., 1986; Chakrabarti and Tuchweber, 1988; 
Lash et al., 2000b; Kumar et al., 2001; Mensing et al., 2002; Lock and Reed, 2006). 
TCE also significantly lowered inorganic phosphate and phospholipids. In order to 
assess the structural and functional integrity of various organelles, the effect of TCE 
was examined on the enzymes of carbohydrate metabolism, brush border 
membrane, lysosomes and oxidative stress. TCE caused specific alterations in 
certain enzymes involved in glycolysis, TCA cycle, gluconeogenesis and HMP-
shunt pathway. The activity of LDH markedly enhanced whereas the acti\'ities of 
MDH, G6Pase and FBPase decreased in the liver, intestine and brain. However, 
these enzymes were differentially affected in renal cortex and medulla. Although 
the actual rates of glycolysis and TCA cycle were not determined, marked increase 
in LDH and decrease in MDH activity indicate a shift in energy production from 
aerobic metabolism alternatively to anaerobic glycolysis most likely due to 
mitochondrial damage caused by TCE (Lash et al., 1995, 2001). The decrease in 
G6Pase and FBPase activities may be the result of decrease in MDH activit}'. Thus 
reduced production of oxaloacetate from malate seems to affect both TCA cycle 
and gluconeogenesis (Banday et al., 2008a, b). The decrease in blood glucose and 
body weight can be attributed to higher consumption of glucose by TCE-induced 
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anaerobic glycolysis (Khan et al., 2009).The activity of G6PDH (HMP-shunt) and 
NADP-malic enzyme (ME), were also differentially altered by TCE exposure. The 
activity of G6PDH profoundly increased whereas ME activity significantly 
decreased in all tissues except medulla where opposite pattern was observed. The 
increased production of NADPH by either enzyme may have increased cholesterol 
biosynthesis and might be responsible for higher blood cholesterol levels. These 
results also support earlier findings that indicated requirement for an NADPH-
generating system for TCE elicited liver toxicity (Allemand et al., 1978). 
Histopathological examinations have shown that TCE caused severe damage to 
kidney and liver (Chakrabarti and Tuchweber, 1988; Kumar et al., 2001; Lash et al., 
2006; Lock and Reed, 2006). The proximal tubule in the kidney was shown to be 
prime TCE target (Chakrabarti and Tuchweber, 1988; Wolfgang et al., 1990; 
Bruning and Bolt, 2000; Lash et al, 2000b). Since brush border membrane (BBM) 
and lysosomes are known TCE targets, the structural and functional integrity was 
assessed by the status of their respective marker enzymes. The activities of BBM 
enzymes; ALP and GOT (except LAP and sucrase in the intestine) were 
significantly but variably decreased in tissue homogenates and in isolated renal and 
mucosal BBM preparations. The decrease in BBM enzyme activities might have 
occurred due to their release from damaged BBM. Excessive excretions of these 
enzymes and other macromolecules were reported in TCE treated rats and rabbits as 
characteristic sign of nephrotoxicity (Chakrabarti and Tuchweber, 1988; Wolfgang 
et al., 1990; Mensing et al., 2002). The activity of lysosomal enzyme, acid 
phosphatase (ACP) was increased in the liver and intestine but decreased in the 
brain. The data convincingly demonstrate that the plasma membranes (especially 
BBM) and lysosomes were selectively affected by TCE exposure although to 
different extents in different tissues. The effect of TCE on renal BBM enzymes was 
accompanied by marked increase in Pi transport across the renal BBM. The 
phosphate required for the production of glycolytic metabolites and ATP infact is 
conserved by the kidney. TCE induced Pi conservation by the kidney appeared to 
improve energy metabolism in kidney as well as in other tissues. However, over 
utilization of Pi may have resulted in lower serum Pi (Khan et al., 2009). Cojocel et 
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al. (1989) have suggested oxidative stress as a possible mechanism in TCE-induced 
nephrotoxicity. Primary biochemical components of the oxidative stress response 
include elevation of lipid peroxidation (LPO), and suppression of GSH and its 
redox cycle enzymes e.g. superoxide dismutase (SOD), GSH-Peroxidase (GSH-Px) 
and/or catalase. TCE has been shown to cause oxidative damage to both liver and 
kidney as indicated by increased LPO (Channel et al., 1998; Torasson et al., 1999). 
TCE induced oxidative stress in the liver has been linked to hepatic peroxisome 
proliferation (Nakajima et al., 2000; Laughter et al., 2004). Increase in LPO and 
decrease in SOD and GSH were also reported in dog plasma (Asian et al., 2000). 
The present results demonstrate that TCE caused perturbation in antioxidant 
defense system as manifested by marked increase in LPO, and decrease in SOD and 
catalase activities. The effect of TCE seems to be tissue specific as the activity of 
SOD profoundly decreased in all the tissues except liver whereas catalase activity 
was preferentially decreased in the liver. The differential effects of TCE observed in 
different tissues on oxidative stress, biochemical and metabolic parameters 
appeared to be due to its variable accumulations and mode of bioactivation which 
occurs by GSH-conjugation and/or cytochrome-P450 oxidation and respectively are 
responsible e.g. renal or liver toxicity (Lash et al., 2001, 2006; Lock and Reed, 
2006). In simimary, the present results demonstrate that TCE administration caused 
specific alterations in the activities of certain enzymes of carbohydrate metabolism, 
BBM and oxidative stress although differentially in different rat tissues. The plasma 
membrane, mitochondria and lysosomes appear to be specific TCE targets as 
evident by the changes in their specific biomarkers. TCE seems to enhance LDH 
activity and Pi transport in order to increase energy dependence on glycolysis due to 
mitochondrial damage. TCE caused reduction in the activities of antioxidant 
enzymes that led to increase in LPO. We conclude that TCE exerts its nephrotoxic 
and other deleterious effects by increasing free radical generation, damaging 
various cellular membranes that ultimately affects energy metabolism. 
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(Part-II 
HvDothesis-II: 
HCB, one of the most persistent environmental pollutant induces porphyria cutanea 
turda (PCT) and produces multiple adverse effects in human and experimental 
animals. The present work was undertaken to determine the effect of HCB induced 
nephrotoxicity and other major adverse effects in different rat tissues. 
Experimental design II; 
The animal experiments were conducted according to the guidelines of the 
committee for Purpose of Control and Supervision of Experiments on Animals, 
Ministry of Environment and Forests, Government of India. Adult male Wistar rats, 
weighing between 150 andl75 g, were acclimatized to the animal facility for a 
week on standard rat diet (Aashirwad Industries, Chandigarh, India) and allowed 
water ad libitum. Two groups of rats (eight to ten rats/ group) were studied. 
HCB treated rats were given HCB (15mg/ kg body weight/ d) in com oil by gavage 
whereas the control rats received same amount of com oil daily for 25 days. After 
25 days of HCB administration, the rats were sacrificed under light ether anesthesia 
and blood samples were collected from non-fasted rats and the kidney, liver, brain 
and intestine (starting from the ligament of Trietz to the end of the ileum) were 
extracted and kept in buffered saline. The intestines were washed by flushing them 
with ice-cold buffered saline (1 mM Tris-HCl, 9 g/L of NaCl, pH 7.4). All the 
preparations and analyses were carried out simultaneously under similar 
experimental conditions to avoid any day-to-day variations (Fig-20). 
Results II; 
Effect of HCB on body weieht and serum parameters: 
Hexachlorobenzene (HCB), one of the most persistent environmental pollutant 
induces porphyria cutanea turda (PCT) and produces multiple adverse effects in 
human and experimental animals (To-Figueras et al , 1997). In spite of great deal of 
information available on HCB-induced hepatotoxicity, its effects especially on 
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Figure 20: Experimental Design II 
rND: normal diet: HCB: Hexachlorobenzene) 
96 
Table 1: Effect of hexachlorobenzene (HCB) consumption on body weight (grams) of 
rats. 
Groups Before treatment After treatment %Change 
Control 
HCB 
160.00±12.02 
165.00±8.56 
172.00±10.06 
128.00±9.20* 
+8% 
-22% 
Results are mean ± SEM of eight different preparations. 
Values in parenthesis represent change from control. 
Significantly different at P<0.05 from controls. 
97 
Table 2: Effect of hexachlorobenzene (HCB) on various serum parameters. 
Groups BUN Creatinine Cholesterol Phospholipid Inorganic PO4 
(mg/dL) (mg/dL) (mg/dL) (figs/mL) (^mol/mL) 
Control 38.00±1.80 0.73±0.01 75.19±1.57 64.16±2.30 5.70±0.12 
HCB 55.61±1.13' 0.86±0.03' 90.25±3.18* 86.17±3.80* 3.]0±0.25' 
(+46%) (+18%) (+20%) (+34%) (-46%) 
Results are mean ± SEM of eight different preparations. 
Values in parenthesis represent change from control, 
'significantly different at P<0.05 from controls. 
kidney, and intestine has not been studied in detail. The present investigation was 
undertaken to determine the effect of HCB on the enzymes of carbohydrate 
metabolism, brush border membrane and oxidative stress in various rat tissues 
including the kidney, liver, intestine and brain for better understanding of its 
mechanism of action. HCB was given orally by gavage with the dose of 15mg/ kg 
b.w/ d for 25 days. This dose was chosen by preliminary experiments that have 
minimal death occurring in experimental animals. Apparently, there was no 
significant difference in daily food and water intake between control and HCB 
treated rats and they remained clinically well throughout the study. HCB treatment 
caused a small decline in the body weight compared to control rats as shown in 
Table 1. 
HCB exposure resulted in significant increase in serum creatinine (+18%) and BUN 
(+46%) indicating HCB induced nephrotoxicity accompanied by significant 
increase in serum cholesterol (+20%) and phospholipids (+34%) whereas inorganic 
phosphate (-46%) was significantly decreased (Table 2). 
Effect of HCB on enzymes of brush border membrane (BBM) and Ivsosome in 
the different tissues: 
To assess the integrity of certain membranes/organelles, the effect of HCB was 
determined on BBM and lysosomal marker enzymes in the liver, brain, intestinal, 
renal cortical and medullary homogenates and in the isolated BBM vesicles from 
renal cortex and intestinal mucosa. The results summarized in Table 3 & 4 show 
that HCB decreased the activities of ALP (-14 to -20%) in all tissues including 
brain albeit differentially in different tissues. The activity of GOT significantly 
decreased in the cortex (-34%), medulla (-24%), liver (-44%) and brain (-52%) by 
HCB exposure to much greater extent compared to ALP activity in these tissues. 
Similarly, HCB exposure also resulted in marked decrease in the activity of LAP in 
almost all tissues. However, in contrast to others tissues, the activities of ALP 
(+31%), GOT (+27%) and LAP (+23%) markedly enhanced in the mucosa) 
homogenates by HCB exposure whereas the activity of sucrase (-36%), an intestinal 
BBM marker was significantly lowered. 
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Table 3: Effect of hexachlorobenzene (HCB) on brush border membrane enzymes in 
cortical and medullary homogenates. 
Tissue ALP GGT LAP ACP 
Cortex 
Control 
HCB 
Medulla 
Control 
HCB 
12.55±0.57 
10.32±0.57 
(-18%) 
29.68±0.72 
25.40±0.41 
(-14%) 
43.38±2.96 
28.43±1.52* 
(-34%) 
27.75±1.35 
21.00±0.99* 
(-24%) 
5.27±0.14 
4.25±0.51 
(-19%) 
6.95±0.31 
4.87±0.ir 
(-30%) 
3.35±0.22 
2.55±0.35' 
(-24%) 
2.31±0.27 
2.02±0.12 
(-13%) 
Results are mean ± SEM of eight different preparations. 
Specific activities are expressed in ^mol/ mg protein/ h. 
Values in parenthesis represent change from control. 
Significantly different at P<0.05 from controls. 
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Table 4: Effect of hexachlorobenzene (HCB) on brush border membrane enzymes in 
intestinal, liver and brain homogenates. 
Tissue ALP GGT LAP ACP Sucrase 
Intestine 
Control 
HCB 
Liver 
Control 
HCB 
Brain 
Control 
HCB 
5.85±0.38 
7.69±0.59* 
(+31%) 
0.95±0.05 
0.76±0.35* 
(-20%) 
1.38±0.02 
1.13±0.01 
(-18%) 
9.20±0.94 
11.72±0.90* 
(+27%) 
5.04±0.40 
2.80±0.50* 
(-44%) 
6.05±0.43 
2.93±0.86* 
(-52%) 
29.21±2.16 
36.00±2.20* 
(+23%) 
6.67+0.37 
5.18+0.50* 
(-22%) 
0.26+0.15 
0.15+0.12* 
(-42%) 
2.15+0.15 
1.75+0.12 
(-19%) 
0.58+0.10 
0.68+0.06 
(+17%) 
1.25+0.12 
0.98+0.05' 
(-22%) 
42.30+5.25 
27.26+1.10* 
(-36%) 
Results are mean + SEM of eight different preparations. 
Specific activities are expressed in nmoU mg protein/ h. 
Values in parenthesis represent change from control. 
Significantly different at P<0.05 fi:om controls. 
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HCB also altered lysosomal enzymes activity, acid phosphatase (ACP) although 
differentially in different tissues. The activity of ACP decreased in the intestine (-
19%), renal cortex (-24%) and medulla (-13%) and brain (-22%) but slightly 
increased (+17%) in liver homogenates. 
Effect of HCB on enzymes of brush border membrane (BBM) in isolated BBM 
preparations from renal cortex and intestinal mucosa: 
The effect of HCB on BBM marker enzymes was further analyzed in BBM 
preparations isolated from renal cortex and intestinal mucosa. The data summarized 
in Table 5a & 5b show a similar activity pattern of BBM enzymes as observed in 
the homogenates, however, the magnitude of HCB effect was more pronounced 
especially in the mucosal BBM. HCB caused profound increase in the activity of 
ALP (+73%), GGT (+174%) and LAP (+64%) but significantly lowered the sucrase 
activity in mucosal BBM. Similar to cortical homogenates, the activities of ALP, 
GGT and LAP significantly decreased in the BBM, isolated from renal cortex (Fig-
21&22). 
Effect of HCB on enzymes of carbohydrate metabolism: 
The main function of kidney i.e. reabsorption of various ions and solutes depends 
on the continuous energy supply as ATP which is generated by various metabolic 
pathways including glycolysis and oxidative metabolism. The acute renal failure 
produced by toxic insuh resulted in reduced oxygen consumption due to damage 
caused to mitochondria and other organelles by toxic insult. The effect of HCB was 
examined on certain enzymes of carbohydrate metabolic pathways. The activities of 
hexokinase and LDH (glycolysis), MDH (TCA cycle), G6Pase and FBPase 
(gluconeogenesis) were determined in the homogenates of various rat tissues. HCB 
treatment caused profound increase in LDH activity in the intestine (+110%) and 
slight increase in brain (+17%) whereas the activity markedly decreased in liver (-
64%), renal medulla (-67%) and to some extent in renal cortex (-13%) compared to 
control rats. However, the activity of other glycolytic enzyme was differentially 
altered (Table 6 & 7). The activity of hexokinase significantly increased in the 
cortex (+24%), liver (+41%) but decreased in renal medulla (-31%), intestine 
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Table 5a: Effect of hexachlorobenzene (HCB) on BBM Vesicles isolated from renal 
cortex. 
Groups ALP GGT LAP 
Control 
HCB 
48.50±3.69 
35.42±0.93* 
(-27%) 
88.90±6.49 
43.95±3.03* 
(-51%) 
54.48±2.64 
40.04±3.14* 
(-27%) 
Table 5b: Effect of hexachlorobenzene (HCB) on BBM Vesicles isolated from small intestine. 
Groups ALP GGT LAP Sucrase 
Control 
HCB 
59.56±3.69 
103.26±6.48* 
(+73%) 
50.60±4.51 
138.89±14.95* 
(+174%) 
25.41±1.16 
41.65±3.17* 
(+64%) 
141.74+23.12 
85.30+13.38* 
(-40%) 
Results are mean ± SEM of eight different preparations. 
Specific activities are expressed in j^ mol/ mg protein/ h. 
Values in parenthesis represent change from control. 
Significantly different at P<0.05 from controls. 
103 
ALP 
_60 
550 
o>40 
E 
?30 
E 
^ 1 0 
Cntrl HCB 
GGT 
nHomog 
oBBM 
CnW HC8 
LAP 
_ 6 0 i 
?50 
0.40 
o30 
j D Homog 
[BBBM_ 
Cntft HCB 
Figure 21: Effect of HCB on the activities of ALP, GGT and LAP in 
cortical homogenates and BBMV. 
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Figure 22: Effect of HCB on the activities of ALP, GOT, LAP 
and sucrase in intestinal homogenates and BBMV. 
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Table 6: Effect of hexachlorobenzene (HCB) on metabolic enzymes in cortical and 
medullary homogenates. 
Tissue 
Cortex 
Control 
HCB 
Medulla 
Control 
HCB 
Hexokinase 
30.88±1.18 
38.34±2.10* 
(+24%) 
36.17±1.50 
24.89±0.87* 
(-31%) 
LDH 
13.16±1.02 
11.51±1.02 
(-13%) 
11.08±1.04 
3.63±0.or 
(-67%) 
MDH 
16.5U2.01 
20.32±2.05* 
(+23%) 
0.27+0.02 
0.41+0.14* 
(+52%) 
Results are mean ± SEM of eight different preparations. 
Specific activities are expressed in |imol/ mg protein/ h. 
Values in parenthesis represent change from control, 
'significantly different at P<0.05 from controls. 
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Table 7: Effect of hexachlorobenzene (HCB) on metabolic enzymes in intestinal, liver 
and brain homogenates. 
Tissue 
Intestine 
Control 
HCB 
Liver 
Control 
HCB 
Brain 
Control 
HCB 
Hexokinase 
54.54±1.73 
36.55±4.15* 
(-33%) 
11.35±1.09 
15.96±1.18* 
(+41%) 
31.22±0.77 
23.13±2.55* 
(-26%) 
LDH 
26.71±2.20 
56.01±2.25* 
(+110%) 
22.00±3.02 
8.00±2.02* 
(-64%) 
6.66±1.02 
7.80+1.82 
(+17%) 
MDH 
4.05+0.32 
3.28+0.22' 
(-19%) 
6.64+0.04 
15.61+1.03' 
(+135%) 
16.77+1.03 
9.66+0.04' 
(-42%) 
Results are mean + SEM of eight different preparations. 
Specific activities are expressed in i^ mol/ mg protein/ h. 
Values in parenthesis represent change from control, 
'significantly different at P<0.05 from controls. 
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(-33%) and brain (-26%). In contrast, HCB caused marked increase in MDH 
activity in all tissues except in brain (-42%) and intestine (-19%) where the activity 
was decreased. 
The effect of hexachlorobenzene was also determined on the activities of enzymes 
involved in gluconeogenesis and hexose monophosphate (HMP) - shunt pathway 
(Table 8 & 9). The enzymes of these pathways were differentially altered by 
hexachlorobenzene in different tissues. The activities of both G6Pase and FBPase 
significantly declined in all tissues albeit differentially. The activities of G6Pase (-
86%) and FBPase (-77%) were maximally decreased in the liver (the major site of 
gluconeogenesis). However, they were also decreased in the renal tissues followed 
by the intestine and brain. The activity of G6PDH was increased in all tissues with 
marked elevation in liver (+156%) whereas ME decreased in all tissues except 
intestine (+35%) and liver (+143%). 
Effect of HCB on the antioxidant parameters: 
It is evident that reactive oxygen species (ROS) generated by various toxins are 
important mediators of cell injury and pathogenesis of various disease. Glutathione 
(GSH) and its redox cycle enzymes e.g. SOD, GSH-Px alongwith lipid peroxidation 
are components of oxidant/ antioxidant system. To ascertain, the role of antioxidant 
system in HCB induced toxicity, the effect of HCB was examined on certain 
enzymatic and non-enzymatic parameters. HCB administration caused significant 
increase in LPO measured as malondialdehyde (MDA) in almost all tissues except 
medulla (Table 10 & 11). It appears that HCB exposure caused severe tissue injur} 
as indicated by profound increase in LPO content in the intestine (+114%), liver 
(+75%), brain (+65%) and renal cortex (+54%). HCB also markedly decreased the 
activity of SOD (-22% to -74%) and catalase (-33% to -71%) although to different 
extent in different tissues. However, HCB caused profound increase in SOD 
(+125%)) and catalase (+178%») activities in medulla that was associated with 
marked decrease in LPO (-75%). 
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Table 8: Effect of hexachlorobenzene (HCB) on metabolic enzymes in cortical and 
medullary homogenates. 
Tissue 
Cortex 
Control 
HCB 
Medulla 
Control 
HCB 
G6Pase 
0.38±0.03 
0.30±0.02* 
(-21%) 
0.42±0.06 
0.17±0.04* 
(-60%) 
FBPase 
0.60±0.02 
0.36±0.05* 
(-40%) 
0.35±0.02 
0.23±0.03* 
(-34%) 
G6PDH 
0.42±0.02 
0.52±0.02* 
(+24%) 
0.32±0.03 
0.38±0.02* 
(+19%) 
ME 
1.34+0.68 
0.84+0.04' 
(-37%) 
0.94+0.21 
0.79+0.01 
(-16%) 
Results are mean ± SEM of eight different preparations. 
Specific activities are expressed in |imol/ mg protein/ h. 
Values in parenthesis represent change from control. 
Significantly different at P<0.05 from controls. 
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Table 9: Effect of hexachlorobenzene (HCB) on metabolic enzymes in intestinal, liver 
and brain homogenates. 
Tissue 
Intestine 
Control 
HCB 
Liver 
Control 
HCB 
Brain 
Control 
HCB 
G6Pase 
1.84±0.08 
1.24±0.20* 
(-33%) 
0.14±0.03 
0.02±0.09* 
(-86%) 
0.29±0.03 
0.21±0.06* 
(-28%) 
FBPase 
0.68±0.09 
0.48±0.03* 
(-29%) 
0.69±0.03 
0.16±0.02* 
(-77%) 
0.32±0.02 
0.26±0.01 
(-19%) 
G6PDH 
0.55±0.02 
0.72±0.09* 
(+31%) 
0.87±0.11 
2.23±0.2r 
(+156%) 
1.96±0.05 
2.62+0.13* 
(+34%) 
ME 
0.43+0.02 
0.58+0.11* 
(+35%) 
0.70+0.07 
1.70+0.02* 
(+143%) 
0.15+0.002 
0.12+0.003* 
(-20%) 
Results are mean ± SEM of eight different preparations. 
Specific activities are expressed in nmol/ mg protein/ h. 
Values in parenthesis represent change from control. 
Significantly different at P<0.05 from controls. 
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Table 10: Effect of hexachlorobenzene (HCB) on enzymatic and non enzymatic 
antioxidant parameters in cortical and medullary homogenates. 
f 
Tissue 
Cortex 
Control 
HCB 
Medulla 
Control 
HCB 
LPO 
151.62±10.30 
233.83±15.42* 
(+54%) 
57.49±7.11 
14.15±1.79* 
(-75%) 
SOD 
44.30±4.63 
22.45±6.10' 
(-49%) 
35.62±5.25 
80.23±5.23* 
(+125%) 
Catalase 
53.85+8.52 
21.24+5.70* 
(-61%) 
86.50+8.02 
240.25+11.00* 
(+178%) 
Results are mean + SEM of eight different preparations. 
LPO is in runoles/ g tissue. 
Specific activities of SOD is in units/ mg protein and catalase is in ^mol/ mg protein/ min. 
Values in parenthesis represent change from control. 
'significantly different at P<0.05 from controls. 
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Table 11: Effect of hexachlorobenzene (HCB) on enzymatic and non enzymatic 
antioxidant parameters in intestinal, liver and brain homogenates. 
Tissue 
Intestine 
Control 
HCB 
Liver 
Control 
HCB 
Brain 
Control 
HCB 
LPO 
52.40±9.72 
111.88±10.36* 
(+114%) 
105.80±5.68 
185.14±8.58* 
(+75%) 
74.02±5.33 
122.17±6.03* 
(+65%) 
SOD 
3.97±0.80 
3.04±0.29* 
(-23%) 
83.64±7.85 
65.16+15.31* 
(-22%) 
62.00+7.50 
15.87+4.22* 
(-74%) 
Catalase 
7.97+0.47 
3.05+0.65* 
(-62%) 
13.08+2.11 
3.82+0.28* 
(-71%) 
123.38+3.25 
82.87+1.23* 
(-33%) 
Results are mean ± SEM of eight different preparations. 
LPO is in nmoles/ g tissue. 
Specific activities of SOD is in units/ mg protein and catalase is in ^mol/ mg protein/ min. 
Values in parenthesis represent change from control. 
Significantly different at P<0.05 from controls. 
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(Discussion-II 
DISCUSSION 
Hexachlorobenzene (HCB), an environmental contaminant and pollutant is an 
aromatic hydrocarbon. It is found in sea ports and shores, and also in whale and 
human serum in detectable amounts (Ohara et al., 1999; Olsson et al., 1999; 
Richardson and Zheng, 1999). HCB is used as a pesticide and fungicide in 
agriculture (Kessabi et al., 1990; Rios de Molina et al., 1996), in the aluminum 
industry (Selden et al., 1997; Selden et al., 1999) and in electrochemical factories 
(Sala et al., 1999; Ballester et al., 2000). The effects of HCB on tissues and blood 
parameters were studied in different species and were shown to be immunotoxic 
(Bemhoft et al., 2000), carcinogenic, hepatotoxic, hepatocarcinogenic (Erturk et al., 
1986; Sala et al., 1999; Kishima et al., 2000), toxic in the reproductive tract 
(Alvarez L et al., 2000), porphyrogenic (Selden et al., 1999; Cochon et al., 1999; 
de Catabi et al., 1999; Fernandez-Tome et al., 2000) and nephrotoxic (Smith et al., 
1983; Andrews et al., 1986; Kessabi et al., 1990; Bouthillier et al., 1991). It also 
had toxic effects on skin, lungs and brown adipose tissue (Chu et al., 1983; Alvarez 
et al , 1999; Michielsen et al., 1999). Porphyria is the major potential toxic 
manifestation of this chemical, both in experimental animals and in humans (To-
Figueras et al., 1997). A porphyria out break has been reported in Turkey between 
1954-1959 by the ingestion of HCB treated seed grains (Gocmen et al., 1986). 
There have been numerous reports on ultrastructural effects of HCB (Mollenhauer 
et al., 1975; 1976; Siersema et al., 1991; Babineau et al, 1991; MacPhee et al., 
1993; Bourque et al., 1995). Morphological studies demonstrated HCB induced 
enlarged hepatocytes, increased liver weight, high content of iron deposits, small 
lipid droplets, polymorphic nuclei and microsteatosis in the liver (Clark et al., 1981; 
Rios de Molina et al., 1996). Koptagel and Bulut. (2002) demonstrated HCB 
induced ultrastructural alterations in the kidney. The study especially revealed 
distinctive renal cortical ultrastructural changes. HCB treated rats demonstrated 
glomeruli with a thickened basement membrane, and hyperaemic and dilated 
capillaries, whereas proximal tubular cells were distinctively degenerated with 
myelin figures in their cytoplasm and increased intracytoplasmic foldings. On the 
other hand, distal tubular cells had large, electron dense mitochondria along with 
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significant microvillous loss and numerous vacuole like structures in their 
cytoplasm. A direct correlation between the oxidative environment and effect 
elicited by the drug on heme metabolism was demonstrated in the renal cortex but 
not in papilla and medulla where the antioxidant systems were higher (Fernandez-
Tome et al, 2000). Since HCB is a highly lipophilic chemical that is frequently 
found in food and accumulates in human tissues after ingestion. Animal studies 
have shown that repeated HCB exposure affects wide range of organ systems 
including kidney, liver, intestine and brain (EHC, 1997). HCB has a very low acute 
toxicity but a considerable chronic toxicity. It is believed that metabolites of HCB 
might be responsible for most HCB induced toxic and other adverse effects. HCB is 
known to metabolize by cytochrome P450 oxidation and glutathione conjugation 
pathways (Koss et al., 1979; 1986). However, the relationship between metabolism 
and toxicity is still not clear. Cytchrome P450 mediated oxidative metabolism has 
been implicated in several toxic effects, notably hypothyroidism (van Raaij et al., 
1991) and porphyria (Van Ommen et al., 1989; Den Besten et al., 1993) in rodent 
chronic studies. 
Although a great deal of information concerning the effect of HCB to some extent 
in the liver has been reported but little is known about the effect of the xenobiotic 
on the enzymes of carbohydrate metabolism, brush border membrane and oxidative 
stress in the kidney, intestine, liver and brain. The present investigation was 
undertaken to understand the biochemical mechanism of HCB induced toxic and 
other adverse effects. The effect of HCB exposure was examined on the enzymes of 
carbohydrate metabolism, brush border membrane, lysosomes and antioxidant 
defense system in rat kidney, intestine, liver and brain. 
Repeated oral exposure of HCB resulted in significant increased of serum 
creatinine, BUN, serum cholesterol indicating HCB induced nephrotoxicity and to 
some extent hepatotoxicity in confirmation of earlier morphological and 
biochemical studies (Mollenhaur et al., 1975; Siersema et al., 1991; Bouthiller et al, 
1991; Rios de Molina et al., 1996; Koptagel and Bulut, 2002; Yasong et al., 2006; 
Chaufan et al., 2006). Serum inorganic phosphate (Pi) significantly decreased and 
the gain in body weight was also lowered by HCB as compared to control rats. 
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In order to assess the effect of HCB on the structural and functional integrity of 
various cellular organelles, the enzymes of carbohydrate metabolism, BBM. 
lysosomes and antioxidant defense were determined. HCB caused specific/ 
selective alterations in certain representative enzymes of glycolysis, TCA cycle, 
gluconeogenesis and HMP-shunt pathway in homogenates of different rat tissues. 
HCB caused significant increase in hexokinase activity in renal cortex and liver but 
the activity profoundly decreased in renal medulla, intestine and brain. In contrast, 
the activity of LDH (a marker enzyme of anaerobic glycolysis) decreased in the 
renal cortex, renal medulla and in the liver but profoundly increased in the intestine 
and slightly in the brain. An opposite pattern of HCB effect was observed in MDH 
activity. The activity of MDH significantly increased both in renal cortex and 
medulla and to much greater extent in the liver whereas decreased in the intestine 
and brain. A marked increase of LDH activity in the intestine appeared to be in 
accordance with the fact that anaerobic glycolysis is more prevalent in the intestine 
to meet energy requirements. A profound increase in MDH activity in renal medulla 
and liver indicate an increase in oxidative metabolism due to suppression of 
glycolysis and this seems to be a compensatory adaptive cellular response. 
The effect of HCB was also observed on the enzymes of gluconeogenesis. The 
activities of G6Pase and FBPase significantly decreased in all the tissues studied by 
HCB exposure. However, the effect was more pronounced in the medulla and liver. 
The results indicate an overall suppression of gluconeogenic activity in most of the 
tissues. Since HCB is very lipophilic and are generally accumulates in lipid and fat 
cells of the body, it might have enhanced lipid metabolism as indicated by large 
increase in MDH activity in rat tissues. HCB has been shown to decrease 
gluconeogenesis to enhance glucose storage Mazetti et al., 2002; Taira et al., 2004). 
Many of these effects are in agreement with previously published reports (Geike, 
1978; Mazetti et al., 2002). 
The activity of G6PDH (HMP-shunt pathway) and NADP-malic enzyme (ME) 
were differentially altered by HCB oral administration. The activity of G6PDH 
significantly increased in the renal cortex, renal medulla, intestine, liver and the 
brain albeit to different extent. The increase in G6PDH activity was much more 
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marked in the liver. In contrast, the activity of ME significantly decreased in the 
cortex, medulla and brain but increased in the liver and intestine. These enzymes 
were reported to be differentially affected by HCB in brown adipose tissue and liver 
(Carvalho et al., 1993; Alvarez, 1999). In brown adipose tissue both G6PDH and 
ME were decreased whereas increased in the liver. Both G6PDH and ME are 
known to produce cellular NADPH which is required in many reductive anabolic 
pathways especially for lipid synthesis and also play an important role in oxidant/ 
antioxidant system. It appears that increased production of NADPH by either/ both 
the enzymes may have increased lipid synthesis as indicated by increased serum 
cholesterol and phospholipids. Although some of the effects on the enzymes of 
carbohydrate metabolism were similar to those observed by trichloroethylene, 
another chlorinated hydrocarbon (Khan et al., 2009), but there were certain specific 
alterations in certain tissues which were different. This might be due to the fact that 
TCE is an aliphatic whereas HCB is an aromatic hydrocarbon. Moreover, 
differences in the reactive metabolites might be another reason. 
Histological examinations and some biochemical studies have shown that HCB 
caused damage to kidney and liver (Koptagel and Bulut, 2002; Chaufan et al., 2006; 
Yasong et al., 2006). The proximal tubule in the renal cortex was shown to be 
critical target of HCB (Bouthiller et al., 1991). Since BBM is the structural and 
functional entity of the cortical proximal tubule, its integrity was assessed by the 
status of biomarkers enzymes. The activities of BBM enzymes; ALP, GOT and 
LAP significantly lowered by HCB administration in the homogenates of renal 
cortex and medulla and in the liver and brain albeit to different extent in different 
tissues. These enzymes are also structural components of the plasma membrane of 
the hepatocytes, neuronal cells and mucosal BBM of the small intestine. In the 
intestine these are involved in terminal digestion and / or in the transport of amino 
acids and Pi (Yusufi et al., 1987). In contrast to kidney, liver and brain, the 
activities of ALP, GGT and LAP were significantly increased in intestine whereas 
sucrase (a specific marker of intestinal BBM) which is involved in intestinal 
digestion and absorption of carbohydrate was significantly decreased by HCB 
exposure. Furthermore, analysis of BBM enzymes in BBM preparations isolated 
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from renal cortex or intestine showed similar pattern of the activities, however, the 
magnitude of the effect of BBM preparation compared to homogenates was much 
more pronounced. The differences in the effect of HCB on BBM enzymes can be 
attributed to differential metabolism/ accumulation/ accessibility of HCB reactive 
metabolites in different rat tissues (To-Figueras et al , 1997) or to the localization of 
ALP, GGT, LAP/ sucrase in the thickness of the BBM/ plasma membrane (Yusufi 
et al., 1994). The activity of acid phosphatase (ACP), a marker enzyme for 
lysosome also significantly decreased in the renal tissues, intestine and brain but 
increased in the liver by HCB. The data clearly indicate that both plasma membrane 
(especially renal cortical BBM) and lysosomes were selectively damaged by HCB 
administration. The decrease in BBM enzymes in renal cortex might have occurred 
due to their release/ dissociation from damaged BBM followed by their excretion in 
the urine or due to loss of microvilli as reported earlier (Bouthllier et al., 1991; 
Koptagel and Bulut, 2002). 
Fernandez-Tome et al. (2000) have suggested induction of oxidative stress as a 
possible mechanism in HCB induced nephrotoxicity. A direct correlation between 
the oxidative environment and the effect elicited by the drug on heme metabolism 
and lipid peroxidation (LPO) parameters was reported in the renal cortex but not in 
papilla and medulla, where the antioxidant systems were higher (Fernandez-Tome 
et al., 2000). Primary biochemical components of the oxidative stress response 
include elevation of LPO, and suppression of GSH and its redox cycle enzymes e.g. 
superoxide dismutase (SOD), GSH-peroxidase (GSH-Px), and/ or catalase. HCB 
has been shown to cause oxidative damage to both liver and kidney as indicated b> 
increased LPO and/ or reduction in SOD, GSH-Px (Rizzardini et al., 1988; Feldman 
et al., 1989; Fernandez-Tome et al., 2000; Mazetti et al., 2002). HCB induced 
decrease in gluconeogenesis and depletion of thyroid hormones have been 
suggested as the consequence of HCB induced oxidative stress (Van Raiij et al., 
1993; Mazetti et al., 2004). Recently, it has been shown that HCB caused an 
increase in LPO accompanied by suppression of SOD, GSH-Px and/ or catalase in 
fish brain and liver (Song et al., 2006) and in the brain, liver and serum of female 
rats (Li et al., 2006). Confirming earlier reports, demonstrated the present results 
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that HCB caused perturbation in antioxidant defense parameters as manifested by 
marked increase in LPO and decrease in SOD and catalase activities in the cortex, 
intestine, liver and brain but not in the medulla. In medulla, LPO was lowered 
below control values whereas the activities of SOD and catalase profoundly 
increased. The effect of HCB seems to be tissue specific as the LPO profoundly 
increased in the intestine followed by the liver, brain and renal cortex but decreased 
in renal medulla. However, HCB induced decrease in the SOD activity was greatly 
observed in the brain followed by the cortex, intestine and least in the liver. The 
activity of catalase was preferentially lowered in the liver followed by intestine, 
cortex and to a lesser extent in the brain. It appears that HCB caused perturbation in 
the antioxidant defense mechanism by decrease in either SOD as in the brain or by 
catalase as in the liver and in intestine or by both as in renal cortex. It has been 
reported that oxidative tissue damage is dependent on prevailing oxidative 
environment (Fernandez-Tome et al., 2000). The opposite pattern of the effect in 
the medulla can be attributed to this fact where antioxidant mechanism is known to 
be higher than in any compartment of the kidney. 
In summary the present results demonstrate that HCB administration caused 
specific alterations in the activities of certain enzymes of carbohydrate metabolism, 
BBM, lysosomes and oxidative stress although differentially in different rat tissues. 
The plasma membrane, mitochondria and lysosomes appeared to be specific HCB 
targets as evident by selective alterations in their specific biomarkers. HCB induced 
nephrotoxic, hepatotoxic and neurotoxic effects appeared to be at least, in part, due 
to selective alteration in the antioxidant defense parameters. The differential effects 
of HCB observed in different tissues on oxidative stress, BBM, biochemical and 
metabolic parameters can be due to its variable accumulations, mode of 
bioactivation and generation of different reactive metabolites. We conclude that 
HCB caused widespread toxic and other adverse effects in many rat tissues. 
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(Part-Ill 
Hypothesis- III 
Aromatic hydrocarbons are the most common form of inhalant use due to their low 
cost and readily accessibility. The best characterized aromatic hydrocarbons are 
benzene and toluene which are the important components of glues and thinner. 
Glues and thirmer sniffing is, thus, a serious medical problem since these 
hydrocarbons can cause severe damage to kidney, liver and brain. The aim of the 
present work is to examine the effects of benzene and toluene on carbohydrate 
metabolism, gluconeogenesis, brush border membrane (BBM) and antioxidant 
defense mechanism in different rat tissues. 
Experimental design III 
The animal experiments were conducted according to the guidelines of the 
committee for Purpose of Control and Supervision of Experiments on Animals, 
Ministry of Environment and Forests, Government of India. Adult male Wistar rats, 
weighing between 150 and 175 g, were acclimatized to the animal facility for a 
week on standard rat diet (Aashirwad Industries, Chandigarh, India) and allowed 
water ad libitum. Three groups of rats (eight to ten rats/ group) were studied. 
Benzene and Toluene treated rats were given benzene 2500mg/ kg b.w/ d and 
toluene 1500mg/ kg b.w/ d in com oil by gavage whereas the control rats received 
same amoimt of com oil daily for 25 days. After 25 days of benzene and toluene 
administration, the rats were sacrificed under light ether anesthesia and blood 
samples were collected firom non-fasted rats and the liver, kidney, brain and 
intestine (starting from the ligament of Trietz to the end of the ileum) were 
extracted and kept in buffered saline. The intestines were washed by flushing them 
with ice-cold buffered saline (1 mM Tris-HCl, 9 g/L of NaCl, pH 7.4). All the 
preparations and analyses were carried out simultaneously under similar 
experimental conditions to avoid any day-to-day variations (Fig-23). 
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Figure 23: Experimental Design III 
(ND: normal diet; BZ/ TL: Benzene/ Toluene) 
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Results III 
Effect of benzene and toluene on body weisht and serum parameters: 
In general, the rats remained active through out the study. There were no significant 
changes in body weights and food intake between any of the treated and control rats 
(Tablel). 
The results summarized in Table 2 describe the effect of benzene and toluene on 
serum parameters. Benzene and toluene exposure resulted in significant increase in 
serum creatinine (+27%; +20%) and BUN (+33%; +78%) indicating benzene and 
toluene induced nephrotoxicity. Serum cholesterol (+22%; +28%) and 
phospholipids (+18%; +19%) were significantly increased whereas inorganic 
phosphate was significantly decreased by both benzene (-62%) and toluene (-64%). 
Effect of benzene and toluene on enzymes of brush border membrane (BBM) and 
Ivsosome in different tissues: 
To assess structural and functional integrity, the effect of benzene and toluene was 
determined on BBM and lysosomal enzymes in the liver, intestine, brain and renal 
cortical and medullary homogenates and in isolated BBM vesicles from renal cortex 
and intestinal mucosa. Benzene and toluene caused differential/ variable alteration 
in BBM enzyme activities in the homogenates of different rat tissues (Table 3 & 4). 
The activity of ALP (-20% to -30%), GGT (-21% to -31%) and LAP (-20% to -
41%) significantly decreased in homogenates of renal cortex and medulla, and brain 
by both benzene and toluene. The activity of these enzymes was significantly 
lowered in liver but the magnitude of the effect was significantly lower in toluene 
compared to benzene treated rats. However, the effect of benzene and toluene was 
differentially observed in the intestine. The activities of ALP and GGT were 
significantly decreased by benzene whereas increased by toluene exposure in 
intestine. However, LAP activity was similarly decreased by both benzene and 
toluene. The activity of sucrase, a marker of intestinal BBM, however, was 
significantly decreased by both benzene (-38%) and toluene (-16%) in the mucosal 
homogenates (Table 4). 
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Table 1: Effect of benzene and toluene consumption on body weight (grams) of rats. 
Groups Before treatment After treatment % change 
Control 
Benzene 
Toluene 
156.7±2.30 
170.8±4.20 
175.6±7.50 
166.7±8.20 
158.6±3.60 
155.0±4.30 
(+6%) 
(-7%) 
(-12%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Values in paranthesis represent percent change from controls 
* Significantly different at p< 0.05 from controls. 
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Table 2: Effect of benzene and toluene on various serum parameters. 
Groups BUN Creatinine Cholesterol Phospholipid Inorganic PO4 
(mg/dL) (mg/dL) (mg/dL) (|ags/mL) (|imol/mL) 
Control 28.24±3.56 0.15±0.41 1.61±0.07 114.00±0.12 0.73±0.07 
Benzene 37.49±2.04* 0.19±1.05' 1.96+0.07* 134.00±0.07' 0.2810.03* 
(+33%) (+27%) (+22%) (+18%) 
Toluene 50.23±0.83 0.1810.67 2.06+0.06 136.0010.12 
(+78%) (+20%) (+28%) (+19%) 
(-62%) 
0.2610.07 
(-64%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Values in paranthesis represent percent change from controls. 
* Significantly different at p< 0.05 from confrols. 
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Table 3: Effect of benzene and toluene on brush border membrane enzymes in cortical 
and medullary homogenates. 
Tissue 
Cortex 
Control 
Benzene 
Toluene 
Medulla 
Control 
Benzene 
Toluene 
ALP 
33.68±1.64 
23.49±0.96* 
(-30%) 
26.46±1.46* 
(-21%) 
26.71±2.79 
21.33±0.40' 
(-20%) 
19.18±1.27* 
(-28%) 
GGT 
39.54±2.68 
31.09±2.70* 
(-21%) 
27.32±2.30' 
(-31%) 
55.67±0.79 
43.40±0.65* 
(-22%) 
40.25±2.9r 
(-28%) 
LAP 
4.31±0.51 
3.09±0.09* 
(-28%) 
3.46±0.28* 
(-20%) 
3.08±0.09 
2.09±0.03* 
(-32%) 
2.19±0.22* 
(-29%) 
ACP 
1.95±0.18 
2.36±0.09* 
(+21%) 
1.64±0.14 
(-16%) 
2.98±0.11 
4.01±0.09* 
(+35%) 
1.03±0.19* 
(-65%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Specific activities are expressed in ^mol/ mg protein/ h. 
Values in paranthesis represent percent change from controls. 
Significantly different at p< 0.05 from controls. 
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Table 4: Effect of benzene and toluene on brush border membrane enzymes in intestinal. 
liver and brain homogenates. 
Tissue ALP GGT LAP ACP Sucrase 
Intestine 
Control 
Benzene 
Toluene 
Liver 
Control 
Benzene 
Toluene 
Brain 
Control 
Benzene 
Toluene 
3.40±0.085 
2.26±0.ir 
(-34%) 
4.25±0.59* 
(+25%) 
1.23±0.05 
0.93±0.03* 
(-24%) 
0.91±0.02* 
(-26%) 
1.36±0.06 
1.01±0.08* 
(-26%) 
0.99±0.06* 
(-27%) 
32.36±1.63 
19.42±0.59* 
(-40%) 
40.43±3.27* 
(+25%) 
20.68+1.83 
13.75+0.41* 
(-34%) 
9.32+0.63* 
(-55%) 
6.00+0.32 
4.80+0.10* 
(-20%) 
4.43+0.16* 
(-26%) 
5.31+0.21 
3.73+0.26* 
(-30%) 
3.54+0.18* 
(-33%) 
0.82+0.02 
0.45+0.02* 
(-45%) 
0.42+0.02* 
(-49%) 
0.17+0.01 
0.13+0.02* 
(-24%) 
0.10+0.01* 
(-41%) 
2.18+0.12 21.2+1.80 
1.48+0.06* 13.10+1.30* 
(-32%) (-38%) 
3.31+0.41* 17.86+2.50 
(+52%) (-16%) 
1.07+0.02 
0.83+0.008* 
(-22%) 
1.16+0.01 
(+8%) 
0.41+0.04 
0.24+0.02* 
(-41%) 
0.30+0.002* 
(-27%) 
Results are expressed as mean + SEM for 6 - 8 rats. 
Specific activities are expressed in /imol/ mg protein/ h. 
Values in paranthesis represent percent change from controls. 
Significantly different at p< 0.05 fi-om controls. 
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Benzene and toluene also altered lysosomal marker enzyme, acid phosphatase 
(ACP), differentially in different tissues. The activity of ACP markedly increased in 
the renal cortex (+21%) and medulla (+35%) whereas significantly decreased in the 
intestine (-32%), liver (-22%) and brain (-41%) by benzene administration. In 
contrast, toluene administration significantly increased ACP activity in the intestine 
(+52%) but decreased in the cortex (-16%), medulla (-65%) and brain (-27%). 
Effect of benzene and toluene on enzymes of brush border membrane (BBM) in 
isolated BBM vreparations from renal cortex and intestinal mucosa: 
The effect of benzene/ toluene on BBM marker enzymes was further analyzed in 
BBM preparation isolated from renal cortex and intestinal mucosa. The data 
summarized in Table 5 a & b showed similar activity pattern of BBM enzymes as 
observed in the respective homogenates, however, the magnitude was different and 
was more apparent. The activities of ALP, GGT and LAP significantly declined by 
benzene treatment in both renal and intestinal BBM preparation. However, the 
activities of these enzymes in renal cortical BBM were decreased by toluene (Table 
5a, Fig-24) but the activity of ALP and GGT were significantly increased whereas 
the activity of LAP and sucrase decreased in the BBM isolated from intestinal 
mucosa. (Table 5b, Fig-25). 
Effect of benzene and toluene on enzymes of carbohydrate metabolism: 
The effect of benzene and toluene were determined on the representative enzymes 
involved in glycolysis, TCA cycle, gluconeogenesis and HMP-shunt pathway in 
renal cortex, medulla, intestine, liver and brain (Table 6 & 7). The activity of 
hexokinase by both benzene and toluene decreased in renal cortex (-17%; -14%), 
medulla (-15%; -18%) and in the brain (-14%; -11%) but increased in the intestine 
(+11%; +25%) and liver (+12%; +17%). However, LDH (a marker of anaerobic 
glycolysis) significantly enhanced in all tissues by benzene and toluene 
administration except in liver where the activity decreased by both benzene (-18%) 
and toluene (-23%). Benzene administration profoundly increased LDH activity in 
the intestine (+198%) followed by brain (+53%), renal cortex (+38%) and renal 
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Table 5a: Effect of benzene and toluene on BBM Vesicles isolated from renal cortex. 
Groups 
Control 
Benzene 
Toluene 
ALP 
133.21±16.48 
63.22±2.6r 
(-53%) 
84.52±4.75* 
(-37%) 
GGT 
122.05±15.06 
71.77±3.69* 
(-41%) 
80.42±2.09* 
(-34%) 
LAP 
45.16±1.05 
29.35±1.95* 
(-35%) 
32.04±2.64* 
(-29%) 
Table 5b; Effect of benzene and toluene BBM Vesicles isolated from small intestine. 
Groups ALP GGT LAP Sucrase 
Control 
Benzene 
Toluene 
66.14±4.70 
40.88±1.48* 
(-38%) 
96.84±8.76* 
(+46%) 
104.28±5.23 
59.36±2.24* 
(-43%) 
135.02 ±7.45' 
(+29%) 
31.35±0.75 
20.52+1.02* 
(-35%) 
19.54+0.89* 
(-38%) 
64.71+4.29 
37.00+1.30* 
(-43%) 
52.07+1.73* 
(-20%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Specific activities are expressed in ^mol/ mg protein/ h. 
Values in parantheses represent percent change from controls. 
Significantly different at p< 0.05 fi-om controls. 
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Figure 24: Effect of benzene (BZ) and toluene (TL) on the activities of ALP, 
GGT and LAP in cortical homogenates and BBMV. 
128 
ALP 
120 
QHomog 
I B B B M 
Cntrt BZ T\. 
GGT 
DHomog 
D B B M 
Cntrl BZ U 
LAP 
Cntrt BZ TL 
Sucrase 
_ 70 
s 60 
| 5 0 
l « 
o 
| 3 0 ^ 
< 10 
" 0 
DHomog 
• BBM 
Cntrt BZ U 
Figure 25: Effect of benzene (BZ) and toluene (TL) on the activities of ALP, 
GGT, LAP and sucrase in intestinal homogenates and BBMV. 
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Table 6: Effect of benzene and toluene on metabolic enzymes in cortical and medullary 
homogenates. 
Tissue 
Cortex 
Control 
Benzene 
Toluene 
Medulla 
Control 
Benzene 
Toluene 
Hexokinase 
44.00±1.00 
36.62±0.76 
(-17%) 
37.72±1.36 
(-14%) 
35.44±1.60 
30.30±0.51 
(-15%) 
29.08±0.40* 
(-18%) 
LDH 
7.33±0.97 
10.14±0.87* 
(+38%) 
10.67±0.62* 
(+46%) 
7.71±0.50 
9.45±1.59* 
(+23%) 
11.35±0.75* 
(+47%) 
MDH 
8.70±0.40 
3.70+0.16* 
(-57%) 
7.50+0.10 
(-14%) 
9.91+0.20 
7.10+0.05* 
(-28%) 
6.70+0.82* 
(-32%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Specific activities are expressed in jamol/ mg protein/ h. 
Values in paranthesis represent percent change from controls. 
* Significantly different at P< 0.05 fi-om controls. 
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Table 7: Effect of benzene and toluene on metabolic enzymes of intestinal, liver and 
brain homogenates. 
Tissue 
Intestine 
Control 
Benzene 
Toluene 
Liver 
Control 
Benzene 
Toluene 
Brain 
Control 
Benzene 
Toluene 
Hexokinase 
63.10+3.33 
70.10±1.28 
(+11%) 
78.90±1.20* 
(+25%) 
10.21+0.16 
11.43±0.24 
(+12%) 
11.97±0.21* 
(+17%) 
19.4810.95 
16.6710.11 
(-14%) 
17.3710.25 
(-11%) 
LDH 
5.35+0.86 
15.93+2.94* 
(+198%) 
16.63+4.70* 
(+211%) 
32.85+1.05 
27.00+1.40* 
(-18%) 
25.20+3.26* 
(-23%) 
3.40+0.10 
5.20+0.24* 
(+53%) 
4.24+0.12* 
(+25%) 
MDH 
11.20+0.13 
5.89+0.42* 
(-47%) 
7.90+0.25* 
(-29%) 
3.82+0.20 
2.20+0.24* 
(-42%) 
2.60+0.26* 
(-32%) 
7.20+0.32 
5.26+0.26* 
(-27%) 
5.90+0.32 
(-18%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Specific activities are expressed in ^mol/ mg protein/ h. 
Values in paranthesis represent percent change from controls. 
* Significantly different at P< 0.05 from controls. 
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medulla (+23%). Similar to benzene, toluene administration markedly increased 
LDH activity in the intestine (+211%), renal medulla (+47%), renal cortex (+46%) 
and brain (+25%). In contrast, benzene and toluene significantly decreased MDH (a 
TCA cycle enzyme) activity in all tissues. Benzene significantly decreased MDH 
activity in renal cortex (-57%), medulla (-28%), intestine (-47%), liver (-42%) and 
brain (-27%). Similarly, the exposure of toluene significantly decreased MDH 
activity in renal medulla (-32%), intestine (-29%), liver (-32%) but slightly in renal 
cortex (-14%) and brain (-18%). 
The effect of benzene and toluene was also determined on enzymes involved in 
gluconeogenesis and HMP-shunt pathway (Table 8 & 9). The enzymes of these 
pathways were differentially altered by both aromatic hydrocarbons. The activity of 
G6Pase and FBPase (enzymes of gluconeogenesis) declined in all tissues albeit 
differentially. The activity of G6PDH and ME were differentially altered in all 
tissues by benzene and toluene exposure. The activity of G6PDH profoundly 
increased in the intestine (+90%; +58%), renal cortex (+63%; +79%), liver (+62%; 
+50%), renal medulla (+32%; +58%) and brain (+25%; +23%) by both benzene and 
toluene administration. In contrast, both benzene and toluene caused significant 
reduction in the activity of ME in all tissues; renal cortex (-48%; -44%), renal 
medulla (-48%; -29%), intestine (-28%; -29%), liver (-39%; -27%) and brain (-
26%; -20%). The results indicate that solvent exposure resulted in decrease in 
gluconeogenesis and oxidative metabolism whereas the activity of LDH (enzyme of 
glycolysis) significantly enhanced. 
Effect of benzene and toluene on the antioxidant parameters: 
As shown in Table 10 & 11, benzene and toluene exposure resulted in profound 
increase in the production of malondialdehyde (MDA), an end product of lipid 
peroxidation (LPO), in the renal cortex and medulla, liver and to some extent in 
brain. The increase in LPO by benzene and toluene was much more pronounced in 
the liver followed by renal cortex and medulla. However, in the intestine benzene 
significantly increased LPO (+20%) whereas toluene caused significant decrease (-
30%) in LPO. Further, benzene significantly enhanced (+32%) LPO but toluene had 
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Table 8: Effect of benzene and toluene on metabolic enzymes in cortical and medullary 
homogenates. 
Tissue 
Cortex 
Control 
Benzene 
Toluene 
Medulla 
Control 
Benzene 
Toluene 
G6Pase 
0.34±0.02 
0.27±0.01* 
(-21%) 
0.24±0.12* 
(-29%) 
0.06±0.01 
0.05±0.004 
(-17%) 
0.02±0.0r 
(-67%) 
FBPase 
2.23±0.05 
1.63±0.02* 
(-27%) 
1.79±0.01* 
(-20%) 
2.43±0.03 
1.53+0.05* 
(-37%) 
1.55±0.09* 
(-36%) 
G6PDH 
4.23±0.28 
6.91±0.50' 
(+63%) 
7.56±0.25* 
(+79%) 
9.30±0.42 
12.30±0.82* 
(+32%) 
14.68+0.98* 
(+58%) 
ME 
5.05+0.04 
2.62+0.01* 
(-48%) 
2.82+0.04* 
(-44%) 
4.23+0.04 
2.21+0.01* 
(-48%) 
3.02+0.04* 
(-29%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Specific activities are expressed in fimol/ mg protein/ h. 
Values in paranthesis represent percent change from controls. 
* Significantly different at P< 0.05 from controls. 
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Table 9: Effect of benzene and toluene on metabolic enzymes in intestinal, liver and 
brain homogenates. 
Tissue G6Pase FBPase G6PDH ME 
Intestine 
Control 
Benzene 
Toluene 
Liver 
Control 
Benzene 
Toluene 
Brain 
Control 
Benzene 
Toluene 
1.61±0.13 
1.06+0.23* 
(-34%) 
1.2310.33* 
(-24%) 
0.17±0.02 
0.03±0.0r 
(-82%) 
0.09±0.003* 
(-47%) 
0.19±0.03 
0.11+0.001* 
(-42%) 
0.0910.02* 
(-53%) 
4.0210.01 
3.2410.20 
(-19%) 
3.0010.30* 
(-25%) 
0.8210.01 
0.7010.02 
(-15%) 
0.5810.01* 
(-29%) 
0.3210.02 
0.2510.01* 
(-22%) 
0.2010.01* 
(-38%) 
12.6410.82 
24.0011.42* 
(+90%) 
20.0011.92* 
(+58%) 
7.5810.08 
12.2610.02* 
(+62%) 
11.3610.05* 
(+50%) 
9.6010.50 
12.0010.01* 
(+25%) 
11.8010.10* 
(+23%) 
4.1510.04 
2.9810.02* 
(-28%) 
2.95+0.01* 
(-29%) 
5.6810.12 
3.4510.08* 
(-39%) 
4.1610.09* 
(-27%) 
4.051080 
3.0010.10* 
(-26%) 
3.2510.15* 
(-20%) 
Results are expressed as mean ± SEM for 6 - 8 rats. 
Specific activities are expressed in ^mol/ mg protein/ h. 
Values in paranthesis represent percent change from controls. 
* Significantly different at P< 0.05 from controls. 
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Table 10: Effect of benzene and toluene on enzymatic and non-enzymatic antioxidant 
parameters in cortical and medullary homogenates. 
Tissue 
Cortex 
Control 
Benzene 
Toluene 
Medulla 
Control 
Benzene 
Toluene 
LPO 
117.10±19.55 
168.45±20.07* 
(+44%) 
183.57±3.77* 
(+57%) 
89.22+2.30 
112.29+4.38* 
(+26%) 
147.29+8.08* 
(+65%) 
SOD 
39.09+4.33 
22.92+1.53* 
(-41%) 
18.13+0.30* 
(-54%) 
61.39+13.72 
20.21+4.51* 
(-67%) 
13.27+0.27* 
(-78%) 
Catalase 
148.17+8.92 
53.59+6.53* 
(-64%) 
15.25+1.99* 
(-90%) 
58.55+2.81 
31.78+7.60* 
(-46%) 
37.83+1.80* 
(-35%) 
Results are mean ± SEM of eight different preparations. 
LPO is in nmoles/ g tissue. 
Specific activities of SOD is in units/ mg protein and catalase is in jamol/ mg protein/ 
min. 
Values in parenthesis represent percentage change from control. 
Significantly different at P< 0.05 from controls. 
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Table 11: Effect of benzene and toluene on enzymatic and non-enzymatic antioxidant 
parameters of intestinal, liver and brain homogenates. 
Tissue LPO SOD Catalase 
Intestine 
Control 
Benzene 
Toluene 
Liver 
Control 
Benzene 
Toluene 
Brain 
Control 
Benzene 
Toluene 
61.02±2.44 
73.00±2.68* 
(+20%) 
42.54±0.14* 
(-30%) 
62.08±5.87 
98.52±2.77' 
(+59%) 
108.78+4.00* 
(+75%) 
114.27+6.78 
150.32+20.72* 
(+32%) 
120.59+20.23 
(+6%) 
82.81+9.82 
45.24+6.35* 
(-45%) 
109.98+3.98* 
(+33%) 
83.27+4.74 
37.58+10.41* 
(-55%) 
34.21+4.98* 
(-59%) 
27.80+7.56 
10.76+0.72* 
(-61%) 
24.03+0.37 
(-14%) 
36.27+1.48 
24.07+3.49* 
(-34%) 
49.30+5.10* 
(+36%) 
95.53+13.17 
77.32+11.65* 
(-19%) 
47.07+10.53* 
(-51%) 
16.20+2.70 
7.18+0.26* 
(-56%) 
12.21+1.97* 
(-25%) 
Results are mean ± SEM of eight different preparations. 
LPO is in nmoles/ g tissue. 
Specific activities of SOD is in units/ mg protein and catalase is in |xmol/ mg protein/ min. 
Values in parenthesis represent percentage change from control. 
*Significantly different at P< 0.05 from controls. 
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no significant effect on LPO in the brain. The increase in LPO was associated with 
marked decrease in the activity of SOD and catalase by benzene/ toluene in most 
tissues except in the intestine where decrease in LPO by toluene was associated 
with significant increase in activities of SOD and catalase. The results indicate that 
both benzene and toluene caused significant perturbation in antioxidant defense 
mechanism, although variably in different rat tissues. 
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(Discussion-III 
DISCUSSION 
Both benzene and toluene caused significant increase in serum creatinine, BUN. 
serum cholesterol and phospholipids indicating solvent(s) induced nephrotoxcity 
and hepatotoxicity in confirming earlier morphological and certain biochemical 
studies (Ravnskov, 2000; Adeyemi et al., 2009). Serum inorganic Pi, however. 
significantly increased by both benzene and toluene. A number of studies have 
documented acute and chronic effects of organic solvents, including benzene and 
to\\iene on \he kidney. Benzens has beeft slwiwn to damage various parts of KV,^ 
nephron especially proximal tubules which has been characterized by tubular 
degeneration, deposits of mineral crystals, intralobular proteins, and interstitial 
inflammation (Browning, 1965; Carpenter et al., 1977; Clayton and Clayton, 1981; 
Mehlman et al., 1984; Gibson and Bus, 1988; Haider et al., 1986) followed by 
urinary excretion of low mass proteins and N-acetyl-p-glucosamidase indicating 
glomerulonephritis and renal failure (Ravnskov, 2000). Mitochondrial respiration 
was shown to be inhibited by benzene suggesting metabolic impairment (Beach et 
al., 1992). Benzene has been shown to cause hepatic structural and biochemical 
damage due to necrosis and plasma membrane dysfunction as manifested by 
increased activities of LDH and ALP in the serum (Rahman et al., 2000; Khan et 
al., 2001) and decreased in hepatic ALP, AC? and y-glutamyl transpeptidase 
(Adeyemi et al., 2009). Similar to benzene, toluene has also been shown to cause 
toxic effects in the kidney, liver, nervous system and gastrointestinal tracts. Toluene 
induced renal tubular necrosis with metabolic acidosis and increased excretion of 
erythrocytes and tubular epithelial cells were reported after toluene exposure. 
Histopathological lesions were also reported in the liver of treated animals such as 
hepatocellular hypertrophy, dilation of RER, variation in shape and decrease in 
serum GTP, y-GTP, reduction in bilirubin and ALP in the liver (Szadkowski et al., 
1976; Miyake, 1979). Both benzene and toluene have been shown to be associated 
with certain adverse effect in GI and brain. In order to assess the effect of benzene/ 
toluene on the structural integrity and functional capacity of various intracellular 
organelles such as plasma membrane BBM, mitochondria and lysosomes, the 
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enzymes of carbohydrate metabolism, BBM, lysosomes and oxidative stress were 
determined in different rat tissues. Both benzene and toluene caused selective 
alterations in certain representative enzymes of glycolysis, TCA cycle. 
gluconeogenesis and HMP-shunt pathway. The activity of hexokinase was similarly 
but variably decreased in the cortex, medulla and brain whereas increased in 
intestine and liver. The activity of LDH, a marker of anaerobic glycolysis 
considerably increased in the cortex, medulla and brain and to much greater extent 
in the intestine but decreased in the liver by both benzene and toluene. In contrast, 
the activity of MDH, a TCA cycle enzyme significantly decreased in all the tissues 
studied upon benzene/ toluene exposure. Although the actual rate of glycolysis/ 
TCA cycle were not determined, a marked increased in LDH activity in most 
tissues (except liver) indicate shift in energy dependence mostly as anaerobic 
alternatively from aerobic metabolism. This is supported by simultaneous decrease 
in MDH activity most likely due to solvent induced mitochondrial damage. Both 
benzene and toluene also caused decrease in the activities of G6Pase and FBPase 
(enzymes of gluconeogenesis). The results suggest an overall suppression of 
gluconeogenic activity in most of the tissues. Taken together, it appears that the 
decrease in MDH activity might be responsible for the decrease of both TCA cycle 
and gluconeogenic activity as oxaloacetate produced by MDH may not be available 
for both the pathways due to benzene/ toluene induced mitochondrial damage. 
The activity of G6PDH (HMP-shunt pathway) and NADP-malic enzyme (ME), 
were also differentially affected by benzene/ toluene exposure. The activity of 
G6PDH significantly increased whereas ME activity decreased in all the tissues 
albeit to different extent by both benzene and toluene. A marked increase in 
G6PDH activity suggests increased production of NADPH that might enhance 
lipogenic activity in the cells/ tissues. The increase in serum cholesterol and 
phospholipids (components of cellular membranes) by benzene and toluene can be 
attributed to increased NADPH production. 
Histopathological examinations have shown that both benzene and toluene caused 
severe damage to kidney and liver (Kamajima et al., 1994; Ravnskov, 2000; 
ASTDR, 2000; Adeyemi et al., 2009). The proximal tubule/ distal tubule in the 
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cortex were shown to be specific targets of benzene/ toluene induced 
glomerulonephritis/ renal dysfunction/ metabolic acidosis (Ravnskov, 2000; Tang et 
al., 2005). ALP, GGT, LAP and/ or sucrase are hydrolytic enzymes located in the 
renal tubular or mucosal brush border membrane. These enzymes (except sucrase) 
are also found in the plasma membranes of hepatocytes in the liver and neuronal 
cells in the brain. These enzymes are involved in the terminal digestion and 
transport of sugars, amino acids and/or Pi. The activities of these enzymes were 
examined in the homogenates and in the BBM preparations isolated from renal 
cortex and intestinal mucosa to assess the effects of benzene/ toluene on the 
structural integrity and functional capacity of various rat tissues. The activities of 
ALP, GGT and LAP were significantly decreased in the cortex, medulla, liver and 
brain in a similar manner by both the hydrocarbons. However, in the intestine 
benzene and toluene caused differential effects on BBM enzymes. The activities of 
ALP and GGT were significantly decreased by benzene whereas increased by 
toluene exposure. However, the activity of LAP and sucrase were similarly 
decreased by both benzene and toluene in the intestine. Further analysis of BBM 
enzymes in BBM preparations isolated fi-om renal cortex and intestinal mucosa 
showed similar pattern of effects. However, the magnitude of the effect was much 
more pronounced in BBM preparations. The decrease in the activity of BBM 
enzymes to a larger extent indicate that benzene and toluene exposure resulted in 
structural and/ or functional alteration in the plasma membranes. The activity of 
ACP (marker of lysosomes) was also differentially affected by the solvents 
exposure. Benzene exposure significantly increased ACP activity in cortex, medulla 
but activity was lowered in the liver, intestine and brain. In contrast, toluene 
declined ACP activity in the cortex, brain and significantly to a greater extent in the 
medulla, but the activity was significantly increased in the intestine and did not 
change in the liver by toluene exposure. The differential effects of benzene and 
toluene on BBM and lysosomal enzymes can be attributed to differential 
metabolism, accumulation and/ or accessibility of the hydrocarbons in different rat 
tissues. Moreover, different organization of the enzymes in the thickness of the 
plasma membranes may also be responsible for variable effects. 
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A few animal and human studies have shown that toluene and benzene can cause 
oxidative damage by changing the activities of antioxidant enzymes (Rao et al., 
1995; Ulakoglu et al., 1998; Halifeoglu et al., 2000). Chronic inhalation of volatile 
substances have shown to alter the level of antioxidant enzymes including SOD, 
GSH-Px associated with increased LPO (Dundaroz et al., 2003) and induce an 
initial cell injury and damage to cell membranes. Several studies have indicated the 
role of apoptosis and oxidative stress in benzene induced liver toxicity. The present 
results demonstrate that both benzene and toluene caused perturbations in the 
antioxidant defense mechanism. Both benzene and toluene caused significant 
increase in MDA levels, an end product of LPO and an indicator of tissue injury, in 
almost all the tissues accompanied by significant decrease in the activities of SOD 
and catalase. Toluene exposure resulted in profound increase in LPO in the renal 
cortex, renal medulla and liver but caused decrease in LPO in the intestine. The 
effect of toluene on LPO was associated with a significant decrease in the SOD and 
catalase activities in all the tissues except in the intestine where the activities of 
both the enzymes increased. The effect of benzene and toluene appeared to be tissue 
specific as evident by variable effects on the activities of SOD and catalase. Thus, 
disturbances in the antioxidant defense system can be considered as one of the 
mechanism for benzene/ toluene induced toxic/ adverse effects in different rat 
tissues. 
In summary, the results of present study show that both benzene and toluene target 
kidney, liver, intestine and brain and cause specific alterations in the enzymes of 
carbohydrate metabolism, brush border membrane, lysosomes and oxidative stress 
although differentially in different rat tissues. Increase in LDH along with decrease 
in MDH activity to a larger extent demonstrates a shift in energy dependence on 
glycolysis rather than on oxidative metabolism most likely due to mitochondrial 
damage. The kidney and liver appeared to be critical benzene/ toluene targets as 
evident by the decrease in BBM and antioxidant enzymes. We conclude that some 
of the effects of benzene/ toluene can be attributed to solvents induced oxidative 
stress. 
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Summary and Conclusion 
To live in the 21^' Century means to live in a toxic world, where we are exposed 
daily to numerous environmental toxins and pollutants. Environmental toxins are on 
the increase and pose a problem in the form of serious health risks, as thousand of 
toxic substances find their way into our air, water and soil in which we grow our 
food. 
We spend our days inhaling pollutants such as car fiimes and cigarette smoke. We 
drink water that has been thoroughly treated with chemicals, and eat food that is 
grown in toxic soil and packaged with preservatives. 
While our livers, kidneys, skin and lymphatic systems work round the clock to 
eliminate these dangerous toxins from our body, they very often just cannot keep 
up, and the result is a build up poisons in the system which destroy body tissues. 
damage organs, depress the immune system and leave the door open to a number of 
serious illnesses. Industrial solvents, in general, are extensively used in industry as 
well as in daily life. They are used for degreasing, dry cleaning, extractions of fats 
and oils and can be found in a wide range of products including paints, thinners, 
glues, inks, pesticides and cosmetics (ATSDR, 1997; Khan et al., 2009). In 
addition, organic solvents have been detected in a variety of urban and rural areas of 
U.S and other regions of the world and have been foimd in food chains, soil and 
drinking water (Veeramachaneni et al., 2001; Lock and Reed, 2006). Thus these 
solvents are major occupational hazards and potential concern to general 
population. Since these solvents are lipophilic in nature, they are readily absorbed 
and widely distributed throughout the body and especially concentrated/ 
accumulated in the kidney. Studies in experimental animals, case reports, case 
studies, and epidemiological studies have documented the acute and chronic effects 
of various industrial solvents on human health (Brautbar, 2004). Industrial solvents 
including aliphatic/ aromatic/ chlorinated hydrocarbons are known to alter the 
structure and fimctions of various organs such as the intestine, liver, kidney and 
brain. Animals studies have shown that a number of xenobiotics reqitire enzymatic 
transformation to reactive metabolites to elicit their toxic effects (Renner et al.. 
1994; Seaton et al., 1995; Medinsky et al., 1995; Snyder and Hedli, 1996; Lash et 
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al., 2000a; DuTeaux et al., 2003). The bioactivation may take place in the kidney or 
in extrarenal tissues, or extrarenally formed metabolites may further metabolize to 
toxic products in the kidney (Voss et al., 2003). In general xenobitics including 
solvents are metabolized by two major pathways; (a) by involving mixed function 
monooxygenases of the cytochrome P450 pathway, (b) by conjugation reaction with 
endogeneous substrates; glucouronic acid, sulphates, amino acids or mainly 
glutathione (Koss et al., 1979; Lash et al., 2000a, b; 2006). The enzymes involved 
in biotransformation vary with structure of compound in question. Although the 
metabolic processes commonly facilitate excretion and reduce toxicity of non-polar, 
lipophilic compounds, in some cases the metabolites are highly reactive and more 
toxic than the parent compound. 
The present thesis mainly focused on two classes of hydrocarbon solvents. 
1. Chlorinated hydrocarbons e.g. trichloroethylene (TCE) and 
hexachlorobenzene (HCB). 
2. Non-chlorinated hydrocarbons e.g. benzene and toluene. 
Exposure to a number of solvents, in general, have been associated with 
nephrotoxicity, hepatotoxicity, neurotoxicity and other disorders of immune, 
endocrine, reproductive and cardiovascular systems. The solvents and metabolites 
are known to be concentrated in the kidney causing solvent induced disruption of 
the structural and functional integrity of the membrane of the kidney cells 
(Ravnskov, 2000; Brautbar, 2004). The proximal tubules of the kidney are 
especially affected resulting in renal dysfunctions (Ravnskov, 2000; Brautbar N, 
2004). The brush border membrane (BBM), mitochondria, microsomes and 
lysosomes were shown to be critical target of solvent induced toxicity. A number of 
studies have demonstrated that solvent exposure is associated with increased risk in 
the development of chronic kidney diseases, glomerulonephritis and renal failure 
(Ravnskov U, 2000). The tubular damage is associated with high/ low molecular 
weight protein excretion and changes in glomerular basement membrane (Mutti, 
1996). Earlier studies identified membranous nephropathy as the most common 
histological type, whereas more recent studies point to IgA nephropathy (Coppo, 
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1988; Emancipator, 1990). Acute and chronic renal failures are also listed as 
occupational and experimental hazards by solvent intoxication. 
The liver has been reported to be the next major target organ after kidney of 
hydrocarbons/ solvent toxicity (San Martin de Viale et al., 1977; Bull, 2000; 
Adeyemi et al., 2009). Histopathological studies have shown that TCE/ HCB/ 
benzene or toluene or their metabolites cause morphological alterations in the liver 
and kidney leading to their enlargement and necrosis (Lash et al., 2000; Ravnsko, 
2000; Rahman et al., 2000; Khan et al., 2001; DuTeaux et al 2003; Chaufan et al., 
2006; Lock and Reed, 2006). Although chlorinated and non-chlorinated 
hydrocarbon/ solvents induced nephrotoxicity, ototoxicity have been extensively 
studied, detailed histological/ biochemical effects of these solvents on kidney, 
intestine, liver and brain, in general, are not completely elucidated. Neither 
biochemical events/ nor mechanism of their toxic and other adverse alterations in 
various tissues are well understood. 
Although studying human biology/ pathophysiology is ideal, such studies are 
neither feasible nor ethical. Thus, a vast majority of current biomedical research is 
performed on laboratory animals such as rats. In view of the above, the present 
studies were performed using Wistar rats as a model for humans due to their close 
physiological proximity to that of humans. 
To understand the mechanism of industrial solvents induced nephrotoxicity and 
other adverse effects in major tissues such as intestine, liver and brain, the 
following parameters/ biomarkers of energy metabolism/ mitochondria/ lysosomes/ 
BBM and oxidative stress were determined. 
a) Serum parameters such as cholesterol, blood urea nitrogen (BUN), 
creatinine, inorganic phosphate, and phospholipids were estimated to 
determine the effect of industrial solvents (TCE, HCB, benzene and 
toluene) induced nephro- and hepatotoxicity. 
b) Various enzymes of carbohydrate metabolism e.g., LDH, MDH, G6Pase, 
FBPase, G6PDH and ME were determined as representatives enzymes of 
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glycolysis, TCA cycle gluconeogenesis and HMP-shunt pathway, 
respectively. 
c) Activities of ALP, GGT, LAP, and/ or sucrase were measured as these 
enzymes are biomarkers of BBM and were used to assess structural/ 
functional integrity renal and mucosal BBMs, which are major TCE/ HCB/ 
benzene and toluene targets. 
d) ACP was determined to assess lysosomal dysfunction, as lysosomes are also 
affected by these hydrocarbon solvents. 
e) LPO, SOD, catalase, were also evaluated as indicators of oxidative stress. 
f) Pi transport was evaluated as a functional marker of BBM, and for its 
involvement in nutrition/ energy metabolism. 
THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS 
Part-I 
(a) Effect of TCE on body weight and various serum parameters: 
The effect of TCE was determined on body weight and various serum parameters 
and on the enzymes of carbohydrate metabolism, brush border membrane (BBM) 
and oxidative stress in different rat tissues. TCE was given orally by gavage with 
the dose of lOOOmg/kg body weight for 25 days. TCE caused a small but significant 
decrease in the body weights. TCE exposure resulted in significant increase in 
serum creatinine and blood urea nitrogen (BUN) whereas serum glucose, inorganic 
phosphate Pi and phospholipids significantly decreased, serum cholesterol and the 
activity of serum alkaline phosphatase increased. 
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(b) Effect of TCE on enzymes of brush border membrane (BBM) and lysosome in 
different tissues: 
The effect of TCE was determined on BBM and lysosomal biomarker enzymes in 
the liver, intestine, brain and renal cortical and medullary homogenates and in the 
isolated BBM vesicles from renal cortex and intestinal mucosa to assess the 
integrity of these organelles by TCE exposure. TCE differentially altered the 
activities of various enzymes in the homogenates of different rat tissues. The 
activity of ALP markedly decreased in all tissues except in brain where the activity 
was only slightly declined. The activity of GGT significantly lowered in intestine, 
renal cortex, renal medulla and liver whereas not affected significantly in brain. In 
contrast, TCE exposure resulted in marked decrease of LAP in the liver and renal 
cortex, increase in the brain and intestine but did not change significantly in renal 
medulla. 
TCE also altered lysosomal enzyme, acid phosphatase (ACP) differentially in 
different tissues. The activity of ACP markedly increased in the intestine and liver 
whereas significantly decreased in the brain but not affected in the kidney. The 
activity of sucrase, a marker of intestinal BBM, however, significantly increased in 
the mucosal homogenate. 
Similar to homogenates, the activities of ALP and GGT decreased whereas those of 
LAP and sucrase significantly increased in intestinal BBM by TCE exposure. 
Accordingly TCE caused significant reduction of ALP, GGT and LAP activities in 
the BBM, isolated fi-om renal cortex. 
(c) Effect of TCE on enzymes of carbohydrate metabolism: 
The effect of TCE was determined on the enzymes involved in various pathways of 
carbohydrate metabolism in diiferent rat tissues to ascertain any effect on energy 
metabolism. TCE administration caused significant increase in hexokinase activity 
in the liver followed by intestine whereas the activity declined in the brain, renal 
cortex and medulla. However, LDH activity, a marker of anaerobic glycolysis 
profoundly increased in the liver, intestine and brain whereas significantly lowered 
in renal cortex and medulla. In contrast, TCE significantly decreased the activity of 
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MDH, a TCA cycle enzyme in the liver, intestine, brain and renal cortex but the 
activity markedly increased in renal medulla. 
The effect of TCE was also determined on the activities of enzymes involved in 
gluconeogenesis and hexose monophosphate (HMP) - shunt pathway. The activities 
of both G6Pase and FBPase declined in the liver, brain and renal cortex whereas 
increased in renal medulla. The maximum decrease and increase was observed in 
renal cortex and renal medulla, respectively. The activity of G6PDH was 
profoundly increased in the liver, intestine, brain and renal cortex whereas 
decreased in renal medulla. In contrast, TCE caused significant reduction in ME 
activity in the liver, brain, renal cortex but not significantly in intestine. However. 
ME activity markedly increased in renal medulla. 
(d) Effect of TCE on Na-gradient dependent transport of ^^inorganic phosphate 
f^Pi) in brush border membrane isolated from renal cortex: 
The Pi is transported by secondary active transport mechanism that requires 
expenditure of energy in the form of ATP generated by cellular metabolism. The 
rate of concentrative uphill uptake of ^^ Pi in the presence of Na-gradient (NaCl in 
the medium) was markedly increased in TCE compared to control rats. However, 
the uptake of ^^Pi at the equilibrium phase, at 120min when Na outside - Na inside was 
not significantly different between the two groups. Also Na-independent uptake (in 
the absence of a Na gradient, when NaCl in the medium was replaced by KCl where 
Koutside> Kinside) of ^^Pi at 30s and 120min were also not affected by TCE treatment 
indicating specific alteration only when Na-gradient was present. The net uptake of 
32 Pi was also significantly enhanced. 
(e) Effect of TCE on oxidant/ antioxidant parameters: 
To ascertain the role of antioxidant system in TCE induced toxicity, the effect of 
TCE was examined on certain parameters of oxidative stress. TCE administration 
caused significant decrease in SOD and catalase activities in almost all tissues. 
However the decrease in SOD and/ or catalase activity was appeared to be tissue 
specific. The decrease in antioxidant enzyme activities was associated with 
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significant elevation in lipid peroxidation (LPO) measured in terms of 
malondialdehyde (MDA). 
Part-II 
(a) Effect ofHCB on body weight and various serum parameters: 
Hexachlorobenzene (HCB), one of the most persistent environmental pollutants 
induces porphyria cutanea turda (PCT) and produces multiple adverse effects in 
human and experimental animals. The present investigation was undertaken to 
determme the effect of HCB on the enzymes of carbohydrate metabolism, brush 
border membrane and oxidative stress in various rat tissues including the kidney, 
liver, intestine and brain for better imderstanding of its mechanism of action. HCB 
was given orally by gavage with the dose of 15mg/ kg b.w/ d for 25 days. HCB 
treated rats had a small decline in the body weight as compared to control rats. HCB 
exposure resulted in significant increase in serum creatinine, BUN, serum 
cholesterol and phospholipids but inorganic phosphate was significantly decreased. 
(b) Effect of HCB on enzymes of brush border membrane and lysosome in the 
different tissues: 
To assess the integrity of certain membranes/organelles, the effect of HCB was 
determined on BBM and lysosomal marker enzymes in the liver, brain, intestinal, 
renal cortical and medullary homogenates and in the isolated BBM vesicles from 
renal cortex and intestinal mucosa. HCB affected the activities of various enzymes 
albeit differentially in all tissues including brain. The activity of ALP, GOT and 
LAP significantly decreased in cortex, medulla, liver and brain. However, the 
activities of these enzymes markedly enhanced in the mucosal homogenates by 
HCB exposure whereas the activity of sucrase, an intestinal BBM marker was 
significantly lowered. Similar activity pattern of BBM enzymes in BBM 
preparations isolated from renal cortex and intestinal mucosa, observed in the 
homogenates, however, the magnitude of HCB effect was more pronounced 
especially in the mucosal BBM. HCB caused profound increase in the activity of 
ALP, GOT and LAP but slightly lowered sucrase activity in intestinal BBM. 
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Similar to cortical homogenates, the activities of ALP, GGT and LAP decrease in 
the renal BBM, isolated from renal cortex. 
HCB also altered lysosomal enzymes activity, acid phosphatase (ACP) but 
differentially in different tissues. The activity of ACP decreased in the intestine. 
renal cortex and medulla and brain but increased in liver homogenates. 
(c) Effect of HCB on enzymes of carbohydrate metabolism: 
The activities of hexokinase and LDH (glycolysis), MDH (TCA cycle), G6Pase and 
FBPase (gluconeogenesis) were determined in the homogenates of various rat 
tissues. HCB treatment caused profound increase in LDH activity in the intestine 
and slight increase in brain whereas the activity markedly decreased in the liver, 
renal medulla and to some extent in renal cortex. The activity of hexokinase 
significantly increased in the cortex and liver but decreased in renal medulla, 
intestine and brain. In contrast, HCB caused marked increase in MDH activity in all 
tissues except in brain and intestine where the activity was decreased. 
The effect of hexachlorobenzene was also determined on the activities of enzymes 
involved in gluconeogenesis and hexose monophosphate (HMP) - shunt pathway. 
The enzymes of these pathways were differentially altered by hexachlorobenzene in 
different tissues. The activity of G6Pase and FBPase significantly lowered in all 
tissues albeit differentially. The activities of G6Pase and FBPase were maximally 
decreased in the liver (the major site of gluconeogenesis). However, they were also 
decreased in the renal tissues followed by the intestine and brain. The activity of 
G6PDH increased in all tissues but to much greater extent in the liver whereas ME 
decreased in all tissues except intestine and liver where they were significantly 
increased. 
(d) Effect of HCB on oxidant/antioxidant parameters: 
To ascertain, the role of antioxidant system in HCB induced tissue injury, the effect 
of HCB was examined on certain enzymatic and non-enzymatic parameters of 
oxidative stress. HCB administration caused significant increase in LPO, measured 
as malondialdehyde (MDA) in ahnost all tissues except medulla. It appears that 
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HCB exposure caused severe tissue injury as indicated by profound increase in LPO 
in the liver, intestine, brain and renal cortex. HCB cause marked decrease in the 
activities of SOD and catalase although to different extent in different tissues. 
However, the effect of HCB on these parameters w^ as differentially observed in the 
medulla where HCB caused profound increase in SOD and catalase activities which 
was associated with marked decrease in LPO. 
Part-Ill 
(a) Effect of benzene and toluene on body weight and various serum parameters: 
In general, the rats remained active through out the study. There were no significant 
changes in body weights and food intake between any of the treated and control 
rats. 
Benzene and toluene exposure resulted in significant increase in serum creatinine 
and BUN indicating benzene and toluene induced nephrotoxicity. Serum cholesterol 
and phospholipids were significantly increased whereas inorganic phosphate 
significantly decreased by both benzene and toluene. 
(b) Effect of benzene and toluene on enzymes of brush border membrane and 
lysosome in different tissues: 
Benzene and toluene caused differential/ and variable alterations in BBM enzyme 
activities in the homogenates of different rat tissues. The activity of ALP, GOT and 
LAP decreased in homogenates of renal cortex and medulla, and brain. The 
activities of these enzymes lowered in liver but the magnitude of the effect was 
significantly lowered in toluene compared to benzene treated rats. The activities of 
ALP and GGT significantly decreased by benzene whereas increased by toluene 
exposure in intestine. In contrast, LAP activity decreased by both benzene and 
toluene. The activity of sucrase, a marker of intestinal BBM, however, was 
significantly decreased by both benzene and toluene in the mucosal homogenate. 
The activity of ACP markedly increased in the renal cortex and medulla whereas 
significantly decreased in the intestine, liver and brain by benzene administration. 
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In contrast, toluene administration significantly increased ACP activit\ in the 
intestine but decreased in the cortex, medulla and brain. Similar to respective 
homogenates, the activities of ALP, GGT and LAP significantly declined by 
benzene treatment in both renal and intestinal BBM preparation. However, the 
activities of these enzymes decreased in renal BBM by toluene whereas the activity 
of ALP and GGT were significantly increased but the activity of LAP and sucrase 
decreased in intestinal BBM by toluene. 
(c) Effect of benzene and toluene on enzymes of carbohydrate metabolism: 
The activity of hexokinase decreased in renal cortex, medulla and in the brain but 
increased in the intestine and liver by both benzene and toluene. However, LDH a 
marker of anaerobic glycolysis significantly enhanced in all tissues by benzene and 
toluene except in liver where the activity decreased by both of them. Benzene 
administration profoimdly increased LDH activity in the intestine followed by 
brain, renal cortex and renal medulla. Similar to benzene, toluene administration 
markedly increased LDH activity in the intestine, renal medulla, renal cortex and 
brain. In contrast, benzene and toluene significantly decreased MDH decreased 
activity in all tissues. Exposure of toluene significantly decreased MDH activity in 
renal medulla, intestine, liver but slightly in renal cortex and brain. 
The activity of G6Pase and FBPase declined in all tissues although differentially. 
The activity of G6PDH and ME were also differentially altered in all tissues by 
benzene and toluene exposure. The activity of G6PDH profoundly increased in the 
intestine, renal cortex, liver, renal medulla and brain by benzene and toluene 
administration. In contrast, both benzene and toluene caused significant reduction in 
the activity of ME in all tissues; renal cortex, renal medulla, intestine, liver and 
brain. The results indicate that solvent exposure resulted in decrease in 
gluconeogenesis and oxidative metabolism whereas the activity of LDH 
significantly enhanced. 
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(d) Effect of benzene and toluene on oxidant/ antioxidant parameters: 
Benzene and toluene exposure resulted in profound increase in the production of 
malondialdehyde (MDA), an end product of lipid peroxidation (LPO), in the renal 
cortex and medulla, liver and to some extent in brain. The increase in LPO by 
benzene and toluene was much more pronounced in the liver followed by renal 
cortex and medulla. However, in the intestine benzene caused significant increase in 
LPO whereas toluene caused significant decrease in LPO. Further, benzene 
significantly enhanced LPO but toluene had no significant effect on LPO in the 
brain. The increase in LPO was associated with marked decrease in the activity of 
SOD and catalase by benzene/ toluene in most tissues except in the intestine where 
decrease in LPO by toluene was associated with significant increase in activities of 
SOD and catalase. The results indicate that both benzene and toluene caused 
significant perturbation in antioxidant defense mechanism, although variably in 
different rat tissues. 
In summary, the results embodied in this thesis demonstrate that exposure of TCE, 
HCB, benzene and toluene caused nephrotoxicity and produce multiple adverse 
effects in different rat tissues as reflected by increase in serum creatinine, BUN, 
cholesterol and decrease in serum Pi, decrease in the activities of brush border 
membrane enzymes, increase in LPO with associated decrease in antioxidant 
enzymes. The results also indicate that these industrial solvents caused global 
toxicity to the kidney, liver, intestine and brain. However, certain alterations 
appeared to be solvent/ tissue specific. The activities of ALP, GOT and LAP 
significantly decreased by TCE, HCB, benzene and toluene in a similar manner in 
almost all the tissues except that HCB increased ALP, GOT and LAP and toluene 
increased ALP and GGT activities in the intestine. The activity of sucrase increased 
by TCE but decreased by HCB, benzene and toluene. The decrease in the activities 
of BBM enzymes especially in the cortex, medulla and liver indicate that these 
solvents caused severe damage to the kidney and liver. In the kidney, renal 
proximal tubule and its BBM appeared to be the critical target as has been shown by 
morphological and some biochemical studies. The activity of ACP, a lysosomal 
enzyme was differentially affected by both types of hydrocarbons. 
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A marked increase in LDH activity and decrease in MDH activity by benzene and 
toluene in most tissues except liver indicated a shift in the energy dependence on 
anaerobic glycolysis rather than on aerobic metabolism most likely due to 
mitochondrial damage. This was accompanied by suppressed gluconeogenic 
activity as reflected by decrease in G6Pase and FBPase activities also due to solvent 
induced mitochondrial dysfunction as oxalate produced by MDH may not be 
available for both TCA cycle and gluconeogenesis. TCE and HCB also affected 
carbohydrate metabolism in the same maimer in some tissues but differentially in 
other tissues e.g., kidney and liver. The activity of G6PDH was significantly 
increased whereas NADP-ME decreased by TCE, HCB, benzene and toluene in 
almost all tissues. The NADPH produced by either enzyme is known to be needed 
for several anabolic reactions especially lipogenic reactions and also play an 
important role in antioxidant defense mechanism. This is supported by the fact that 
serum cholesterol and to some extent phospholipids increased in significant amount 
following the exposure of solvents. These are membrane components and may be 
required for regeneration processes after solvents exposure. 
Taken together, the data indicated that solvent caused impairment in the energy 
metabolism followed by certain adaptive changes. The nephrotoxic and other 
adverse effects appeared to mediated in part due to solvents induced oxidative 
damage as reflected by an increase in LPO and decrease in the activities of SOD 
and catalase in all the tissues by TCE, HCB, benzene and toluene except in medulla 
by HCB and in the intestine by toluene where an opposite pattern was observed. 
The mechanism by which TCE, HCB, benzene or toluene produce toxic effects are 
not well understood. It has been reported that these solvents/ hydrocarbons must be 
bioactivated to exert their toxic effects. In general, they are metabolized by 
glutathione conjugation and/ or by cytochrome P450 dependent oxidation pathways. 
In the case of TCE, reactive metabolites derived fi-om P450 oxidation are associated 
with liver, lung and reproductive toxicity (Halmes et al., 1997; Lash et al., 2000a, b; 
Forkert et al., 2003) where as those derived from GSH conjugation is responsible 
for kidney and hematopoietic system (Lash et al., 2001; Lock and Reed, 2006). 
However, some has not been specified for HCB, benzene and toluene. The binding 
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of reactive metabolites with cellular macromolecules are considered an initiating 
event in target-tissue organ toxicities (Bruning and Bolt, 2000). Histopathological 
studies has revealed that these metabolites caused morphological/ structural/ 
biochemical alteration in the proximal tubule of the kidney and liver (Nomiyama et 
al., 1986; Goel et al.,1992; Lash et al., 2000b; Kumar et al., 2001; Lock and Reed. 
2006). Little has been reported on the effects of these industrial solvents on 
gastrointestinal tract (or small intestine). Generation of ROS and other free radicals 
have been considered as one of the mechanism for tissue injury (Cojocel et al., 
1989). 
In conclusion, the present results show that solvents including TCE, HCB, benzene 
and toluene induce global toxicity in different rat tissues. They elicited nephrotoxic 
and other deleterious effects by causing major damage to mitochondria, lysosomes, 
plasma membrane especially renal proximal tubular and mucosal BBM as reflected 
by decrease in the activities of their specific biomarkers with some exceptions 
confirming earlier morphological and biochemical observations. Exposure of these 
solvents caused alterations in the energy metabolism and in certain cases energy 
dependence was shifted from oxidative metabolism to anaerobic glycolysis. The 
nephrotoxic, hepatotoxic, neurotoxic or gastrotoxic effects appeared to be 
medicated at least in part due to imbalances in the antioxidant defense mechanism. 
The variation in effect by different solvents in different tissue can be attributed to 
the differences in their metabolism and accumulation and interaction of the reactive 
metabolites produced. 
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A B S T R A C T 
Trichloroethylene (TCE), an Industrial solvent, is a major environmental contaminant. Histopathological 
examinations revealed that TCE caused liver and kidney toxicity and carcinogenicity. However, biochem-
ical mechanism and tissue response to toxic insult are not completely elucidated. We hypothesized that 
TCE induces oxidative stress to various rat tissues and alters their metabolic functions. Male Wistar rats 
were given TCE (lOOOmg/kg/day) in corn oil oraliy for 25 d. Blood and tissues were collected and ana-
lyzed for various biochemical and enzymatic parameters. TCE administration increased blood urea nitro-
gen, serum creatinine, cholesterol and alkaline phosphatase but decreased serum glucose, inorganic 
phosphate and phospholipids indicating kidney and liver toxicity. Activity of hexokinase, lactate dehy-
drogenase increased in the intestine and liver whereas decreased in renal tissues. Malate dehydrogenase 
and glucose-6-phosphatase and fructose-1, 6-bisphosphatase decreased in all tissues whereas increased 
in medulla. Clucose-6-phosphate dehydrogenase increased but NADP-malic enzyme decreased in all tis-
sues except in medulla. The activity of BBM enzymes decreased but renal Na/Pi transport increased. 
Superoxide dismutase and catalase activities variably declined whereas lipid peroxidation significantly 
enhanced in all tissues. The preseilt results indicate that TCE caused severe damage to kidney, intestine, 
liver and brain; altered carbohydrate metabolism and suppressed antioxidant defense system. 
© 2009 Elsevier Ltd. All rights reserved. 
1. Introduction 
A number of environmental contaminants including certain 
chemicals, drugs and various organic solvents alter the structure 
and functions of various organs including intestine, liver, heart 
and kidney and produce multiple adverse effects (Fatima et al., 
2004, 2005; Kohn et al., 2005; Ruder, 2006; Farooq et al., 2007; 
Banday et al., 2008a,b). Trichloroethylene (TCE) is a chlorinated or-
ganic solvent that has been extensively used in consumer products 
(paints, glues, and spot removers), industrial applications (degreas-
ing and computer chip manufacturing) and as general purpose sol-
vent. In addition to being found in the work place, TCE has been 
detected in a variety of urban and rural areas of the U.S. and other 
region of the world and has been found in food chain, soil and 
drinking water (Veeramachaneni et al.. 2001; Lock and Reed, 
2006). It has been shown to be hazardous to human and domestic 
animals (Ramlow, 1995; Bruning et al., 1998). Acute and chronic 
TCE exposure caused toxicity in variety of organs in human and 
experimental animals (Lash et al., 2006; Lock and Reed, 2006; Ru-
• Corresponding author. Tel.: +91 571 2700741; fax: +91 571 2706002. 
E-mail address: yusufi®lycos.com (A.N.K. Yusufi). 
0278-6915/J - see front matter © 2009 Elsevier Ltd. All rights reserved, 
doi: 1 O.I 016/j.fct.2009.04.002 
der, 2006). These include neurological effects, kidney and liver 
damage, gastrointestinal effects, reproductive effects, cardiovascu-
lar effects and cancer (Allemand et al., 1978; Ruijten et al., 1991; 
Chakrabarti and Tuchweber, 1988; Bruning and Bolt, 2000; Lash 
et al., 2001; DuTeaux et al.. 2003; Norman, 2005). However, the 
liver and kidney were found to be two prominent TCE targets (Bull, 
2Q00: Ush et a!., 2000b, 2001). 
If has been reported that TCE must be bioactivated to elicit its 
t£xie effects (Lash et al., 1995, 2000a; DuTeaux et al., 2003). TCE 
"is metabolized by glutathione (GSH) conjugarion and cytochrome 
P450-dependent oxidation pathways (Allemand et al.. 1978; Lash 
et al., 2000a,b. 2006). The reactive metabolites derived from P450 
dependent oxidation have been directly associated with liver, 
lung and reproductive toxicity (Halmes et al., 1997; Lash et al., 
2000a.b; Forkert et al.. 2003) whereas those derived from GSH 
conjugation are associated with the kidney and hematopoietic 
system (Lash et al., 2001; Lock and Reed, 2006). The binding of 
these metabolites with cellular macromolecules is considered an 
initiating event in target-tissue organ toxicities (Bruning and Bolt, 
2000). Histopathological studies have shown that TCE or its 
metabolites caused morphological alterations in the kidney and 
liver leading to their enlargement, renal tubular damage, necrosis 
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(Lash et al., 2000b; Lock and Reed, 2006) and hepatic histological 
and biochemical changes (Nomiyama et aL, 1986; Gbel et aL, 
1992; Kumar et aL. 2001). The nephrotoxicity was characterized 
by increased serum creatinine, BUN and release of alkaline phos-
phatase (ALP), Y-glutamyl transpeptidase (GGT) and other protei-
nic components in the urine (Chakrabarti and Tuchweber, 1988; 
Lash et aL, 2000a.b; Mensing et aL. 2002; Bolt et aL, 2004) 
whereas hepatotoxicity was manifested by increased serum cho-
lesterol, acid and alkaline phosphatase, SCOT, SGPT (Goel et aL, 
1992; Kumar et aL, 2001). However, biochemical events and the 
mechanism involved in the cellular response to renal, liver and/ 
or intestinal injury are not completely elucidated. We hypothe-
sized that TCE induces oxidative stress, causes damage to cellular 
membranes and hence alters the cellular metabolism and other 
functions. 
To address the above hypothesis, the effect of TCE was exam-
ined on the enzymes of carbohydrate metabolism, brush border 
membrane (BBM) and antioxidant defense mechanism in different 
rat tissues. The results demonstrate that oral exposure of TCE re-
sulted in increased blood urea nitrogen (BUN), serum creatinine, 
cholesterol and alkaline phosphatase (ALP) and decreased serum 
Pi. phospholipids and glucose levels. The enzymes of carbohydrate 
metabolism were selectively altered and the activities of BBM en-
zymes; ALP and GGT significantly decreased in all tissues. Lipid 
peroxidation (LPO), an indicator of tissue injury significantly en-
hanced whereas the activity of superoxide dismutase (SOD) and 
catalase decreased. 
The results indicate that TCE exposure produced significant bio-
chemical and metabolic alterations in different rat tissues albeit 
differentially most likely by inducing oxidative stress. 
2. Materials and methods 
2.1. Materials 
Trichloroethylene (TCE) was purchased from Sisco Research Laboratory (Mum-
bai, India). Sucrose, p-nitrophenyl phosphate, NADH and NADP+ were purchased 
from Sigma Chemical Co. (St Louis. MO. USA). All other chemicals used were of ana-
lytical grade and were purchased from Sigma Chemical Co. or Sisco Research Labo-
ratory (Mumbai, India). 
2.2. Experimental design 
The animal experiments were conducted according to the guidelines of the 
committee for Purpose of Control and Supervision of Experiments on Animals, Min-
istry of Environment and Forests, Government of India. Adult male Wistar rats, 
weighing between 150 and 175 g. were acclimatized to the animal facility for a 
week on standard rat diet (Aashirwad Industries. Chandigarh. India) and allowed 
water ad libitum. Two groups of rats (eight to ten rats/group) were studied. 
TCE treated rats were given TCE (1000 mg/kg body weight/d) in corn oil by ga-
vage whereas the control rats received same amount of corn oil daily for 25 days. 
The effert of TCE was observed on rats because TCE and its metabolites were 
found toxic to greater extent in male rats compared to female rats and both forms 
of mice (Green et al., 1997; Vaidya et al., 2003). The selection of dose was based 
on preliminary experiments (500-2500 mg/kg/day) at which TCE produced neph-
rotoxicity with minimal animals death. After 25 days of TCE administration, the 
rats were sacrificed under light ether anesthesia blood samples were collected 
from non-fasted rats and the liver, kidney, brain and intestine (starting from 
the ligament of Trietz to the end of the ileum) were extracted and kept in buffered 
saline. The intestines were washed by flushing them with ice-cold buffered saline 
(1 mM Tris-HCI, 9g/L of NaCI, pH-7.4). All the preparations and analyses were 
carried out simultaneously under similar experimental conditions to avoid any 
day-to-day variations. 
2.3. Preparation of homogenates 
The washed intestines were slit in the middle and the entire mucosa was gently 
scraped with a glass slide and weighed. A 6.5% homogenate of this mucosa was pre-
pared in 50 mM mannitol, pH-7.0, in a glass Teflon homogenizer (Remi Motors, 
Mumbai, India) with five complete strokes. The homogenate was then subjected 
to a high-speed Ultra-Turrex homogenizer (Type T-25, Janke & Kunkel GMBH & 
Co. KG., Staufen) for three pulses of 30 s each with an interval of 30 s between each 
stroke. 
The kidneys were decapsulated and kept in ice-cold 154 mM NaCI and 5 mM 
Tris-HEPES buffer, pH-7.5. The cortical and medullary regions were carefully sepa-
rated and homogenized (as mentioned above) in 50 mM mannitol buffer to obtain 
10% (w/v) homogenate. The 10% liver and brain homogenate were similarly pre-
pared In 10 mM Tris-HCI buffer pH-7.5. 
One part of the homogenates (of intestine, kidney, liver and brain) was centri-
fuged at 2000g for 10 min at 4 °C and the supernatant was saved for assaying the 
enzymes of carbohydrate metabolism, the second part was centrifuged at 3000g 
for 15 min at 4 °C and the supernatant was used for assay of free radical scavenging 
enzymes and the third part was used for the estimation of LPO, 
2.4. Preparation of brush border membrane 
Intestinal BBM was prepared at 4 °C using differential precipitation by CaCb 
(Kessler et al., 1978). Mucosa scraped from four to five washed intestines was used 
for each BBM preparation. CaCb was added to the homogenate to the final concen-
tration of 10 mM and the mixture was srirred for 20 min on ice. The final membrane 
preparations were suspended in 50 mM sodium maleate buffer pH-6.8, with four 
passes by a loose fitting Dounce homogenizer (Thomson PA. Wheatson IL, USA) in 
a 15 ml corex tube and centrifuged at 35,000g for 20 min. The outer white fluffy 
layer of pellet is resuspended in sodium maleate buffer. Aliquots of homogenates 
(after high speed homogenization) and BBM thus prepared were saved and stored 
at -20 °C until further analysis. 
Kidney BBM was prepared from whole cortex homogenate using the MgClj pre-
cipitations method as described by (Yusufi et al., 1994). The final preparations were 
suspended in 300 mM mannitol, pH-7.4, and the BBM thus prepared were saved 
and stored at -20 °C until further analysis for BBM enzymes. Each sample of BBM 
was prepared by pooling tissues from two to three rats. 
2.5. Senitn biochemical parameters 
Serum samples were deproteinized with 3% trichloroacetic acid at a ratio of 1:3, 
left for 10 min, and centrifuged at 2000g for 10 min. The protein-free supernatant 
was used to determine Pi. The precipitate was used to quantitate total phospholip-
ids. Serum urea nitrogen and cholesterol levels were determined directly in serum 
samples. Glucose was estimated by an o-toluidine method using kit from Span 
Diagnostics (Mumbai, India). These parameters were determined by standard pro-
cedures as mentioned in a previous study (Farooq et al., 2006). 
2.6. Assay of carbohydrate metabolism enzymes 
The activities of the enzymes involving oxidation of reduced nicotinamide ade-
nine dinucleotide or reduction of nicotinamide adenine dinucjeotide phosphate 
were determined spectrophotometrically on a Cintra 5 fixed for 340 nm using 
3 ml of assays in a 1-cm cuvette at room temperature (28-30 °C). The enzymes as-
says of lactate dehydrogenase (LDH, E.C.I.1.1.27), malate dehydrogenase 
(E.C.I.1.1.37), malic enzyme (ME, E.C.I. 1.1.40), glucose-6-phosphate dehydroge-
nase (G6PDH, E.C.1.1.1,49), glucose-6-phosphatase (G6Pase, E.C.3.I.3.3), and fruc-
tose 1.6-bisphosphatase (FBPase. EC.3.1.3.11) activities were studied as described 
by (Khundmiri et aL, 2004). Hexokinase was estimated by the method of Crane 
and Sols (1953) and the remaining glucose was measured by method of Nelson 
(1944). 
2.7. Assay of BBM marker enzymes and lysosomal marker enzymes 
The activiries of alkaline phosphatase (ALP), leucine amino peptidase (LAP), y-
glutamyl transferase (GGT). sucrase and acid phosphatase (ACP) were determined 
as described by Farooq et al. (2004). 
2.8. Assay of enzymes involved in free radical scavenging 
Superoxide dismutase (SOD, E.C.1.15.1.1) was assayed by method of (Marklund 
and Marklund, 1974). Catalase (E.C.I.11.1.6) acrivity was assayed by the method of 
CirietaL(1996). 
2.9. Transport of ^ ^inorganic phosphate (Pi) 
Measurement of "Pi (Bhabha Atomic Research Center) uptake in BBMV was 
carried out at 25 °C by rapid filtration technique as described by Yusufi et al. 
(1994) either in the presence or absence of Na-gradient. Uptake was initiated by 
addition of incubation medium (30 pi) containing lOOmmol/l mannitol, NaCI/KCl 
lOOmmol/L 5mmol/l Tris-HEPES, pH-7 5, 0 I mmol/l K2H"P04 to 15 pi BBM 
suspension (50-100 pg protein) and incubated for the desired time intervals 
(see Results). The uptake was stopped by the addition of 3 ml ice cold stop solution 
(containing 135 mmol/l NaCI, 5 mmol/l Tris-HEPES and 10 mmoi/l sodium arsenate, 
pH-7-5) and filtered immediately through 0 45 pm DAWP Millipore filter, (Millipore 
Corporation. Billerica, MA, USA) and washed three times with the stop solution 
using a Cornwall type syringe (Wheaton, IL. USA). Correction for non-specific 
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binding to filters was made by subtracting from all data the value of corresponding 
blank obtained by filtration of the incubation buffer without vesicles. The radioac-
tivity of dried filters was measured by liquid scintillation counting (Reckbeta, LKB, 
Wallac. Sweden) with 10 ml scintillation fluid (Cocktail T, Sisco Research Ubora-
tory, India). 
2.10. U^ estimation 
WO was estimated by the method of Ohkawa et al. (1979). 
2.11. Statistical analysis 
All results are expressed as mean ± SEM for at least three to four separate prep-
arations. The data were analyzed for statistical significance by Student's t-test for 
group comparisons or by analysis of variance. P < 0.05 was considered statistically 
significant. 
3. Results 
3.1. Effect ofTCE on body weight and serum parameters 
The effect of TCE was determined on body weight and various 
serum parameters and on the enzymes of carbohydrate metabo-
lism, brush border membrane (BBM) and oxidative stress in differ-
ent rat tissues. TCE was given orally by gavage with the dose of 
1000mg/i<g body weight for 25 days. This dose was chosen on 
the basis of preliminary experiments that have minimal death 
occurring in experimental animals. Apparently, there was no 
significant difference in food and water intake between control 
and TCE treated rats. However, TCE caused a small but significant 
decrease in the body weights (Table 1). 
TCE exposure resulted in significant increase in serum 
creatinine (+18%) and blood urea nitrogen (BUN. +52%) indicating 
TCE-induced nephrotoxicity. Serum glucose (-37%), inorganic 
phosphate Pi (-37%) and phosphohpids (-20%) significantly de-
clined whereas serum cholesterol (+25%) and the activity of serum 
alkaline phosphatase (ALP, +20%) increased by TCE administration 
(Table 2). 
3.2. Effect of TCE on enzymes of carbohydrate metaboUsm 
The effect of TCE was determined on the enzymes involved in 
various pathways of carbohydrate metabolism in different rat 
tissues (Table 3) to ascertain any effect on energy metabolism 
TCE administration caused significant increase in hexokinase 
(glycolysis) activity in the liver (+90%) followed by intestine 
(+9%) whereas the activity declined in the brain (-12%), renal 
Table 1 
Effect of trichloroethylene (TCE) consumption 
Groups 
Control 
TCE 
Before treatment 
150 i 10.2 
156 ±6.25 
on body weight (grams) of 
After treatment 
157.75 ±5.25 
137 ±8.29' 
rats. 
% Change 
+5 
-12 
cortex (-18%) and medulla (-17%). However, LDH activity, a mar-
ker of anaerobic glycolysis profoundly increased in the liver 
(+265%). intestine (+105%) and brain (+21%) whereas significantly 
lowered in renal cortex (-50%) and medulla (-11%). In contrast, 
TCE significantly decreased the activity of MDH, a TCA cycle enzyme 
in the liver (-22%), intestine (-39%). brain (-46%) and renal cortex 
(-23%) but the activity markedly increased in renal medulla (+73%). 
The effect of TCE was also determined on the activities of en-
zymes involved in gluconeogenesis and hexose monophosphate 
(HMP) - shunt pathway (Table 4). The enzymes of these pathways 
were differentially altered by TCE in different tissues. The activities 
of both G6Pase and FBPase significantly declined in the liver, brain 
and renal cortex whereas increased in renal medulla. The maxi-
mum decrease and increase was observed in renal cortex and 
renal medulla, respectively. The activity of G6FDH was profoundly 
increased in the liver (+590%), intestine (+205%), brain (+71%) and 
renal cortex (+177%) whereas decreased in renal medulla (-59%). 
In contrast, TCE caused significant reduction in ME artivity in the 
liver (-41%), brain (-43%), renal cortex (-35%) but not signifi-
cantly in intestine (-8%). However. ME activity markedly increased 
in renal medulla (+56%). 
3.3. Effect of TCE on enzymes of brush border membrane (BBM) and 
lysosome in different tissues 
The effect of TCE was determined on BBM and lysosomal bio-
marker enzymes in the liver, intestine, brain and renal cortical 
Table 3 
Effect of trichloroethylene (TCE) on metabolic enzymes on different tissue 
homogenates. 
Tissues 
Cortex 
Control 
TCE 
Medulla 
Control 
TCE 
Intestine 
Control 
TCH 
Liver 
Control 
TCE 
Brain 
Control 
TCE 
Hexokinase 
(junol/mg prot/h) 
25.26 ±1.57 
20.68 ±1.49 
(-18%) 
60.56 ±1.30 
50.38 ±1.48 
(-17%) 
64.84 ± 5.94 
70.92 + 1.73 
(+9%) 
8.71+0.15 
16.60 +1,87" 
(+902) 
41.03 + 4.06 
36.09 ± / l 3 
(-12S) 
LDH 
(nmol/mg prot/h) 
10.00 ±1.35 
5.00+1.00" 
(-50%) 
13.04 ±0.41 
11.57 ±0.50 
(-11%) 
3.23 ±1.03 
6.64 ±7.07' 
(+105%) 
17.21 ± 5.54 
62.80 ±3.92" ' 
(+265%) 
6.56 ±0.120 
7.93 ±1.00" 
(+21%) 
MDH 
(nmol/rag prot/h) 
11.41 ±1.06 
8.75 ±0.39' 
(-23%) 
21.59 ±0.20 
27.-ie ±2.22' 
(+73%) 
10.57 ±1.03 
6.42 + 1.02" 
(-39%) 
3.62 ± 0.60 
2,83 ± 0.33* 
(-22%) 
14.81 ±2.22 
8.07 ± 0.56' 
(-46%) 
Results are mean ± SEM of eight different preparations. 
Values in parenthesis represent percentage change from control. 
' Significantly different at P < 0.05 from controls. 
Results are mean ± SEM of eight different preparations. 
Values in parenthesis represent percentage change from control. 
Significantly different at P< 0.05 from controls. 
Table 2 
Effect of trichloroethylene (TCE) on various serum parameters. 
Groups 
Control 
TCE 
BUN 
(mg/dL) 
16.16 ±0.38 
24.59 ± 0.49" 
(+52%) 
Creatinine 
(mg/dL) 
0.66 ± 0.09 
0.78 + 0.92" 
(+18%) 
Cholesterol 
(mg/dL) 
170 + 10.90 
213 ±10.80' 
(+25%) 
Phospholipid 
(Mgs/mL) 
162 ±13.46 
130± 16.94' 
(-20%) 
Inorganic phosphate 
(nmol/mL) 
1.30 ±0.78 
0.82 ± 0.08" 
(-37%) 
ALP 
(KAunits) 
45.02 ±1.64 
54.07 ±0.18" 
(+20%) 
Glucose 
(mg/dL) 
78.83 ± 7.35 
49.56 ±2.39' 
(-37%) 
Results are mean ± SEM of eight different preparations. 
Values in parenthesis represent percentage change from control. 
Significantly different at P < 0.05 from controls. 
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Table 4 
Effect of trichloroethylene (TCE) on metabolic enzymes on different tissue 
homogenates. 
Tissues 
Cortex 
Control 
TCE 
Medulla 
Control 
TCE 
Intestine 
Control 
TCE 
Liver 
Control 
TCE 
Brain 
Control 
TCE 
C6Pase 
(^mol/mg 
prot/h) 
0.78 ± 0.05 
0.43 ±0 .01 ' 
(-45%) 
0.67 ± 0.01 
1.01 ±0.06" 
(+51%) 
2.14 ±0.33 
1.93 ±0.28 
(-10%) 
0.18 ±0.01 
0.14 ±0.00' 
(-22%) 
0.27 ± 0.01 
0.23 ± 0.02 
(-15%) 
FBPase 
(Hmol/mg 
prot/h) 
0.78 + 0.01 
0.50 + 0.05* 
(-36%) 
0.35 ±0.01 
0.41 ±0.01" 
(+17%) 
1.42 ±0.01 
1.24 ±0.08 
(-13%) 
0.37 ± 0.01 
0.35 ±0.01 
(-5%) 
0.32 ± 0.02 
0.26 ± 0.004" 
(-19%) 
G6PDH 
((imol/mg 
prot/h) 
3.03 ±0.48 
8.40 ±0.40' 
(+177%) 
8.20 + 0.41 
3 J 7 + 0.27' 
(-59%) 
12.00 + 0.57 
36.60 ± 1.45* 
(+205%) 
5.54 + 0.54 
38.23 + 0.75* 
(+590%) 
7^0 ±0.50 
12.80 ±2.77' 
(+71%) 
ME 
((unol/mg 
prot/h) 
2.43 ±0.04 
1.57 ±0.10" 
(-35%) 
1.83 + 0.01 
2.86 ±0.09' 
(+56%) 
3.14 ±0.005 
2.90 ±0.14 
(-8%) 
2.45 ±0.08 
1 .45±0. i r 
(-41%) 
3.05 + 0.11 
1.74 ±0.13* 
(-43%) 
Results are mean ± SEM of eight different preparations. 
Values in parenthesis represent percentage change from control. 
• Significantly different at P<0.05 from controls. 
and medullary homogenates and in the isolated BBM vesicles from 
renal cortex and intestinal mucosa to assess the integrity of these 
organelles by TCE exposure. The results summarize in (Table 5) 
demonstrate that TCE differentially altered the activities of various 
enzymes in the homogenates of different rat tissues. The activity of 
ALP markedly decreased in all tissues (-27% to -44%) except in 
brain where the activity was only slightly declined (-12%). The 
activity of GGT significantly lowered in intestine (-36%), renal cor-
tex (-24%) and medulla (-18%) whereas not affected significantly 
in the liver (-17%) and brain (-13%). In contrast, TCE exposure 
resulted in marked decrease of LAP in the liver (-53%) and renal 
cortex (-27%) whereas increased in the brain (+56%) and intestine 
(+23%) but not changed significantly in renal medulla. 
TCE also altered lysosomal enzyme, acid phosphatase (ACP) dif-
ferentially in different tissues. The activity of ACP markedly in-
creased in the liver (+96%) and intestine (+111%) whereas 
significantly decreased in the brain (-44%) but not affected signif-
icantly in the kidney. The activity of sucrase, a marker of intestinal 
BBM, however, significantly increased (+72%) in the mucosal 
homogenate (Table 5). 
Similar to homogenates, the activities of ALP and GGT decreased 
whereas those of LAP and sucrase significantly increased in intes-
tinal BBM by TCE exposure (Table 6). In accordance with the alter-
ations in cortical homogenate, TCE caused significant decline of 
ALP, GGT and LAP activities in the BBM, isolated from renal cortex 
(Table 6). 
3.4, E e^ct of TCE on Na-gradient dependent transport o/^^inorganic 
phosphate (^Pi) in brush border membrane isolated from renal cortex 
The bulk of filtered Pi in the kidney is reabsorbed by its proxi-
mal tubule. The Na-gradient dependent (Naoutside > Namside) trans-
port of Pi in renal proximal tubule across its luminal brush 
border membrane (BBM) is an initial and regulatory step. The Pi 
is transported by secondary active transport mechanism requires 
expenditure of energy in the form of ATP generated by cellular 
metabolism. The effect of TCE on the uptake of "Pi was determined 
in the presence and absence of a Na-gradient in the initial uphill 
phase (10 s, 30 s) and at equilibrium after 120 min in BBM prepa-
rations. The rate of concentrative uphill uptake of ^^ Pi in the pres-
ence of Na-gradient (NaCI in the medium) was markedly increased 
in TCE compared to control rats (Table 7). However, the uptake of 
^^ Pi at the equilibrium phase, at 120 min when Naoutside = Najnside 
was not significantly different between the two groups. Also Na-
independent uptake (in the absence of a Na gradient, when NaCI 
in the medium was replaced by KCl where Koutside > Kinside) of ^^ Pi 
at 30 s and 120 min were also not affected by TCE treatment indi-
cating specific alteration only when Na-gradient was present. The 
net uptake of ^^ Pi (Table 7) was also significantly enhanced. 
Table 5 
Effect of trichloroethylene (TCE) on brush border membrane enzymes in different tissue homogenates. 
Tissue 
Cortex 
Control 
TCE 
MeduUa. 
Control 
TCE 
Intestine 
Conrtol 
TCE 
Uver 
Control 
TCE 
Brain 
Control 
TCE 
ALP 
(pmol/mg prot/h) 
12.73 + 2.17 
8.13 + 1.36* 
(-36%) 
12.78 + 1.14 
7,81+0.35" 
(-39%) 
5.92 ± 2.03 
4.34 ±0.49" 
(-27%) 
1.43 ±0.19 
0.80 ± 0.04" 
(-44%) 
0.97 + 0.00 
0.85 ± 0.02 
(-12%) 
GOT 
(Hmol/mg prot/h) 
44,94 ± 2,05 • 
33,94 ± 4,79" 
(-24%) 
34.33 ±2,18 
28.11+2,60" 
(-18%) 
29.82 ± 3.91 
19.11 ±0.11* 
(-36%) 
17.55 ±1.05 
14.53 ±0.08* 
(-17%) 
11.75 + 0.77 
10.23 ±1.90 
(-13%) 
LAI* / 
(pmol/mg prot/h) 
8.82 ±0,55 
6.40 + 0.29" 
(-27%) 
11.11+0.59 / 
10.17 + 0.49 
(-8%) 
6.59 ±0.14 
8.rtf±0.66" 
(+23%) 
0.88 + 0,10 
0,41 ± 0.03" 
(-53%) 
0.27 ± 0.09 
0.42 ± 0.02" 
(+56%) 
ACP 
(nmol/mg prot/h) 
3.13 ±0.25 
2.69 + 0.29 
(-14%) 
1.55 ±0.15 
1.36 ±020 
(-12%) 
0.76 ±0.09 
1.60 ±0,10" 
(+111%) 
0.28 ±0.03 
0.55 ± 0,08" 
(+96%) 
1,55 ±0,22 
0.87 ±0.10" 
(-44%) 
Sucrase 
(nmol/mg prot/h) 
• ' 
16.78 ±1.82 
28.83 ±3.15" 
(+72%) 
Values in parenthesis represent percentage change from control. 
Significantly different at P< 0,05 from controls. 
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Table 6 
Effect of trichloroettiylene on BBM Vesicles isolated from small intestine and renal cortex. 
Croups 
I 
Coiitrol 
TCE 
Small intestine 
ALP 
((xmoi/mg prot/h) 
28.10 + 3.71 
16.32 + 3.48' 
(-42%) 
GCT 
(nmol/mg prot/h) 
98.19 ±3.55 
54.84 + 2.45* 
(-44%) 
LAP 
(Hmo!/mg prot/h) 
24.47 + 4.86 
42.12+4.15* 
(+72%) 
: ' . • . « ; • 
Sucrase 
(nmol/mg prot/h) 
4 5 J 2 + 2.73 
78,49 + 6.97* 
(+73%) 
Cortex 
ALP 
((imol/mg prot/h) 
74.9 ± 10.77 
41.58 ±5.98* 
(-44%) 
GCT 
(nmol/mg prot/h) 
353.65 + 1.61 
232.86 ±12.97* 
(-34%) 
(funol/mg prot/h) 
85.87 ±0.55 
64.00 ±0.29* 
(-25%) 
Results are mean + SEM of eight different preparations. 
Values in parenthesis represent percentage change from control. 
'Significantly different at P < 0.05 from controls. 
Table 7 
Effect of TCE administration on uptake of Pi by BBMV. 
(a) Na+gradient dependent uptake 
Groups 
Control 
TCE 
10s 
509 ±96.12 
1049 + 98.80' 
(+106%) 
(b) Na+gradient independent uptake 
Groups 30s 
Control 118 ±2.17 
TCE 197 ±14.14" 
(+67%) 
(c) Net Na+gradient dependent uptake at 30 s 
Groups Na+gradient dependent 
(lOOmMNaCl) 
Control 
TCE 
993 ±9523 
1877 + 77.42* 
(+89%) 
30s 
993 ±95,23 
1877 ±77.42' 
(+89%) 
120min 
2012 ±207 
2151 ±680 
(+7%) 
Na-gradient independent 
(lOOmMNaCI) 
118±2.17 
197 + 14.14' 
(+67%) 
120min 
1534 ±160 
1688 ±92.30 
(+10%) 
Net uptake (Na-K) 
875 ±92 
1680 ±63.28" 
(+92%) 
BBMV were prepared from whole cortex of rats 25 days after administration TCE or corn oil (control). Values in parenthesis is percent change from control. 
Uptake of '•'Pi is expressed as pmole/mg protein. 
Significantly different at P < 0.05 from respective controls. 
3.5. Effect of TCE on the antioxidant parameters 
It is evident that reactive oxygen species (ROS) generated by 
various toxins are important mediators of cell injury and patho-
genesis of various diseases especially in the kidney and other 
tissues (Walker et a/., 1999). A major cellular defense against 
ROS is provided by superoxide dismutase (SOD), cata]ase and some 
other enzymes. To ascertain the role of antioxidant system in 
TCE-induced toxicity, the effect of TCE was examined on certain 
parameters of oxidative stress. TCE administration caused signifi-
cant decrease in SOD and catalase activities in almost all tissues 
(Table 8). However the decrease in SOD and/or catalase activity 
was appeared to be tissue specific. The decrease in antioxidant 
enzyme activities was associated with significant elevated lipid 
peroxidation (LPO) measured in terms of malondialdehyde (MDA). 
4. Discussion 
Trichloroethylene (TCE) is a major environmental contaminant 
that is both an occupational concern and a potential concern for 
the general population because of its widespread use (Maull and 
Lash, 1998; Ruder. 2006). TCE produces acute toxicity or tumors 
in several tissues, with target organ specificity and sensitivity 
exhibiting species, strain and sex dependent differences (Bruning 
and Bolt, 2000; Lash et al., 2000a,b, 2001, 2006; Lock and Reed, 
2006), Most TCE toxicity is dependent on bioactivation, which oc-
curs by two pathways, cytochrome P450 dependent oxidation and 
glutathione (GSH) conjugation (Lash et al., 2000b, 2001). The pres-
ent investigation was undertaken to understand the mechanism of 
TCE-induced toxic effects in different rat tissues. TCE administra-
Table 8 
Effect of trichloroethylene on enzymatic and non enzymatic antioxidant parameters 
in different tissue homogenates. 
Tissues 
Cortex 
Control 
TCE , 
.*' 
Medulla 
Control 
TCE 
intestine 
Control 
TCE 
Liver 
Control 
TCE 
Brain 
Control 
TCE 
LPO 
(nmolcs/gm tissue) 
98.83 ± 5.53 
132.29 ±5.32* 
(+34%) 
54.22 ±3,07 
101,04 ±3.46' 
(+86%) 
39.51 ±1.06 
49.02 ± 3^0 ' 
(+24%)' 
180.9 ±7,11 
289.26 ±0,27* 
(+60%) 
207.53 ±10.57 
283.48 ± 4.40' 
(+37%) 
SOD 
(Units/mg prot) 
37.86 + 5.16 
19.24 ±3.42" 
(-49%) 
54.55 ±2.25 ' ' 
9.14 ±1,00' 
(-83%) 
31.48 ±3.63 
8.06 ±0.168" 
(-74%) 
90.40 ± 20.3 
78.08 ±0.36 
(-14%) 
51.86 ±3.05 
25,11 ±1,70' 
(-52%) 
CAT 
(Hmoles/mg prot/min) 
224,68 + 12.47 
108,88 ±13,78' 
(-52%) 
133,70 ±1,45 
93,55 ± 2.37* 
(-30%) 
11,15 ±0,48 
6,76 ± 0,06* 
(-39%) 
31,36 ±0.09 
9.89 + 0.52" 
(-68%) 
95,10 ±2,49 
56,07 + 1,70* 
(-41%) 
Results are mean + SEM of eight different preparations. 
Values in parenthesis represent percentage change from control. 
Significantly different at P< 0,05 from controls. 
tion significantly increased serum creatinine, BUN, serum choles-
terol and alkaline phosphatase activity indicating TCE-induced 
nephrotoxicity and hepatotoxicity in confirmation of earlier 
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morphological and biochemical studies (Nomiyama et al., 1986; 
Chakrabarti and Tuchweber, 1988; Ush et al., 2000b; Kumar 
et al.. 2001; Mensing et al., 2002; Lock and Reed, 2006). TCE also 
significantly lowered serum glucose, inorganic phosphate and 
phospholipids. 
In order to assess the structural and functional integrity of var-
ious organelles, the effect of TCE was examined on the enzymes of 
carbohydrate metabolism, brush border membrane, lysosomes and 
oxidative stress. TCE caused specific alterations in certain enzymes 
involved in glycolysis, TCA cycle, gluconeogenesis and HMP-shunt 
pathway. The activity of LDH markedly enhanced whereas the 
activities of MDH, G6Pase and FBPase decreased in the liver, intes-
tine and brain. However, these enzymes were differentially af-
fected in renal cortex and medulla. Although the actual rates of 
glycolysis and TCA cycle were not determined, marked increase 
in LDH and decrease in MDH activity indicate a shift in energy pro-
duction from aerobic metabolism alternatively to anaerobic glycol-
ysis most likely due to mitochondrial damage caused by TCE (Lash 
et al.. 1995, 2001). The decrease in G6Pase and FBPase activities 
may be the result of decrease in MDH activity. Thus reduced pro-
duction of oxaloacetate from malate seems to affect both TCA cycle 
and gluconeogenesis (Banday et al., 2008a.b). The decrease in 
blood glucose and body weight can be attributed to higher con-
sumption of glucose by TCE-induced anaerobic glycolysis (Khan 
et al.. 2009). 
The activity of G6PDH (HMP-shunt) and NADP-malic enzyme 
(ME), were also differentially altered by TCE exposure. The activity 
of G6PDH profoundly inaeased whereas ME activity significantly 
decreased in all tissues except medulla where opposite pattern 
was observed. The increased production of NADPH by either en-
zyme may have increased cholesterol biosynthesis and might be 
responsible for higher blood cholesterol levels. These results also 
support earlier findings that indicated requirement for an 
NADPH-generating system for TCE elicited liver toxicity (Allemand 
etal., 1978). 
Histopathological examinations have shown that TCE caused 
severe damage to kidney and liver (Chakrabarti and Tuchweber, 
1988; Kumar et al., 2001; Lash et al., 2006; Lock and Reed, 
2006). The proximal tubule in the kidney was shown to be prime 
TCE target (Chakrabarti and Tuchweber. 1988; Wolfgang et al., 
1990; Bruning and Bolt, 2000; Lash et al., 2000b), Since brush 
border membrane (BBM) and lysosomes are known TCE targets, 
the structural and functional integrity was assessed by the status 
of their respective marker enzymes. The activities of BBM en-
zymes; ALP and GGT (except LAP and sucrase in the intestine) 
were significantly but variably decreased in tissue homogenates 
and in isolated renal and mucosal BBM preparations. The de-
crease in BBM enzyme activities might have occurred due to 
their release from damaged BBM. Excessive excretions of these 
enzymes and other macromolecules were reported in TCE trea-
ted rats and rabbits as characteristic sign of nephrotoxicity 
(Chakrabarti and Tuchweber, 1988; Wolfgang et al., 1990; Mens-
ing et al., 2002). The activity of lysosomal enzyme, acid phospha-
tase (ACP) was increased in the liver and intestine but decreased 
in the brain. The data convincingly demonstrate that the plasma 
membranes (especially BBM) and lysosomes were selectively af-
fected by TCE exposure although to different extents in different 
tissues. The effect of TCE on renal BBM enzymes was accompa-
nied by marked increase in P, transport across the renal BBM. 
The phosphate required for the producrion of glycolyric metabo-
lites and ATP mfact is conserved by the kidney. TCE induced P, 
conservation by the kidney appeared to improve energy metab-
olism in kidney as well as in other rissues. However, over utili-
zation of Pi may have resulted in lower serum Pi (Khan et al., 
2009). 
Cojocel et al. (1989) have suggested oxidative stress as a pos-
sible mechanism in TCE-induced nephrotoxicity. Primary bio-
chemical components of the oxidative stress response include 
elevation of lipid peroxidation (LPO), and suppression of GSK 
and its redox cycle enzymes e.g. superoxide dismutase (SOD), 
GSH-Peroxidase (GSH-Px) and/or catalase. TCE has been shown 
to cause oxidative damage to both liver and kidney as indicated 
by increased LPO (Channel et al., 1998; Torasson et al., 1999). 
TCE induced oxidative stress in the liver has been linked to hepa-
tic peroxisome proliferation (Nakajima et al., 2000; Laughter 
et al., 2004). Increase in LPO and decrease in SOD and GSH were 
also reported in dog plasma (Asian et al., 2000). The present re-
sults demonstrate that TCE caused perturbation in antioxidant de-
fense system as manifested by marked increase in LPO, and 
decrease in SOD and catalase activities. The effect of TCE seems 
to be tissue specific as the activity of SOD profoundly decreased 
in all the tissues except liver whereas catalase activity was pref-
erentially decreased in the liver. The differential effects of TCE ob-
served in different tissues on oxidative stress, biochemical and 
metabolic parameters appeared to be due to its variable accumu-
lations and mode of bioactivation which occurs by GSH-conjuga-
tion and/or cytochrome-P450 oxidation and respectively are 
responsible e.g. renal or liver toxicity (Lash et al., 2001, 2006; 
Lock and Reed, 2006). 
In summary, the present results demonstrate that TCE adminis-
tration caused specific alterations in the activities of certain en-
zymes of carbohydrate metabolism, BBM and oxidative stress 
although differentially in different rat tissues. The plasma mem-
brane, mitochondria and lysosomes appear to be specific TCE tar-
gets as evident by the changes in their specific biomarkers. TCE 
seems to enhance LDH activity and Pi transport in order to increase 
energy dependence on glycolysis due to mitochondrial damage. 
TCE caused reduction in the activities of antioxidant enzymes that 
led to increase in LPO. We conclude that TCE exerts its nephrotoxic 
and other deleterious effects by increasing free radical generation, 
damaging various cellular membranes that ukimately affects en-
ergy metabolism. 
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